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Abstract 
 
Campylobacteriosis is common in both developing and developed countries.  Although there 
had been numerous studies performed to gain a better understanding of the disease, much still 
remains to be unravel.  In this project, the interactions between the bacteria and host cells or 
organisms were interrogated.  Raman based imaging was initially investigated using an 
established Salmonella Typhimurium and cell infection model.  The results obtained showed 
the potential for real-time imaging.  However, due to the instability of the laser system of the 
microscope, reproducible results could not be obtained.  Therefore, this technique was not 
applied to Campylobacter jejuni.  Zebrafish embryo was established as a new infection model 
suitable for C. jejuni studies.  C. jejuni strains and mutants were screened using this model to 
determine their virulence.  This model was used to screen two type six secretion system 
mutants constructed in this study.  The results obtained showed that one of the mutants, 
Cj1∆tssM(syn)::kanR_cas, was attenuated in the ZFE model.  Subsequent competitive index 
challenges performed in piglets with C. jejuni wild-type and the two T6SS mutants, also 
showed that Cj1∆tssM(syn)::kanR_cas was attenuated.  Both T6SS mutants had shown 
increased adherence to macrophages and Cj1∆tssM(syn)::kanR_cas also showed increased 
cell invasion.  Together, these findings suggested that the T6SS is involved in establishment 
of infection in ZFE and piglet and as well as in adhesion and invasion of macrophages.      
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Chapter 1: Introduction to Campylobacter and Imaging of 
infection 
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1.1 Campylobacter jejuni 
 
Campylobacter jejuni is the principal bacterial cause of diarrhoeal disease in the developed 
world (Allos, 2001). In the course of infection, acute and self-limiting gastrointestinal illness 
develops and is characterized by diarrhoea, fever, and abdominal cramps (Allos, 2001).  
Clinical infection with C. jejuni and more rarely C. coli is called Campylobacteriosis and 
usually occurs after an incubation period of between two to five days following the ingestion 
of contaminated food or drink (Butzler and Oosterom, 1991; Dasti et al., 2010; Young et al., 
2007; Zilbauer et al., 2008).  An infection dose of as low as 500 organisms has been reported 
to cause infection in humans (Janssen et al., 2008; Young et al., 2007).  Rarely, post-infection 
complications such as reactive arthritis, urticaria, erythema nodosum and Guillain-Barré 
syndrome (GBS) will occur once the primary C. jejuni infection has resolved (Hannu et al., 
2002; Moore et al., 2005).  The occurrence of GBS ranges from 0.6 to 4 cases per 100,000 
(Vucic et al., 2009) and among these, C. jejuni infection preceding the development of GBS 
was reported to be approximately 30% (Allos, 2001; Hughes et al., 1999; Sivadon-Tardy et 
al., 2010).  GBS is a type of autoimmune disease, where the immune system attacks the 
gangliosides on the peripheral nervous system (Israeli et al., 2010).  The association between 
C. jejuni infection and GBS has made Campylobacteriosis a major public health issue (Moore 
et al., 2005). 
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1.1.1 Microbiology of C. jejuni 
 
Campylobacter belongs to the epsilon class of proteobacteria (Young et al., 2007) which are 
spirally-curved, microaerophillic, Gram-negative bacteria (Peterson, 1994).  As it shares 
similar morphology with Vibrio (spiral appearance) the organism was initially classified 
under the Vibrio genus by Theobald Smith in 1918 (Moore et al., 2005; Moore and Matsuda, 
2002; Skirrow, 2006).  However, in 1963, a new genus name Campylobacter was proposed, 
from the Greek "Campylo-", meanining "curved" and "bacter", meaning "rod" (Moore and 
Matsuda, 2002).   
 
Campylobacter differs from Vibrio in that it utilises different carbon sources and its G+C 
content is also distinct (Moore et al., 2005; Moore and Matsuda, 2002).  The G+C content of 
C. fetus ranges from 33-35% while V. cholerae ranges from 44-50% (Moore et al., 2005; 
Moore and Matsuda, 2002).  C. fetus is not able to oxidise or ferment carbohydrates while V. 
cholerae can ferment glucose (Moore et al., 2005; Moore and Matsuda, 2002).  
Campylobacter is a motile organism with unipolar or dipolar flagellae (Allos, 2001).  It is a 
slow growing organism and optimal growing temperature is 42°C under microaerophilic 
conditions of 5% (v/v) oxygen, 10% (v/v) carbon dioxide and 85% (v/v) nitrogen (Allos, 
2001; Moore et al., 2005).  Most Campylobacter are resistant to the antibiotics cephalothin, 
vancomycin, polymyxin and trimethoprim (Allos, 2001; Moore et al., 2005), and these are 
commonly used in selection media.   
 
In the early days, C. jejuni were recovered from faecal specimens after membrane filtration 
(mean pore size of the filter was 0.65 µm) (Skirrow, 1977).  C. jejuni being smaller in size 
was able to pass through the filter and was then plated onto non-selective media for culturing 
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(Skirrow, 1977).  However, in this method, any bacterium that is similar or smaller in size 
would be able to pass through the filter as well.  In 1977, owing to the naturally occurring 
antibiotic resistance properties of Campylobacter, Skirrow formulated a selective medium 
that contains vancomycin, polymyxin B and trimethoprim for culturing of C. jejuni and C. 
coli from faecal specimens (Skirrow, 1977), and the filtration procedure was abandoned.  
However, it has been reported that although Skirrow’s medium was successful in isolation of 
Campylobacter from human faeces, when it was tested on other types of specimens from 
other sources (e.g. animals and avian), microorganisms other than Campylobacter were 
cultured (Bolton and Robertson, 1982), this led to development of a more refined selective 
medium, Preston medium, by Bolton and Robertson (Bolton and Robertson, 1982).  In the 
Preston medium, vancomycin was replaced by rifampicin and actidione and results have 
shown that beside being more selective, it was also more sensitive as Campylobacter was 
isolated from more specimens as compared to Skirrow’s medium (Bolton and Robertson, 
1982).  It has also been reported that most C. jejuni are able to hydrolyze hippurate, hence it 
is a commonly used biochemical assay used to differentiate C. jejuni from other bacteria 
(Harvey, 1980; Hébert et al., 1982).   
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1.1.2 Epidemiology and public health 
 
The World Health Organisation (WHO) has reported that diarrhoea is a major problem 
around the world.  Diarrhoea, a symptom of gastrointestinal infection, may last for a few days, 
or up to several weeks and severe diarrhoea may lead to death due to excessive water loss.  
Diarrhoea cases arising from gastrointestinal infections have been reported to cause 2.2 
million deaths annually; the majority are children - especially those in developing countries 
where poor sanitation and hygiene are serious problems (Ali et al., 2003). 
 
A vast number of pathogens, ranging from viruses to bacteria to parasites, for example 
protozoan and helminths, can cause diarrhoea.  Among these pathogens (Ashbolt, 2004) the 
prevalence of C. jejuni induced diarrhoeal illness in both developed and developing countries; 
are often higher than Salmonella and Shigella induced cases (Ali et al., 2003; Allos, 2001; 
Blaser, 1997; Coker et al., 2002). 
 
The prevalence of Campylobacteriosis in the United States has been estimated to be between 
2.1 to 2.4 million cases in human annually (Altekruse et al., 1999).  In the European Union, 
the reported incidence of Campylobacteriosis was higher than the reported incidence of 
Salmonellosis.  In Germany, there are more than 60,000 reported cases annually (Allos, 2001; 
Dasti et al., 2010).  In the United Kingdom, more than 64,000 cases of Campylobacteriosis 
were reported in Scotland, England and Wales in 2009.  However, it was believed that the 
reported figure should be approximately 450,000 due to under-reporting (Strachan and Forbes, 
2010).  The reported figure represents a yearly rise of 30% in Scotland and 14% in England 
and Wales (Strachan and Forbes, 2010).  Campylobacter is associated with approximately 5% 
of food-related deaths and responsible for about 17% of food-borne infections that require 
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hospitalisation (Dasti et al., 2010).  This indicates that Campylobacteriosis is a significant 
public health burden.   
 
In developed countries, the symptomatic disease Campylobacteriosis occurs in children and 
adults, with 2 age-peaks; first at less than a year old and a second peak at 15 to 44 years old.  
It had also been noted that occurrence of this disease is higher in males (Allos, 2001; Bessell 
et al., 2010): in developing countries, it predominantly affects young children of less than 2 
years old (Ali et al., 2003; Allos, 2001; Blaser, 1997; Coker et al., 2002; Taylor et al., 1988).   
 
C. jejuni, the most prevalent Campylobacter species causing human infection, can be found 
in several environmental reservoirs such as poultry and in surface water - in association with 
protozoans (Young et al., 2007).  C. jejuni can be found in wild and domesticated animals for 
example poultry, and cattle, as normal intestinal flora.  It may also be carried by household 
pets such as cats and dogs.  Host animals can shed C. jejuni in faeces which may contaminate 
soil and surface water (Blaser, 1997).  Transmission of C. jejuni to human could be through 
consumption of contaminated food and drink, for example undercooked chicken, raw milk, 
untreated water and barbequed foods, and through contact with infected or carrier animals 
(Altekruse et al., 1999).     
 
In England and Wales, there is an annual peak in Campylobacter infection between May and 
June and an evaluation study was conducted on several factors as possible seasonal drivers: 
one indicated that transmission by flies could be a driving factor behind the seasonal trends 
(Nichols, 2005).  This hypothesis was supported by studies that had shown that diarrhoea 
cases were reduced when flies population was controlled (Nichols, 2005).  It has been 
suggested that due to the natural behaviour of flies, which patronise animal and human 
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excreta as well as food and drink for human consumption, these insects could be a vector for 
dissemination of the bacteria (Rosef and Kapperud, 1983).  It has been proposed that flies 
could transmit the bacteria in one of four ways: i) carriage of bacteria on the hairs and 
surfaces of the fly's body; ii) bacteria sticking to the glandular hairs of the feet; iii) 
regurgitation of vomitus that contains bacteria; and iv) passage of bacteria through the 
alimentary tract which are then defecated out (Rosef and Kapperud, 1983).  A study 
conducted by Rosef and Kapperud, showed that C. jejuni was isolated from 43.2% and 50.7% 
of the flies captured in pig and chicken farms respectively (Rosef and Kapperud, 1983).   
 
Generally, the bacteria generally does not survive well outside the gut.  It is sensitive to 
freezing, acidic conditions, disinfectant, oxygen and desiccation at high temperatures 
(Altekruse et al., 1999; Axelsson-Olsson et al., 2005).  However, C. jejuni are often isolated 
from environmental water, such as wells and rivers, indicating that the bacteria has the 
capability of surviving in the environment.  A study has shown that C. jejuni is able to 
survive within the vacuoles of Acanthamoeba polyphaga after internalisation (Axelsson-
Olsson et al., 2005).  A similar study has also demonstrated that some bacteria had entered a 
viable but non-culturable (VBNC) stage and were able to revert back to full culturability after 
passage through amoeba (Axelsson-Olsson et al., 2005).  With the abundance of amoeba 
present in the environment, these findings suggest that the bacteria could take refuge in 
amoeba which act as a shield from harsh environmental conditions.  Currently, isolation of C. 
jejuni from amoeba from the environment and the ability of the bacteria to infect a host after 
passage through amoeba have not been well reported.   
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1.1.3 Detection of C. jejuni 
 
There are several approaches towards the detection of Campylobacter.  Conventionally, 
detection of C. jejuni relied on culturing methods.  The major disadvantages of culturing 
methodologies are: i) slow to obtain outcomes (in days) as Campylobacters are slow growing 
bacteria and phenotypic tests need to be performed for confirmation (Moore et al., 2005), ii) 
selection against less common species (e.g. C. lari and C. upsalienesis) (Moore et al., 2005), 
iii) inability to detect VBNC Campylobacter.  In view of the various drawbacks of culturing 
methods for detection and diagnosis of Campylobacter, other more rapid approaches such as 
immunological-based detection, for example latex agglutination test and enzyme-linked 
immunosorbent assays (ELISA) and molecular-based assays, for example polymerase chain 
reaction (PCR) have been developed (Moore et al., 2005).   
 
PCR is a very powerful method that can deliver fast and sensitive results.  It is able to detect 
the presence of pathogens including those that have entered the VBNC stage unlike the 
culturing method.  However, PCR assays: i) are usually quite expensive to perform; ii) their 
potential sensitivity could be limited by sample preparation steps prior to the assay (such as 
deoxyribonucleic acid, DNA, extraction step); iii) their performance could be hampered by 
factors present in the sample that inhibits the reaction from taking place; iv) they can not 
differentiate between live-dead cells (Moore et al., 2005).  With regards to live-dead cell 
differentiation, enhancement of PCR to test for messenger ribonucleic acid (mRNA) could 
help to differentiate between live-dead cells (Moore et al., 2005). 
 
In clinical laboratories, detection of leukocytes in faecal specimens of patients suspected of 
bacterial enteritis under bright-field microscopy is often a recommended test procedure.  
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However, the presence of leukocytes in faeces could be caused by a number of 
gastrointestinal pathogens such as Salmonella and Campylobacter (Paisley et al., 1982).  
Hence, Paisley et al explored on the possibility of using dark-field microscopy for the 
visualisation of Campylobacter motility (CM) as a rapid, simple, sensitive and specific 
methodology for diagnosis in faecal specimens (Paisley et al., 1982).  However, their findings 
showed that the longer the time taken between CM observation and specimen collection 
could result in false negative outcomes, and the presence of other bacteria with similar 
motility, for example Vibrio spp. and Pseudomonas spp., could lead to false positive results 
(Paisley et al., 1982).   
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1.1.4 Campylobacter jejuni genomic information 
 
The complete genome and plasmids sequencing of C. jejuni has shed some light into the 
factors which could participate in the bacterial pathogenesis.  The bacteria has a small  
genome size of 1.6-2.0 megabases; and there are very few repetitive DNA sequences. (Dasti 
et al., 2010; Parkhill et al., 2000; Young et al., 2007).  In general, the Campylobacter genome 
has only 25-33% of genes compared to Escherichia coli, and would likely consist of essential 
genes and a few auxiliary genes (Friis et al., 2010).  In C. jejuni strain NCTC11168, the 
chromosome was predicted to encode 1,654 proteins and 54 stable RNAs (Parkhill et al., 
2000).  Around 61% of the genes are transcribed from the plus strand (Parkhill et al., 2000).  
There are two regions within the genome with low G+C content, and these two regions fall 
within the lipooligosaccharide (LOS) and extracellular polysaccharide biosynthesis cluster 
(Parkhill et al., 2000).   It has only four repeated sequences, one of which was a ribosomal 
RNA operon (Parkhill et al., 2000).  No functional inserted sequence element, transposons, 
retrons or prophages were found in the C. jejuni NCTC11168 genome, with the exception of 
Cj0752, which is similar to Helicobacter pylori IS605 tnpB (Parkhill et al., 2000).  It was also 
observed that there are only a few gene operons or clusters (Parkhill et al., 2000).  The 
presence of hypervariable sequences that consists of homopolymeric tracts was also observed 
(Parkhill et al., 2000; Young et al., 2007).  Since the initial annotation of C. jejuni 
NCTC11168 genome in 2000, numerous literatures follows providing large amount of 
information.  The genome of NCTC11168 was then re-analysed and re-annotated in 2007 
(Gundogdu et al., 2007).  The re-annontation reduces the total number of CDS from 1654 to 
1643; made modification to the  LOS, O-linked glycosylation and capsule loci; and added a 
N-linked glycosylation pathway that was not previously described (Gundogdu et al., 2007).    
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A plasmid, pVir, present in some but not all C. jejuni strains was previously reported to 
contain four open reading frames (ORF) and sequence information showed that it shared 
significant similarity to H. pylori proteins (Bacon et al., 2000).  The sequence information 
indicated that the proteins encoded by three of the ORFs (comB1, comB2 and comB3) are 
similar to H. pylori proteins involved in natural transformation and DNA uptake competency 
(Bacon et al., 2000).  These proteins also shared some homology with components of a Type 
IV secretion system utilised by other pathogens, such as Legionella pneumophilia and 
Rickettsia prowazekii, for transportation of proteins during intracellular survival (Bacon et al., 
2000).  The protein encoded by the fourth ORF (virB11) has the highest sequence identity 
with a H. pylori protein which is proposed to be part of a Type IV secretion system involved 
in virulence (Bacon et al., 2000).  It was reported that comB3 and virB11 mutants had shown 
reduction in adhesion and internalisation of C. jejuni as compared to wild-type when 
infecting INT-407 cells (human embryonic intestine cells, with epithelial-like morphology) 
and resulting in less severe symptoms in the ferret model (Bacon et al., 2000).  These plasmid 
encoded factors might play a part in C. jejuni pathogenesis; however, as only about 10% of 
clinical isolates harbour this plasmid, virulence must involve other mechanisms (Bacon et al., 
2000; Bacon et al., 2002). 
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1.1.5 Pathogenesis of C. jejuni 
 
Several factors encoded in the genome of C. jejuni have been identified that could participate 
in host cell invasion and pathogenesis (Dasti et al., 2010).  Yet, unlike other diarrhoea 
causing pathogens, C. jejuni does not appear to express a large number of classical virulence 
factors (Dasti et al., 2010).   
 
After gaining entry into the body system via the gastrointestinal (GI) tract, the bacteria must 
survive the acidic stomach environment (Butzler and Oosterom, 1991; Janssen et al., 2008) to 
reach and colonise the lower intestinal tract (Dasti et al., 2010).  Inside the GI tract the first 
line of defence is formed by the mucus layer, in order to establish itself the bacteria harbours 
traits such as motility and a cork-screw shape to facilitate its penetration through the mucus 
layer and allow interaction with the epithelial cells (Young et al., 2007).  The bacteria can 
then invade the epithelial cells via microtubule polymerisation and some strains require 
microfilament polymerisation as well (Young et al., 2007).  The process of epithelial cells 
extending out pseudopods and enveloping the bacteria has been reported (Biswas et al., 2000).  
After internalisation the bacteria is contained within the vacuole, however its fate and 
activities involved in pathogenesis is still unknown (Young et al., 2007). 
 
Two mechanisms used by Campylobacter during the course of infection have been proposed: 
the first mechanism suggested that adhesion of the bacteria to the intestine takes place 
followed by production of toxin that alters the intestine fluid absorption capability, which will 
then lead to secretory diarrhoea (Butzler and Oosterom, 1991; Janssen et al., 2008).  The 
other mechanism proposed involved invasion and proliferation of the bacteria within the 
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intestinal mucosa, which would lead to inflammatory responses and eventually bloody 
diarrhoea (Janssen et al., 2008). 
 
1.1.5.1 Adhesion and invasion 
 
In order to establish colonisation, factors involved in adhesion and binding are important 
(Dasti et al., 2010; Young et al., 2007).  Several factors have been identified with adhesion or 
binding capability; fibronectin-binding outer membrane protein (CadF); autotransporter 
(CapA); periplasmic binding protein (Peb1) and surface exposed lipoprotein (JlpA).  
Mutagenesis has confirmed cadF as an important factor participating in pathogenicity (Dasti 
et al., 2010; Young et al., 2007).  Besides binding to fibronectin that is present on the 
epithelial cells, CadF also activates host small GTPases Rac1 and Cdc42 leading to its 
internalisation by the host cell (Dasti et al., 2010). 
 
Intracellular C. jejuni were observed from various tissue culture models - such as INT407 and 
Caco-2 cells (Dasti et al., 2010; Grant et al., 1993; Rivera-Amill et al., 2001; Wassenaar et al., 
1991) - demonstrates the ability of the bacteria to invade cells.  This is further strengthened 
with findings from experiments performed on the non-human primate Macaca mulatta which 
demonstrated that diarrhoeal disease is related to the bacteria’s invasion ability (Dasti et al., 
2010).  However, different C. jejuni strains have varying ability to invade host cells (Newell 
et al., 1985).  Several factors have been identified to play a part in this process, such as 
flagellum, LOS, Campylobacter-invasive antigens (Cia) and capsular polysaccharide. 
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1.1.5.2 Intracellular survival 
 
The ability to survive inside host cells after internalisation might be crucial in the 
establishment of disease. It has been reported that C. jejuni is able to survive inside 
phagocytic cells (murine peritoneal macrophages and human peripheral blood monocytes) for 
at least 6 days (Hickey et al., 2005; Kiehlbauch et al., 1985), whereas in the absence of 
phagocytic cells the bacterium lost viability after 2 days (Kiehlbauch et al., 1985).  These 
findings suggested that phagocytosis promotes C. jejuni survival (Kiehlbauch et al., 1985).  A 
separate study conducted by Day et al had demonstrated that a heme-containing catalase 
expressed in C. jejuni, conferring hydrogen peroxide resistance, contributed to the 
intracellular survivability of the bacteria within macrophages (Day et al., 2000).  It has also 
been observed that the spiral bacteria changed morphology to a coccal form 4 to 8 hours after 
being internalised into vacuoles, and by 72 to 96 hours all internalised bacteria appeared in 
coccal form (Kiehlbauch et al., 1985).  Although, this transformation process was not unique 
to internalised C. jejuni - it was observed that in the absence of phagocytic cells, the process 
started after 24 hours and was complete by 48 hours (Kiehlbauch et al., 1985).  The 
intracellular coccal bacteria were recovered from phagocytic cells and were shown to be 
viable through culturing (Kiehlbauch et al., 1985).     
 
Besides macrophages, C. jejuni has also been reported to be internalised by epithelial cells 
(Hep-2 cells) (De Melo et al., 1989).  Like C. jejuni internalised by phagocytic cells, the 
morphology of the bacteria changed from a spiral to a coccal form inside epithelial cells (De 
Melo et al., 1989).  However, unlike in phagocytic cells, the bacteria did not survive well.  It 
had been observed that after 6 hours of incubation, the colony forming unit (CFU) count of 
internalised C. jejuni did not increase and after 12 hours, it dropped (De Melo et al., 1989).  
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The decreased CFU count coincided with the period when phagosome-lysosome fusion took 
place (De Melo et al., 1989): similar trends were observed by Day et al (2000) and Watson 
and Galán (2008).  Day et al reported that the internalised bacteria underwent an initial death 
phase between 6 to 48 hours post-infection (hpi) (approximately 90% death), however, the 
survivors were able to multiply intracellularly by 72 hpi: although the total CFU count 
remained low (Day et al., 2000).  Day et al had also demonstrated that, unlike in 
macrophages, the expression of catalase does not contribute to the survival of C. jejuni in 
epithelial cells (Day et al., 2000).   
 
Watson and Galán observed that the total intracellular bacteria count dropped by 
approximately 500 fold from 4 to 24 hpi (Watson and Galan, 2008).  However, further studies 
conducted by the team showed that the viability assessment through culturing was not a 
representation of true viable count as C. jejuni had entered the VBNC state (Watson and 
Galan, 2008).  The bacterial cells in this state could not be enumerated by the standard culture 
approach.  A live-dead staining method was used to determined the total number of viable 
intracellular C. jejuni, and results obtained showed that the viable number remained relatively 
constant between 4 to 24 hpi (Watson and Galan, 2008).  Watson and Galán had also shown 
that when monkey kidney epithelial cell line (Cos-1) was infected with C. jejuni, the bacteria 
containing vacuoles did not fuse with lysosomes (Watson and Galan, 2008).  Hence, their 
findings suggested that C. jejuni was able to survive within intestinal epithelial cells and 
avoid lysosome fusion (Watson and Galan, 2008).  This finding contradicts previously 
reported work on the fate of C. jejuni after internalisation by epithelial cells (Day et al., 2000; 
De Melo et al., 1989). 
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In the same study, Watson and Galán also showed that the bacteria was not able to survive 
within bone marrow-derived macrophages as bacteria could not be recovered at 24 hpi and 
vacuoles containing C. jejuni were delivered to lysosomes (Watson and Galan, 2008).  This 
finding again contradicts previously reported work on C. jejuni which had demonstrated that 
the bacteria could survive for at least 6 days within macrophages (Hickey et al., 2005; 
Kiehlbauch et al., 1985).  The epithelial cells and macrophages used in Watson and Galán 
studies were from different sources to those previously reported, hence, it could suggest that 
C. jejuni interacts differently with host cells from different lineages. 
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1.1.6 Factors involved in virulence of C. jejuni  
 
1.1.6.1 Flagellum 
 
C. jejuni harbours a single unsheathed flagellum at either one or both poles (Zilbauer et al., 
2008).  The flagellum enables motility.  Motility plays a vital role during the colonisation 
process.  It allows the bacteria to overcome peristalsis and penetrate the mucous layer 
(Zilbauer et al., 2008).  It has also been reported to participate in host cell invasion (Young et 
al., 2007).  The flagellum is made up of O-linked glycosylated flagellin (Dasti et al., 2010).  
Defects in O-linked glycosylation lead to a loss of motility (Dasti et al., 2010).  The role of  
flagella in invasion was originally uncertain (Novik et al., 2010), hence, flaA amd motA 
mutants were constructed with the former being non-motile due to a lack of flagellin, and the 
latter, although non-motile, possessing complete flagellar structures.  The results obtained 
demonstrated that motility is required for bacteria internalisation, but this process was not 
directly mediated by flagellin or proteins secreted via the flagellar apparatus, for example 
ciaB (Novik et al., 2010). 
 
1.1.6.2 LOS and capsule 
 
LOS and capsule are factors expressed in C. jejuni that might play a role in pathogenesis.  
Some structures of LOS in C. jejuni mimic human neuronal gangliosides and it was thought 
that this mimicry could be one of the factors leading to post-infection autoimmune disorders; 
such as GBS (Dasti et al., 2010; Young et al., 2007).  The relatively short O-sidechain of the 
LOS has also been proposed to assist in penetration of the mucus layer inside the GI tract by 
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reducing the non-specific binding of the bacteria to the mucin glycoprotein (Young et al., 
2007).   
 
The potential for C. jejuni to synthesise capsule polysaccharide was only revealed after 
genome sequence information was obtained where kps genes, which could take part in 
synthesis of capsule, were identified (Karlyshev et al., 2000).  The capsule on C. jejuni may 
enable serum resistance, epithelial cell adhesion, and invasion and colonisation in chicks or 
virulence in ferrets (Young et al., 2007; Zilbauer et al., 2008).  It has been reported that 
capsule-deficient mutants show a reduction in invasion in in-vitro and ferret models, but 
show no differences from wild-type strain when colonising chicken gut (Zilbauer et al., 2008).  
This suggests that the participation of the capsule in interaction with host could be host-
dependent.  Besides involvement in interaction with host cells, the capsule could potentially 
provide protection to the bacteria against desiccation or infection by bacteriophages (Young 
et al., 2007).   
 
1.1.6.3 Toxins 
 
The presence of transient watery diarrhoea leading to bloody diarrhoea suggests that bacterial 
toxins might play a role in this process (Dasti et al., 2010).  In C. jejuni, cytolethal distending 
toxin (CDT) is the only verified toxin to date (Dasti et al., 2010).  It was first identified in C. 
jejuni in 1987 (Johnson and Lior, 1988a).  It is also produced by other Campylobacter such as 
C. lari, C. coli, C. fetus and C. upsaliensis (Dasti et al., 2010) and several other Gram-
negative bacteria such as Escherichia coli, Salmonella, Haemophilus ducreyi, Helicobacter 
spp. and Actinobacillus actinomycetemcomitans (Cope et al., 1997; Haghjoo and Galan, 2004; 
Johnson and Lior, 1988b; Sugai et al., 1998; Young et al., 2000).  CDT acts by arresting host 
19 
 
cells at G1/S or G2/M transition in the cell cycle, which prevents the cells entering mitosis and 
eventually leads to cell death (Young et al., 2007; Zilbauer et al., 2008).  CDT is a holotoxin 
that is made up of 3 sub-units; CdtA, CdtB and CdtC (Dasti et al., 2010; Young et al., 2007; 
Zilbauer et al., 2008).  CdtB is the active component of the CdtABC complex, showing 
DNaseI-like activity and may cause DNA damage after gaining entry to the cell nucleus 
(Dasti et al., 2010; Young et al., 2007), whereas CdtA and CdtC aid in the delivery of CdtB 
to the nucleus (Dasti et al., 2010).  These two protein subunits possess lectin-like regions that 
are similar to the receptor-binding component of ricin - which is responsible for endocytosis 
(Dasti et al., 2010; Young et al., 2007).  All three subunits are membrane-bound proteins, 
hence, CdtA and CdtC remain at the host cell membrane after delivery of CdtB subunit into 
the cytoplasm (Dasti et al., 2010; Zilbauer et al., 2008).  Inside the cytoplasm, CdtB is 
transported via the Golgi apparatus to the endoplasmic reticulum and eventually gains access 
to the host cell nucleus; its path is aided by the nuclear localisation signal that it harbours 
(Dasti et al., 2010; Young et al., 2007).  Although much is known about the role played by 
each of the subunits, the actual role of CDT in C. jejuni pathogenesis has not been determined, 
however, it has been suggested that it might be important in invasiveness and modulation of 
immune response (Dasti et al., 2010). 
 
1.1.6.4 Protein  secretion systems  
 
The active movement of protein from the site of synthesis across membranes to the exterior 
of the bacterial cell is an important process termed "protein secretion" (Desvaux et al., 2009).  
It needs to be carried out in a regulated and efficient manner.  The secretion systems direct 
the delivery of the proteins just out of the bacterial cell into the exterior medium or into target 
cells (Coulthurst, 2013).  This process may take place in either a one-step or two-step manner 
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(Coulthurst, 2013).  Besides being a machinery for protein export, some secretion systems 
have also been shown to play a crucial role in virulence (Coulthurst, 2013).  The types of 
secretion systems and the number of each secretion system harboured by the bacteria varies 
(Coulthurst, 2013).   
 
Currently, there are eight such secretion systems - type one to eight - identified in Gram 
negative bacteria, Figure 1.1 (Desvaux et al., 2009).  The type six secretion system (T6SS) is 
the most recently identified system and it secretes protein in a single step manner (Coulthurst, 
2013).  The type seven secretion system was previously called the chaperone-usher pathway 
in Gram negative bacteria (Desvaux et al., 2009).  Similarly, the type eight secretion system 
was previously named the extracellular nucleation-precipitation pathway (Desvaux et al., 
2009). 
 
C. jejuni has been reported to harbour putative type two, three and four secretion systems.  A 
typical type two secretion system comprise of a minimal of 12 proteins, and in C, jejuni strain 
81-176, five out of the 12 proetins had been identified (Wiesner et al., 2003).  The genes 
identified in strain 81-176 were simillar to the type two secretion system genes involved in 
transporation of macromolecules such as pilus subunits, toxins and exoenzyme; and were 
suggested to promote natural transformation (Wiesner et al., 2003). 
 
The flagellum in C. jejuni is also being used  as a type three secretion system, involved in the 
secretion of Campylobacter invasion antigens (Cia) proteins into host celll cytosol (Neal-
McKinney and Konkel, 2012).  It has been reported that either one of the flagellar filament - 
FlaA or FlaB - is sufficient for secretion of Cia proteins via the flagellum (Konkel et al., 
2004).  Four Cia proteins - CiaB, CiaC, CiaD and CiaI - were secreted via the flagellum and 
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they played a role in secretion (CiaB), host cell invasion (CiaC), secretion of host chemokine 
(CiaD) and intracellular survival (CiaI) (Buelow et al., 2011; Christensen et al., 2009; Konkel 
et al., 1999; Neal-McKinney and Konkel, 2012; Samuelson et al., 2013).  
 
A gene cluster consisting of 7 genes found in pVir of C. jejuni strain 81-176 were orthologs 
of H. pylori type four secretion system (Bacon et al., 2002).  Type four secretion system had 
been described in various bacteria to be involved in DNA export, bacterial conjugation and 
protein secretion (Bacon et al., 2002). 
 
Beside the three putative secretion systems, a T6SS had also been recently identified in C, 
jejuni. 
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Figure 1. 1: Schematic representation of type I to VIII secretion systems in Gram negative bacteria.  The secreted 
proteins could end up in four possible locations; (i) anchored to the outer membrane (OM) via Omp85 
on cell surface; (ii) formed part of cell surface appendages;  (iii) released into extracellular matrix 
(Ext); or (iv) injected into target host cell.  The exported proteins could either be (a) released via 
cytoplasmic membrane (CM) protein into the periplasm; (b) anchored to either the cytoplasmic or 
outer membrane on the periplasmic side; or (c) translocated across the outer membrane.  Black 
arrows - movement of proteins with N-terminal signal peptide (SP) targeted to cytoplasmic membrane.  
Blue arrows - movement of proteins without the N-terminal signal peptide.  Red arrows - path of 
proteins towards secretion (indicated as blue proteins). Violet arrows - path of proteins towards 
integration as membrane protein (IMP).  Green arrows - path of proteins towards exportation but not 
secretion (indicated as green proteins).  Extracted from Desvaux et al, 2009.  
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1.1.6.4.1 Type six  secretion system (T6SS)  
 
The prototypic T6SS was identified in 2006 following the study of a vas genes cluster in 
Vibrio cholerae (Pukatzki et al., 2006).  It was shown to be involved in protein secretion and 
cytotoxicity towards macrophages and amoebae (Pukatzki et al., 2006).  Prior to the official 
classification of such a system as the T6SS, gene clusters having similar functions and 
components had already been reported.  The impaired nitrogen fixation (imp) locus in 
Rhizobium leguminosarum was reported to be involved in protein secretion and blocking of 
infection in pea plants (Bladergroen et al., 2003).  The Hcp protein, a component of the T6SS, 
was reported a decade earlier in V. cholerae (Williams et al., 1996).  Other components such 
as the icmGCDJBF locus in Legionella pneumophilia (Purcell and Shuman, 1998) and icmF 
in Salmonella enterica (Folkesson et al., 2002) were also reported before the official T6SS 
classification came about.  Initially, the T6SS was wrongly classified as a sub-type of T4SS 
due to the presence of two components - IcmF and DotU (Cascales, 2008; Filloux, 2013).  
The subsequent in silico screening of 506 bacterial genome sequences revealed that 176 
T6SS loci were found in 92 different bacteria species (Boyer et al., 2009).  Among the 176 
T6SS loci screened, 13 conserved orthologous groups (COG) were found to be present at a 
frequency of more than 70 percent, which was significantly higher than other COGs screened 
(Boyer et al., 2009).  A potentially functional T6SS would harbour the 13 COG proteins, 
termed "TssA to TssM", on a single locus, which make up the basic secretion apparatus 
(Coulthurst, 2013).  A hallmark indicator for a functional T6SS in bacteria would be the 
presence of TssD, also commonly known as Hcp, in culture media (Pukatzki et al., 2007).   
 
The T6SS is found mainly in Proteobacteria with the exception of the epsilon sub-group 
(Coulthurst, 2013).  Around a third of genomes harbouring the T6SS genes were found to 
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have more than one T6SS cluster (Boyer et al., 2009).  In Yersinia species 5 to 6 gene clusters 
of T6SS loci were identified.  In Burkholderia species, it ranges from 2 to 6 T6SS gene 
clusters.  In Pseudomonas species, 2 to 3 T6SS gene clusters have been found (Boyer et al., 
2009).   
 
In Campylobacter 4 components of T6SS (TssJ, TssK, TssC and TssD) were first detected in 
C. concisus cellular proteins by mass spectrometry (Kaakoush et al., 2011).  There were no 
further reports on this secretion system in Camplylobacter until Lertpiriyapong et al 
presented their work on a functional T6SS in Campylobacter jejuni in 2012 (Lertpiriyapong 
et al., 2012).  To date, there are only two reports on functional T6SS in Campylobacter jejuni.  
In both studies, only a single copy of the T6SS locus was reported for each strain (Bleumink-
Pluym et al., 2013; Lertpiriyapong et al., 2012).   
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Figure 1.2: Assembly of T6SS.  Left: T6SS secreting "true" effectors proteins into target cells.  Right: T6SS 
ultilising evolved VgrG to interact with target cell.  Extracted from Coulthurst, 2013.   
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The T6SS machinery (Figure 1.1) has been commonly described as an inverted bacteriophage 
tail-like structure that operates in the reverse direction (Filloux, 2013; Leiman et al., 2009; 
Pukatzki et al., 2009; Silverman et al., 2012).  Various components of T6SS, such as TssB, 
TssC, TssD, TssE and TssI, have been reported to have homology to bacteriophage proteins 
(Coulthurst, 2013; Filloux, 2013; Pukatzki et al., 2009; Silverman et al., 2012).  TssD 
(commonly known as Hcp) and TssI (commonly known as VgrG) share structural similarity 
to gp19 and gp27/gp5 of bacteriophage protein (Filloux, 2013; Silverman et al., 2012).  The 
gp19 protein is the basic unit of the phage tail tube (Filloux, 2013).  A three-dimensional 
structure of TssD from P. aeruginosa showed that the protein formed hexameric units with a 
central channel of 40 Å (Mougous et al., 2006).  These units were stacked to form a nanotube 
resembling the phage tail tube formed by gp19 (Leiman et al., 2009).  The TssI protein of V. 
cholerae had been reported to be a fusion of phage tail protein gp27 and gp 5 at the N- and C-
terminal respectively (Pukatzki et al., 2007).  The phage gp27/gp5 complex is a puncturing 
device that creates a hole in the target cell membrane (Filloux, 2013).  The gp27/gp5 complex 
sits at the end of the gp19 tail tube and the tail tube is sheathed by multiple copies of gp18 
proteins (Filloux, 2013).  Similarly in the T6SS machinery, TssI was proposed to cap the 
TssD tubule (Filloux, 2013; Silverman et al., 2012).  It has been reported that an extension to 
the TssI spike, involving in attachment of effectors, was formed by proteins belonging to the 
proline-alanine-alanine-arginine (PAAR) repeat super-family (Shneider et al., 2013).  
Structural analysis of the PAAR repeat proteins bound to TssI showed that the proteins 
sharpen the tip of the TssI spike and plays an essential role in secretion and killing of target 
cells in V. cholerae and Acinetobacter baylyi (Shneider et al., 2013).  The TssD tubule was 
sheathed by a complex made up of two proteins; TssB and TssC (Filloux, 2013; Silverman et 
al., 2012).  The TssB/TssC complex resembles the phage gp18 (Filloux, 2013): the phage 
gp18 protein complex is contractile.  When it contracts, it pushes the phage tail tube (gp19) 
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and the puncturing device (gp27/gp5) into the target cell (Filloux, 2013).  The TssB/TssC 
complex has been reported to exist in two conformations, extended and contracted 
(Silverman et al., 2012). It has been suggested that the contraction of the sheath - Tssb/TssC 
complex - provides the energy for translocation of proteins into target cells (Basler et al., 
2012).  With the structural similarity to phage tail structure, the assembly of TssD, TssI, TssB 
and TssC could potentially perform a similar structural function in the T6SS machinery.  In 
bacteriophage, a group of proteins, gp6/gp25/gp53 formed a wedge around the gp27/gp5 
puncturing device, and similarity between gp25 and TssE of T6SS has been demonstrated 
(Filloux, 2013).  
 
There are other components of the T6SS machinery (TssJ, TssL and TssM), that do not have 
any resemblance to bacteriophage proteins (Filloux, 2013).  TssM (commonly known as 
IcmF) is localised in the periplasm and is made up of two sub-domains (Silverman et al., 
2012).  It has been demonstrated to interact with TssJ - a lipoprotein anchored to the outer 
membrane (Kapitein and Mogk, 2013; Silverman et al., 2012).  TssM also interacts with TssL 
- an inner membrane protein (Kapitein and Mogk, 2013; Silverman et al., 2012).  TssJ has 
been reported to engaged in homomeric interactions and TssL has also been demonstrated to 
oligomerise (Silverman et al., 2012).  Together, the TssL-TssM-TssJ complex forms a ring-
like structure that spans the cell envelope to create a channel (Silverman et al., 2012).  This 
trans-membrane complex forms a part of the T6SS assembly and anchors it to the cell 
envelope (Coulthurst, 2013).  It has also been shown that TssM interacts with components of 
the bacteriophage tail-like structure TssB and TssD (Silverman et al., 2012).  This suggests 
that the bacteriophage tail-like structure (TssD, TssI, TssB and TssC) of the T6SS machinery 
is embedded within the channel form by the TssL-TssM-TssJ complex (Kapitein and Mogk, 
2013; Silverman et al., 2012).  The TssB/TssC tubular complex contracts to push the TssD 
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tubule out of the cell (Silverman et al., 2012).  The contracted TssB/TssC complex would 
need to disassemble and reassemble for the next round of contraction (Coulthurst, 2013; 
Silverman et al., 2012).  The disassembly process is energy consuming and involves the 
AAA+-family ATPase protein, TssH (commonly known as ClpV) (Kapitein and Mogk, 
2013).   
 
In the two strains of C. jejuni reported to harbour a gene cluster of the T6SS, both lacks one 
of the core components, that is TssH (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 
2012).  However, although TssH is absent, the T6SS in both strains were demonstrated to be 
functional (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012).  It has been reported 
that in the absence of TssH, the TssB/TssC complex was still able to contract to push the 
TssD tubule out of the cell (Zheng et al., 2011).  As the complex could not dissemble due to 
the absence of TssH, it may render the T6SS less efficient (Zheng et al., 2011).  
 
The T6SS has been reported to participate in the interaction of bacteria with eukaryotic cells 
and/or other bacterial cells within the niche in a cell-to-cell contact dependent manner 
(Coulthurst, 2013; Pukatzki et al., 2006; Suarez et al., 2010).   
 
It has been reported in V. cholerae and Aeromonas hydrophila that the VgrG (TssI) 
component of its T6SS was involved in interacting with host cell actin (Pukatzki et al., 2007; 
Suarez et al., 2010).  There are two types of VgrGs: canonical and evolved (Filloux, 2013).  
The former had no C-terminal extension, thus it was suggested that it could interact with free 
toxin and carry the effectors into target cell (Filloux, 2013). The evolved VgrG has an 
extension at the C-terminal with an effector domain and delivers the effector domain into 
target cells (Coulthurst, 2013; Filloux, 2013).  It was thus suggested that the VgrG might play 
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a dual role; one in puncturing the target cell and the other in transportation of effectors 
(Filloux, 2013; Pukatzki et al., 2007).   
 
In V. cholerae, which contains an evolved VgrG, VgrG-1 has an actin cross-linking domain 
(ACD) at the C-terminal (Pukatzki et al., 2007).  The ACD in VgrG-1 has been shown to 
polymerise monomeric G-actin in vitro and leads to cytotoxicity in both macrophages and 
amoeba host (Pukatzki et al., 2007; Pukatzki et al., 2006).  It was also reported that cross-
linking of actin in phagocytic cells only takes place after the bacteria had been internalised 
which inhibited further phagocytosis (Ma et al., 2009).  In an infant mouse model study the 
outcome of the animal challenged with V. cholerae lacking the ACD in VgrG-1 was shown to 
be similar to a non-infected control.  There was no fluid accumulation, no cellular infiltration 
into the small intestine lumen and no induction of inflammatory responses observed (Ma and 
Mekalanos, 2010).  The induction of the inflammatory response may enhance the survival 
and/or replication of V. cholerae in the gut (Ma and Mekalanos, 2010).    
 
In A. hydrophila, another evolved VgrG was identified.  Its VgrG1 has a vegetative 
insecticidal (VIP-2) domain at the C-terminal (Suarez et al., 2010).  The VIP-2 domain 
possesses an ADP-ribosyltransferase activity that interacts with actin (Suarez et al., 2010).  It 
has been reported that the VIP-2 domain of VgrG1 was responsible for the disruption of 
HeLa cells actin cytoskeleton, rounding up of the cell and an increase in cell apoptosis 
(Suarez et al., 2010).  The action of VIP-2 on HeLa cells required direct contact between the 
bacterium and HeLa cells (Suarez et al., 2010).        
 
In Burkholderia species, up to six clusters of T6SS are present (Boyer et al., 2009).  T6SS-1 
in B. mallei and B. pseudomallei (or named as T6SS-5 in B. thailandensis) has been shown to 
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play a role in virulence in rodent models (Burtnick et al., 2011; Schell et al., 2007; Schwarz 
et al., 2010).  It has also been reported that T6SS-1 plays a role in facilitating actin-based 
motility, formation of multi-nucleated giant cell (MNGC), intracellular spreading through 
membrane fusion and intracellular growth (Burtnick et al., 2011; Burtnick et al., 2010; 
French et al., 2011).  Membrane fusion required contact between intracellular bacteria and 
host cell membrane, and this process is facilitated by T6SS-1 (French et al., 2011).  The cell-
to-cell fusion and formation of MNGC in phagocytic and non-phagocytic cells has been 
reported as a trademark of B. pseudomallei infection (Harley et al., 1998; Kespichayawattana 
et al., 2000).  In B. cenocepacia, it has been demonstrated that T6SS is involved in the 
disruption of the membrane of B. cenocepacia containing vacuoles (Rosales-Reyes et al., 
2012).  The disruption of the membrane facilitates the movement of proteins secreted by 
T2SS into the cytoplasm of macrophages, thereby ensuring bacterial survival inside 
macrophages (Rosales-Reyes et al., 2012).      
 
In C. jejuni, the presence of T6SS in strain ATCC 43431 has been shown to increase the 
susceptibility of the bacteria to deoxycholic acid - a bile salt found in human intestine 
(Lertpiriyapong et al., 2012).  In the same strain, the T6SS was required for adherence and 
invasion of both human epithelial and mouse macrophage cells.  It was also reported to be 
required for colonisation in IL-10 deficient mice (Lertpiriyapong et al., 2012).  In another 
study, the T6SS of another strain, strain 108, caused hemolysis of red blood cells in a contact 
dependent manner (Bleumink-Pluym et al., 2013).  The efficiency of T6SS in the lysis of 
RBC was affected by the presence of the bacterium capsule polysaccharide (Bleumink-Pluym 
et al., 2013).  The T6SS did not facilitate the bacterium in escaping from the vacuole in Caco-
2 cells and did not cause cytotoxicity towards mouse macrophages (Bleumink-Pluym et al., 
2013).   
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Besides interacting with host cells, some T6SS have been reported to act against other 
bacterial cells.  For example, in P. aeruginosa, its HI-T6SS has been demonstrated to 
transport three toxins, Tse 1 to 3, into neighbouring bacterial cells (Russell et al., 2011).  
Tse1 and Tse3, a peptidoglycan amidase and a muramidase respectively, work at the 
periplasm of Gram negative cells and degrade the peptidoglycan (Russell et al., 2011).  Tse2 
is a cytoplasmic acting toxin that might inhibit growth in prokaryotic cells (Hood et al., 2010).  
The effects of the three toxins are neutralised by their respective immunity proteins, Tsi 1 to 
3 (Hood et al., 2010; Russell et al., 2011).  P. aeruginosa producing Tse1-3 also produce 
Tsi1-3 at the same time (Hood et al., 2010; Russell et al., 2011).  Consequently, Tse1-3 is 
injected into neighbouring cells, which are killed if they do not have the ability to produce 
immunity protein - Tsi1-3.  Similar mechanisms of the utilisation of toxins and immunity 
proteins have been reported in other bacteria, such as V. cholerae, B. thailandensis and 
Serratia marcescens (Coulthurst, 2013; Filloux, 2013).  This anti-bacterial mechanism might 
help a bacterium to compete with other bacteria in a host or environmental niche, shaping the 
composition of the microbial population in a particular niche or within mixed species biofilm 
(Filloux, 2013).  
 
The C. jejuni strain 108 was co-cultured with E. coli DH5α and T6SS-negative C. jejuni 
strain 81116.  It was reported that the T6SS-positive strain 108 had no growth advantage over 
bacterial strains without T6SS (Bleumink-Pluym et al., 2013).  This indicates that the T6SS 
in strain 108 is unlikely to be involved in interaction with other bacteria.   
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1.1.7 Animal models 
 
A good animal model is essential in understanding of disease and the patho-physiology of an 
infection.  In understanding Campylobacteriosis, an ideal animal model should be able to 
reproduce the disease as it would occur in humans; the route of infection used should be 
similar to natural occurrence in humans, challenge dosage should be low, there should be 
reproducible results and cost of using the model is economical (Ruiz-Palacios et al., 1981).  
Several animal models that have been explored for understanding Campylobacteriosis are 
summarised in Table 1.1.   
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Table 1.1: Summary on the pros and cons of various animal models. 
 
Animal model Pros Cons Reference 
Bovine  Exhibit diarrhoea via oral 
route 
 Inoculum size not defined 
 High cost and maintenance 
 Jones and Little, 1931a 
 
Canine and 
feline 
  Did not develop diarrhoea 
via oral route 
 Prescott and Karmali, 1978 
Avian  Watery diarrhoea in young 
chicks via oral route 
  Ruiz-Palacios et al, 1981 
 Sanyal et al, 1984 
Murine  Knock-out technology 
available 
 Did not present similar 
clinical symptoms as in 
human infection 
 Presented gastroenteritis 
only in infant mice via 
intra-peritoneal route  
 Young et al, 2007 
 Janssen et al, 2008 
Newborn 
piglets 
 Exhibit clinical and 
histological damages 
similar to human infection  
 Lack competing intestinal 
flora and maternal 
antibodies 
 High cost and maintenance  Babakhani et al, 1993 
Ferret  Able to colonise and 
induce human-like 
symptoms 
 High cost and maintenance 
 No knock-out technology 
 Young et al, 2007 
 Janssen et al, 2008 
Rabbit   Procedure involved 
surgery due to the use of a 
removable intestine tie 
 Janssen et al, 2008 
Non-human 
primate (NHP) 
 Exhibit pathology and 
symptoms similar to 
human infection  
 High cost and maintenance  Jones et al, 2006 
 Russell et al, 1989 
Galleria 
mellonella 
 Ease of manipulation 
 Low cost and maintenance 
 Ethically acceptable 
 Genome not sequenced 
 Limited genetic 
traceability 
 Lack mutagenesis methods 
 Does not have adaptive 
immunity 
 Long time to monitor 
killing 
 Oral route not possible 
 Champion et al, 2010 
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1.1.7.1 Bovine 
 
One of the earliest studies was conducted by Jones et al.  They fed faeces from spontaneously 
infected cows exhibiting severe diarrhoea to calves and managed to induce similar disease 
outcomes (Jones and Little, 1931a).  Pure cultures were isolated from the experimentally 
infected calves and then fed to other calves.  These calves also developed similar diarrhoea 
and enteritis (Jones and Little, 1931a).  In these studies, they observed that the jejunum was 
the primary locus of the infection.  When the disease became chronic, the entire small 
intestine would be affected (Jones and Little, 1931b).  Before the proposal of a new genus 
“Campylobacter”, the bacteria Jones et al worked on was classified as "Vibrio" and they 
noticed the slight differences in the morphology (length, number of coils, depth of coils) of 
the bacteria compared to the closely related groups (Vibrio): as the primary focus of infection 
for this bacteria was lesions in the jejunum, they proposed the name Vibrio jejuni (Jones et al., 
1931).  The disease progression in calves was reproducible in the studies conducted by Jones 
et al - and it also exhibited traits observed during human infection such as bloody diarrhoea, 
however, the inoculum size was not defined.  At this point it was not clear if the calves would 
exhibit similar disease outcomes when challenged with a lower dosage.  The cost of 
maintaining the calves as infection models would be high.  These factors render calves as 
models less attractive.   
 
1.1.7.2 Canine and feline 
 
Following Jones et al, another group tried to explore infection models using kittens and 
puppies.  They were not successful as the animals failed to develope diarrhoea after being fed 
with the bacteria at a dose much higher than the amount that would evoke disease in humans 
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(Prescott and Karmali, 1978).  The testing of the gnotobiotic dog as an infection model has 
also been reported.  However, the diseases developed were milder compared to outcomes in 
human infection (Prescott et al., 1981).  The cats and dogs models explored were not able to 
reproduce the disease outcomes as it would proceed in humans, thus were not considered to 
be good models. 
 
1.1.7.3 Avian 
 
As avian species, especially chickens, are common reservoirs for C. jejuni, the possibility of 
using it as a model has been explored.  It was reported that 36 to 72 hour old chicks develop 
watery diarrhoea with small oral inoculums, and the occurrence rate was high and 
reproducible, indicating that young chickens were highly susceptible to the bacteria (Ruiz-
Palacios et al., 1981; Sanyal et al., 1984).  Further reports state that older chickens were more 
resistant to the bacteria challenge thus avoiding diarrhoea (Ruiz-Palacios et al., 1981).  Since 
C. jejuni does not cause disease symptoms in chickens, and is often regarded as a commensal 
bacteria, chickens are not the best models to use to understand pathogenesis mechanisms.  
However, they do remain a good model for the study of C. jejuni colonisation, for example in 
vivo survival (persistency) mechanisms (Janssen et al., 2008).  
 
1.1.7.4 Murine 
 
Mice are commonly used for the study of bacteria infections.  When used for 
Campylobacteriosis studies the results obtained were inconsistent.  The animals did not 
present similar clinical symptoms to human infection (Young et al., 2007).  There were 
successful attempts to induce gastroenteritis in infant mice through intra-peritoneal injection.  
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In these successful models the route of infection used was not the natural route (via ingestion), 
and the innate immune system of the mice had not fully developed, thus rendering them 
unsuitable model for studying immunological response (Janssen et al., 2008).  A major 
advantage of the murine model is that the technology for creation of mice with defined 
deletions in innate or adaptive immunity components (e.g. NF-κB, IL-10, Nramp1 or MyD88 
deficient mice) is established, thus this could help to elucidate the host factors involved in 
host protection (Janssen et al., 2008). 
 
1.1.7.5 Swine 
 
Newborn piglets deprived of colostrum, have shown to be a model for C. jejuni pathogenesis 
studies (Babakhani et al., 1993).  Piglets orally challenged with C. jejuni exhibited clinical 
and histological damages similar to human infection (Babakhani et al., 1993).  In this model 
C. jejuni was observed to be internalised within the intestinal cells and the disruption of 
microvilli in the affected area was also observed (Babakhani et al., 1993).  The competitive 
advantages of fucose transport and FeoB-mediated ferrous iron acquisition in C. jejuni during 
colonisation has also been demonstrated using colostrum deprived piglet infection model 
(Naikare et al., 2006; Stahl et al., 2011).  The newborn piglet lacks a competing intestinal 
flora and, being deprived of colostrums, maternal antibodies are also absent (Babakhani et al., 
1993).  These are two advantageous features of this model, alongside the similarities of the 
swine digestive system to human system, mades it the preferred model for studying of 
Campylobacteriosis (Babakhani et al., 1993).  However, the cost of using this model is high. 
 
  
37 
 
1.1.7.6 Ferret, rabbit and NHP 
 
Some other animal models have been explored including ferret, rabbit and NHPs (Janssen et 
al., 2008; Young et al., 2007).  In ferrets, C. jejuni was able to colonise and induce human-
like symptoms, but the cost involved in the use of this model is high and knock-out 
technology for ferrets is not as established as in the murine models.  This makes them a less 
attractive model for studies investigating host factor involvement (Young et al., 2007).  There 
is another potential complication for use of ferrets.  As wild ferrets prey on chicks they could 
acquire relative resistance to Campylobacteriosis (Janssen et al., 2008).   
 
The rabbit model explored used a removable intestinal tie in adult rabbit, thus this procedure 
required surgery, hence was not commonly used (Janssen et al., 2008).   
 
NHPs challenged with C. jejuni were shown to exhibit pathology and symptoms similar to 
human infection, colonisation, shedding in faeces and diarrhoea.  Also results were 
reproducible (Jones et al., 2006; Russell et al., 1989).  Unfortunately, NHPs are a very 
expensive as models.      
 
1.1.7.7 Invertebrates   
 
In recent years, there has been interest in the use of invertebrates as a surrogate for vertebrate 
animal models.  The attractive factors of using invertebrate systems are the ease of 
manipulation, lower cost and maintenance, and ethical acceptability (Mukherjee et al., 2010; 
Mylonakis et al., 2005).   Larvae of Galleria mellonella (common name: Greater Wax Moth), 
have been used in several pathogenesis studies of human pathogens; for example 
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Pseudomonas aeruginosa, Bacillus cereus and Listeria spp. ((Mukherjee et al., 2010).  It has 
also been demonstrated that larvae of Galleria mellonella are susceptible to C. jejuni 
infection.  This host system has successfully been used to identify a new virulence factor 
(Champion et al., 2010), yet there are some limitations on the use of Galleria mellonella; i) 
the genome of this organism has not been sequenced, so it has limited genetic tractability; ii) 
there is a lack of well-established methods in mutant generation; iii) it does not have an 
adaptive immune system; iv) it requires a relatively long time to monitor the killing of larvae;  
v) there is an inability to assess oral infections (Mukherjee et al., 2010; Mylonakis et al., 
2005).  
 
1.1.7.8 Zebrafish embryo as a possible infection model for Campylobacteriosis study 
 
Zebrafish (ZF) have gained popularity for studying host-pathogen interactions studies.  
Successful models had been established for a range of pathogens including Salmonella 
enterica serovar Typhimurium (van der Sar et al., 2003), Bacillus subtilis (Phelps and Neely, 
2005), Mycobacterium (Davis et al., 2002) and Pseudomonas (Clatworthy et al., 2009).   
 
In Mycobacterium studies, disease progression in mouse models differs to that seen in human 
infection as granulomas were not observed (Wang, 2010).  However, infected ZF embryos 
(ZFE) formed granulomas similar to those seen in human tuberculosis (Pozos and 
Ramakrishnan, 2004) making it an attractive model for study on granuloma formation.  It has 
been reported that with the use of the ZFE model, granulomas had been shown to form when 
only innate immunity was developed - in the absence of adaptive immunity (Davis et al., 
2002).  Real-time imaging of infected ZFE had shown that the bacteria could be disseminated 
either through direct transfer between macrophages via the membrane tethers or when the 
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"clean" macrophage picks up bacteria that remained associated with dead macrophages 
(Davis et al., 2002).     
 
Another study, which involved looking at Salmonella Typhimurium pathogenesis, ZFE were 
infected with wild-type cells and a lipopolysaccharide (LPS) mutant.  The LPS mutant 
showed attenuation indicating the role of LPS in pathogenesis.  In this study, real-time 
visualisation of infected embryos showed that some of the bacteria were lysed inside 
macrophages, but most of the bacteria remained viable and were able to replicate.  
Extracellular bacteria cells were observed to have migrated to remote regions where they 
replicated and formed micro-colonies.  This finding addressed and answered a long standing 
anomally with regards to the site of multiplication for S. Typhimurium in host organisms (van 
der Sar et al., 2003).    
 
To date, there is no report on the use of ZFE as an infection model for Campylobacter.  With 
the seemingly numerous advantages of ZFE models it would be worthwhile exploring the 
possibility.  The infection model could perhaps help to answer a long standing question on 
the interaction between C. jejuni and monocytes in vivo (Young et al., 2007).        
 
ZF provide several advantages as a model organism.  They are relatively cheap to work with 
in terms of cost and maintenance; similar to invertebrate models.  Also the storage space 
required for maintaining infected fish or embryos is minimal.  ZF have a similar immune 
system (innate and adaptive) to human and other vertebrates (Phelps and Neely, 2005).  They 
are easy to handle and its embryo develops outside the adult.  The ex vivo embryo allows 
disease pathogenesis to be studied at different developmental stages as the immune systems 
establish in the organism (Phelps and Neely, 2005).  Studies can be conducted at the 26 
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somites stage (~22 hours post-fertilisation, hpf), where macrophage-like cells are found 
within the yolk-sac (Herbomel et al., 1999) - also at later stages, when primitive granulocytes 
start to circulate (at 48 hpf) (Lieschke et al., 2001), or when mature neutrophils are found in 
different tissues (at 72 hpf) (Willett et al., 1999).  Macrophages and neutrophils form an 
important part of the innate immunity system and macrophages in ZFE were shown to be 
involved in the clearing of bacteria inoculated into the embryo (Herbomel et al., 1999).  
Adaptive immunity does not mature until 4 to 6 weeks post fertilisation (Clatworthy et al., 
2009).  As innate immunity establishes prior to adaptive immunity in ZF development 
(Phelps and Neely, 2005), and with its ex vivo embryo development, it is possible to study 
host-pathogen interactions in ZFE at stages when only innate immunity is involved.  This is 
not possible in other animal models.  The participation of adaptive immunity could be studied 
when embryos are allowed to grow into adulthood (Phelps and Neely, 2005). 
 
ZFE remains transparent for the first three weeks of their development and this property 
makes live and real-time visualisation of bacteria inside ZFE possible (Phelps and Neely, 
2005).  For example, colonisation of fluorescent labelled fish pathogen, Vibrio anguillarum, 
could be visualised in real-time and this was used to study mode and site of entry of this 
pathogen (O'Toole et al., 2004).  The optical transparency property also allows real-time 
monitoring of interactions between bacteria and host immune cells (Davis et al., 2002; van 
der Sar et al., 2003).  
 
ZF are genetically tractable with the ability to create transgenic lines by both forward and 
reverse genetic approaches (Howe et al., 2013).  Its forward genetics surpasses reverse 
genetics due to its lack of embryonic stem cells and homologous recombination (Pozos and 
Ramakrishnan, 2004).  Genetic manipulation tools are available for ZF.  Specific host genes 
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could be knocked down to have a better understanding of their roles played during host-
pathogen interaction.  Transgenic lines with fluorescently tagged immune cells, such as GFP-
expressing neutrophils and mCherry-expressing macrophage, are also available (Gray et al., 
2011).  They are used to track interaction between pathogen and host immune cells in real-
time.  GFP-neutrophils have been used to demonstrate its interaction with Staphylococcus 
aureus at 2 hours after the bacteria was inoculated into the embryo (Prajsnar et al., 2008).  In 
addition, transient knockdown of specific host genes is achievable with the use of 
morpholinos (Nasevicius and Ekker, 2000; Trede et al., 2004).   
 
The bacterium of interest is commonly inoculated into ZFE through microinjection.  The 
blood stream, for example axial vein (van der Sar et al., 2003), yolk-sac circulation valley 
(Clatworthy et al., 2009) or yolk-sac (Prajsnar et al., 2008) are common sites of inoculation.  
Due to its low cost and minimal maintenance requirement, it makes the screening of large 
number of strains or mutants feasible.  A major drawback to large-scale screening is that it is 
labour intensive.  The embryos will continue to develop throughout the microinjection 
process.  It is crucial to have all the embryos infected at developmental stage as close to each 
other as possible.  This limits the number of embryos that can be injected within a set time 
frame.  Automating the injection process would be a solution to this issue.  It has been 
reported that an automated robotic microinjection system could inoculate 15 ZFE per minute 
and the embryos survival rate was 98% (Wang et al., 2007).   
 
A point to note is that ZFE survive best in water temperatures ranging between 22°C to 33°C 
(Tobin et al., 2012).  The embryos are commonly incubated at 28°C post-bacteria challenge.  
The incubation temperature might affect the expression of some temperature regulated 
bacterial virulence genes (Prajsnar et al., 2008). 
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1.2 Imaging of infection 
 
The concept of direct observation of C. jejuni is advantageous as it can avoid the lengthy wait 
during culturing as well as multiple procedural steps from setting up immune and molecular-
based assays.  Fluorescence microscopy is a commonly used technique for cell visualisation 
(Rodriguez et al., 2006).  However, the sample to be analysed would need to be fluorescing 
which often requires the introduction of a fluorescence molecule.  The introduction of 
fluorescence is an invasive process; it might alter molecular properties, distribution and 
functionality of the target; it also raises the problem of quenching and photo-bleaching 
(Rodriguez et al., 2006): a non-invasive and chemically selective microscopy technique 
would be preferable - this was made possible with the coupling of vibrational spectroscopy 
(which includes Raman scattering) with an optical microscope known as "Raman micro-
spectroscopy" (Rodriguez et al., 2006).  In this project, the two techniques (fluorescence and 
Raman microscopy) were used for the interrogation of interactions between bacteria and host 
cells or organisms.    
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1.2.1 Brief history of microscopy techniques 
 
Microscopy aids the viewing of objects not visible to naked eyes.  The first light microscope 
was most probably made in 1590 by Zaccharias Janssen and Hans Janssen.  In later years, 
Antony van Leeuwenhoek (Parker, 1965) used the microscope to see small living structures 
such as yeast and protozoan.  Robert Hooke described the presence of "cells" in cork after 
viewing under the microscope (Gest, 2005).  After this, many researchers began to build 
more complex and powerful microscopes with a typical magnification of 1,000 times i.e. 100 
times magnification from objective and 10 times magnification from eye piece.  However, the 
resolving capability of light microscopy was restricted by the wavelength of white light, 
hence structures smaller than half the light wavelength (e.g. <0.25 µm), could not be 
visualised (Barer, 1974).  This criterion is actually due to Rayleigh, which specifies the 
minimum separation required between two light sources in order to obtain resolved image.   
 
The limitation of white light microscopy has led to the development of higher resolution 
microscopes.  This was achieved by moving away from the use of white light to electron 
beam in the development of electron microscopy in 1931 (Cosslett, 1962).  Electron 
microscopy uses beams of electrons with a wavelength one hundred-thousandth of the white 
light wavelength, and when focused on a cell, the electrons will either be absorbed or 
scattered by the components within the cell and this is captured on to an electron sensitive 
plate as an image detector (Barer, 1974).  Although this technology enables visualisation of 
structures of much smaller size, down to one angstrom, it requires extensive sample 
preparation and so, unlike light microscopy, it is not able to visualise real-time changes 
within the cell.  Thus, although light microscopy does not have high resolving power, it 
remains the most widely used technique for microbial visualisation.   
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Along the lineage of optical microscopy development, several enhancements have been made 
to enable better visualisation of different types of samples.  For example, phase contrast 
microscopy has enabled better visualisation of cells without staining; fluorescence 
microscopy enabled the visualisation of compounds either using their intrinsic fluorescence 
or, after the attachment of a fluorescent label.  The resolution of the light microscope was 
maximised through the development of Confocal Laser Scanning Microscopy (CLSM) in 
1978 by Thomas and Christoph Cremer (Cremer and Cremer, 1978).  By passing the light 
through a pinhole, scattered light collection is minimised and three dimensional image 
stackes can be obtained by scanning the pinhole in three dimensions over the sample.   
 
In 1989 Denk et al. (Denk et al., 1990) filed a patent on the invention of a new type of 
fluorescence microscope after integrating a laser scanning microscope and a mode-locked 
laser (generating pulses of near-infrared light), the "two-photon excitation microscopy 
(TPEM)". It has been demonstrated that TPEM is superior to CLSM as it allows imaging 
from thicker specimens and restricts photo-bleaching or photo-damage to the focal plane 
thereby allowing frequent interval of long period interrogation of the specimen (Periasamy et 
al., 1999; Squirrell et al., 1999). The limitation of this technology is that it is only suitable for 
fluorescent imaging and can not be used on highly pigmented specimens or specimens that 
absorb near-infrared light (Masters and So, 2004). 
 
Raman scattering is the inelastic scattering of light due to excitation of vibrational modes in 
the target molecules.  The spectrum emited provides a chemical fingerprint of a material. The 
possibility of imaging the distribution of a particular bond in a sample has long been 
recognised, but Raman scattering is very weak and the imaging times were at first too long to 
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make this practicable.  Coherent excitation of the vibrations offers increased sensitivity and a 
shift in paradigm took place when Duncan et al. (Duncan et al., 1982) used coherent anti-
Stokes Raman scattering (CARS) in a microscopic system in 1982.   However, its use in 
biological specimens did not take off until two decades later, when laser systems and 
techniques had developed (Rodriguez et al., 2006).  This technique now provides a non-
invasive, chemical selective and quantitative approach to imaging biological specimens, 
especially in living cells, which was not achievable in the previously discussed microscopy 
technologies.   
 
The most recent development in imaging is the super-resolution microscopy.  It is a form of 
light microscopy where live-cell imaging and three dimension reconstruction of the sample 
are possible (Huang et al., 2009); and had overcome the diffraction limit and is able to 
generate images down to 25 nm, a resolution close to that of electron microscopy (Biteen and 
Moerner, 2010).  This is acheived by serveral approaches, namely: structured illumination, 
reduction of point spread function and activation of single fluorophore (Bhuvanendran et al., 
2014).   
 
Table 1.2 summarises characteristics of various microscopy techniques. 
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Table 1.2: Summary on the characteristics of microscopy techniques 
 
Type of Microscopy Characteristics 
White light  • Specimens need to be stained to provide contrast 
• Unable to perform live cell imaging unless with the use of 
intravital dyes 
• Features smaller than 0.25 µm cannot be visualised 
Phase-contrast  • Specimens does not need to be stained 
• Able to perform live cell imaging 
• Features smaller than 0.25 µm cannot be visualised 
Fluorescence  • Specimens need to be fluorescing 
• Specimens subjected to photo-bleaching and photo-
cytoxicity 
• Able to perform live cell imaging 
• Features smaller than 0.25 µm cannot be visualised 
Confocal • Specimens need to be fluorescing 
• Specimens subjected to photo-bleaching and photo-
toxicity 
• Able to perform live cell imaging 
• Able to perform optical sectioning  
• Features smaller than 0.25 µm cannot be visualised 
Two-photon • Specimens need to be fluorescing 
• Specimens subjected to lesser extend photo-bleaching and 
photo-cytoxicity as compare to Confocal 
• Able to perform optical sectioning  
• Able to image thicker specimens as compare to Confocal 
• Features smaller than 0.25 µm cannot be visualised 
Electron • Specimens need to be stained 
• Unable to perform live cell imaging 
• Able to image features down to one angstrom 
Raman base • Specimens do not need to be stained 
• Able to perform live cell imaging 
• Not subjected to photo-bleaching and photo-toxicity 
• Able to perform optical sectioning 
• Features detectable is dependent on the strength of the 
chemical bond vibrational signals 
Super-resolution  • Able to perform live cell imaging 
• Able to perform three dimension reconstruction 
• Resolution down to 25 nm, close to electron microscopy 
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1.2.2 Fluorescence microscopy 
 
When fluorophores within a specimen are excited with incident light, they absorb the light 
energy and enter a singlet excited state.  In this state the excited molecule is unstable and will 
have to emit the excess energy gain in order to return to its ground state.  Energy is lost 
through vibration and release light energy in the form of fluorescence (Webb and Brown, 
2013).  There are three fundamental properties of a fluorophore: i) its ability to absorb light 
energy at a given wavelength; ii) the percentage of absorbed light energy released as 
fluorescence; iii) its photo-stability when in the excited state (Webb and Brown, 2013).  An 
important drawback on the use of fluorophores is photo-bleaching.  It occurs when the 
excited molecule enters triplet state resulting in non-reversible destruction of the fluorophore 
as it cannot cycle between ground and excited states.  The triplet state also generates oxygen 
radicals that destroys the fluorophores and is toxic to living cells (Webb and Brown, 2013).   
 
The first observation of fluorescence was made by Sir John Frederik William Herschel in 
1845 when he observed that a colourless and transparent quinine solution exhibited a vivid 
blue colour when the solution was illuminated and observed under certain incident lights 
(Renz, 2013).  In 1852, George Stokes observed that a mineral (fluorspar) emitted red light 
when illuminated with blue light and the emitted light was at a wavelength longer than the 
light used to excite it.  He termed this observation "fluorescence" and the shift in wavelength 
as "Stokes shift" (Ghiran, 2011).   
 
Along with the discovery of fluorescence properties in substances, improvement towards 
better image resolution in microscopy was also on-going.  In 1873 Ernst Abbe demonstrated 
the limitation of using transmitted light and around 1886 the highest practical numerical 
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aperture of objective was achieved (Ghiran, 2011; Renz, 2013).  The first fluorescence 
microscope was built by Carl Zeiss and Carl Reichert at the beginning of the twentieth 
century.  In 1929 Ellinger and Hirt switched to the use of reflected light instead of transmitted 
light for visualisation of living organisms.  They treated the live organism with fluorescent 
compounds, illuminated it with UV light and using interposed filters between the objective 
and eyepiece to reflect incident rays and transmit red-shift fluorescence light.  Their approach 
set the foundation for modern fluorescence microscopy.  Ways to label specimens with 
fluorophores were explored and in the early 1940s the development of fluorescent tagged 
antibodies was an important step forward for fluorescence labelling and microscopy.  A 
major drawback of fluorescence labelling are that fluorophores attached to biological 
molecules might alter the properties or functions of the biological molecules (Rodriguez et al., 
2006).  By the 1990s, with the advancement of cloning technology, cloning of GFP, as well 
as development of its spectral variants, were made possible (Renz, 2013).  To date epi-
fluorescence microscopy and CLSM are two of the most commonly used type of fluorescence 
microscopy.   
 
 
  
49 
 
1.2.3 Vibrational spectroscopy 
 
When light interacts with matter, the photons can either be absorbed or scattered (Petry et al., 
2003).  Absorption usually occurs when infrared (IR) and ultraviolet (UV) light sources are 
used (Petry et al., 2003).  The absorption of IR photons will result in excitation of vibrational 
modes in molecules while absorption of UV photons will excite molecules to undergo 
electronic transition followed by emission of radiation, termed "fluorescence" (Petry et al., 
2003).  When light is scattered; the majority of the photons will be scattered with the same 
wavelength as the light source; this is known as "elastic scattering" (Petry et al., 2003).  
However, a small percentage of the photons will scatter in an inelastic manner where the 
frequencies of the scattered photons differs from that of the light source; this effect is termed 
the "Raman effect" or "Raman scattering" (Petry et al., 2003).  This effect was first reported 
in 1928 (Raman and Krishnan, 1928).        
 
Vibrational spectroscopy is based on the photoexcitation of chemical bonds on molecules 
(Rodriguez et al., 2006) and measures the vibrational energy of the excited bonds (Huang et 
al., 2004).  When light is shone onto a molecule, electrons within the molecule move into an 
excited state.  The distribution of electrons around the atomic nuclei become distorted and 
this leads to various types of chemical bond resonance such as bending, stretching and 
rotating (Rodriguez et al., 2006).  The chemical bond resonant frequencies are independent of 
the electric field applied, but when the applied electric field matches a particular resonant 
frequency a significant amount of the energy will be absorbed which will then be distributed 
to other parts of the molecule, or released as low energy photons (Rodriguez et al., 2006).  
There are two widely used techniques in vibrational spectroscopy (Huang et al., 2004); i) 
fourier transform infrared (FT-IR) spectroscopy; ii) Raman spectroscopy.  The main 
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difference between these two is that FT-IR measures absorption of light while Raman 
spectroscopy measures Raman scattering (Huang et al., 2004).  IR requires long wavelengths 
to excite a sample.  Water molecules present in the sample will absorb strongly thereby 
masking potential frequencies of interest (Müller and Zumbusch, 2007; Rodriguez et al., 
2006).  These factors cause IR to have poor spatial resolution this method is thus less 
favourable for biological imaging (Downes and Elfick, 2010; Müller and Zumbusch, 2007; 
Rodriguez et al., 2006).  Raman spectroscopy, on the other hand, is relatively unaffected by 
the presence of water molecules, because the vibrational modes of water are relatively weak 
and well-defined so it is able to generate sharper, more distinguishable spectra of specific 
molecules (Huang et al., 2004). 
 
  
51 
 
1.2.4 Raman spectroscopy 
 
Raman spectroscopy is a non-invasive and label-free (Downes and Elfick, 2010) technique 
that uses light source in the visible or near infrared regions to excite a sample (Rodriguez et 
al., 2006).  When a molecule absorbs energy from the light source (photons) it goes into an 
excited state and returns rapidly to a lower energy state that is above original ground state and 
still consists of vibrational energy.  This is achieved by the emission of photons that are 
longer in wavelength as compared to the initial light source.  
 
The Raman spectrum generated from excitation of chemical bonds is unique to each 
biological sample, therefore it could be used as a “chemical fingerprint” to differentiate 
between samples (Huang et al., 2004).  By coupling the spectrometer to an optical 
microscope spectra can be obtained with cell-scale spatial resolution (Huang et al., 2010).  In 
the Raman microscope a laser replaces the normal white light as the photon source and is 
focused on the sample through the microscope objective lens (Huang et al., 2004).  Raman 
micro-spectroscopy is a non-invasive and non-destructive spectroscopic technique for 
acquisition of chemical signals from a small volume, such as single bacterial cell, and it 
provides the phenotypic classification with minimal physiological interference (Huang et al., 
2004; Huang et al., 2010).  It has been shown to discriminate between different bacteria 
species and differentiates between different stages of growth within each species tested 
(Huang et al., 2004).  By obtaining spectra from a single cell it should be possible to 
distinguish between cells at different growth stages could enable the use of Raman 
microscopy for interrogation of metabolically active and dormant cells during host-pathogen 
interaction.  These beneficial qualities of vibration spectroscopy could also potentially enable 
the examination of micro-organisms in their natural habitat (Huang et al., 2004). 
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The limitation is that because the Raman signal is so weak, long imaging times are required.  
More recent advances, for example, the development of CARS and stimulated Raman 
scattering (SRS) (Freudiger et al., 2011), may be able to overcome this.   
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1.2.5 Coherent Raman scattering (CRS) microscopy 
 
CRS is a non-linear optical process - that is it has a non-linear dependence on the intensity of 
incoming light; and produce a coherent radiation.  Through excitation with short pulses, this 
process can be exploited to allow fast Raman imaging (Alfonso-García et al., 2014).  CRS 
generates its image based on vibrational Raman contrast, a phenomenon initially discovered 
in 1962 (Alfonso-García et al., 2014; Freudiger et al., 2008).  Raman contrast is used as a 
contrast mechanism in label-free imaging of biological samples (Alfonso-García et al., 2014; 
Wang, 2010).  Two synchronised pulsed laser sources are required to coherently excite the 
sample in order to generate the CRS signals (Alfonso-García et al., 2014; Freudiger et al., 
2011; Wang, 2010).  The two incident beams are set at pump frequency (ωp) and Stokes 
frequency (ωS) respectively to drives the chemical bond into motion (Alfonso-García et al., 
2014).  When the difference in frequency (∆ω=ωp-ωS) between the pump and Stokes 
frequency matches the sample's intrinsic molecular vibration (Ω), new radiative frequencies 
are generated (Alfonso-García et al., 2014; Freudiger et al., 2008).  These frequencies (ωp±Ω 
and ωS±Ω) are CRS signals (Alfonso-García et al., 2014).  There are four basic CRS signals; 
i) coherent Stokes Raman scattering - ωS-Ω; ii) coherent anti-Stokes Raman scattering 
(CARS) - ωp+Ω; iii) stimulated Raman gain (SRG) - ωp-Ω=ωS; iv) stimulated Raman loss 
(SRL) - ωS+Ω=ωp (Alfonso-García et al., 2014; Freudiger et al., 2008).  The two most 
commonly used techniques are CARS and SRS (Wang, 2010).     
 
CARS  is a version of Raman spectroscopy, hence it inherits all the beneficial capabilities of 
Raman spectroscopy (Rodriguez et al., 2006).  Similarly, when applied to microscopic 
system, which uses multiple photons, it is able to peform optical sectioning capability, to 
distinguish from auto-fluorescence and to generate quantitative information (Robinson et al., 
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2009; Rodriguez et al., 2006).  There are several configurations of CARS; i) forward-detected 
CARS (F-CARS); ii) forward-detected polarisation CARS; iii) backward-detected or epi-
detected CARS (E-CARS); iv) counter propagating CARS (Rodriguez et al., 2006).  F-CARS 
will generate the strongest signal with features of interest being overwhelmed by non-
resonant scattering, while E-CARS has reduced non-resonant background - but it loses signal 
strength (Rodriguez et al., 2006). 
 
However, there are several disadvantages to CARS.  In CARS a non-resonant background 
signal is present when there is no vibrational resonance, resulting in limited sensitivity 
(Freudiger et al., 2011; Saar et al., 2010).  Because of its complex pattern, this background 
signal is very difficult to subtract from the measured signal.  The shape of the spectral peaks 
is also distorted and the signal intensity depends nonlinearly on bond concentration 
(Freudiger et al., 2008; Saar et al., 2010). These shortcomings are not present in SRS 
(Freudiger et al., 2011; Freudiger et al., 2008; Saar et al., 2010).    
 
The improved sensitivity of SRS is close to the shot-noise limit and signals generated scale 
linearly with the concentration of chemical bonds within the sample volume (Freudiger et al., 
2011).  SRS also avoids image artefacts due to spectral distortions or coherent signal 
additions and acheive Raman signal amplification by stimulated excitation.  In SRG the 
intensity of the Stokes beam experiences a gain, while in SRL the intensity of the pump beam 
experiences a loss.  In SRS, SRG and SRL could not occur when ∆ω does not match Ω.  Thus, 
unlike CARS, it will not exhibit a non-resonant background (Freudiger et al., 2008).  These 
features make SRS a preferable technique for imaging infection.   
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1.3 Project aims  
 
The central aim of the project was to develop tools to study host-pathogen interactions in the 
poorly understood bacterium, C. jejuni.  First, work was undertaken to determine the 
molecular make-up of bacteria using Raman spectroscopy and to use the information for 
imaging host-pathogen interaction during infection.  The next part of the project was to 
establish ZFE as an optically clear animal model for Campylobacter and to use it for 
interrogating infection.  As T6SS was only recently identified in some C. jejuni strains its 
roles in interaction with eukaryotic host were studied. 
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Chapter 2:  Materials and methods 
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2.1 Bacterial strains, plasmids and primers  
 
All the plasmids, bacterial strains, eukaryotic host strains and primers used in this study are 
tabulated in Tables 2.1, 2.2, 2.3 and 2.4 respectively. 
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Table 2.1: List of plasmids  
 
Plasmids Descriptions Sources 
pWM1015 Kanamycin resistance, pWM1007∆lacZΩ[(T1)4-
Pc-gfp-λt0], promoter: Campylobacter consensus 
promoter sequence (Wosten et al., 1998) with 
minor modifications within non-consensus 
regions to minimise formation of RNA secondary 
structures (Miller et al., 2000) 
USDA-ARS 
laboratory 
pWM1018 Kanamycin resistance, pWM1008∆lacZΩ[(T1)4-
Pc-yfp-λt0], promoter: Campylobacter consensus 
promoter sequence (Wosten et al., 1998) with 
minor modifications within non-consensus 
regions to minimise formation of RNA secondary 
structures (Miller et al., 2000) 
USDA-ARS 
laboratory 
pWM1019 Kanamycin resistance, pWM1009∆lacZΩ[(T1)4-
Pc-cfp-λt0], promoter: Campylobacter consensus 
promoter sequence (Wosten et al., 1998) with 
minor modifications within non-consensus 
regions to minimise formation of RNA secondary 
structures (Miller et al., 2000) 
USDA-ARS 
laboratory 
pUC57 Ampicillin resistance, multiple cloning site 
(MCS) within lacZ gene, plasmid size is 2710bp 
GenScript 
pUC_tssD(syn) Cloning of tssD(syn) into MCS of pUC57 by 
EcoRV  
GenScript 
pUC_tssM(syn) Cloning of tssM(syn) into MCS of pUC57 by 
EcoRV 
GenScript 
pGEM-Teasy Ampicillin resistance, multiple cloning site 
(MCS) within lacZ gene, plasmid size is 3015bp 
Promega 
pGEM_tssD(syn) Cloning of tssD(syn) into MCS of pGEM-Teasy 
by SpeI and NdeI 
GenScript 
pGEM_tssM(syn) Cloning of tssM(syn) into MCS of pGEM-Teasy 
by SpeI and NdeI 
GenScript 
pGEM_tssD(syn)::kanR_cas Cloning of kanR_cas into tssD(syn) in 
pGEM_tssD(syn) by BamHI 
This study 
pGEM_tssM(syn)::kanR_cas Cloning of kanR_cas into tssM(syn) in 
pGEM_tssM(syn) by BamHI 
This study 
pJMK30 Ampicillin resistance, contains a kanR_cas within 
BamHI sites (source of kanR_cas) 
Institute of Food 
Research, UK 
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Table 2.2: List of bacterial strains 
 
Strains Descriptions Sources 
S. Typhimurium SL1344 wild-type NCTC13347 Lab stock 
S. Typhimurium SL1344 fliC::gfp NCTC13347, fliC::gfp Lab stock 
E. coli RM2282 DH5-α, pWM1015; kanamycin resistance USDA-ARS 
laboratory 
E. coli RM2285 DH5-α, pWM1018; kanamycin resistance USDA-ARS 
laboratory 
E. coli RM2286 DH5-α, pWM1019; kanamycin resistance USDA-ARS 
laboratory 
C. jejuni Cj11168H wild-type Hypermotile variant of sequence strain NCTC11168 LSHTM 
Cj11168H/cj0079 Cj11168H Cytolethal distending toxin (CDT) 
mutant; kanamycin resistance 
Lab stock 
Cj11168H/cj1132c to cj1152c Deletion of lipooligosaccharide (LOS)  biosynthesis 
region; Cj11168H LOS mutant; kanamycin 
resistance  
Lab stock 
Cj11168H/cj1339 Cj11168H aflagellate mutant; kanamycin resistance Lab stock 
Cj11168H/cj1413 Deficient in capsule production; Cj11168H acapsular 
mutant; kanamycin resistance 
Lab stock 
C. jejuni Cj11168H CFP reporter Cj11168H, pWM1019; kanamycin resistance This study 
C. jejuni Cj11168H GFP reporter Cj11168H, pWM1015; kanamycin resistance This study 
C. jejuni Cj11168H YFP reporter Cj11168H, pWM1018; kanamycin resistance This study 
C. jejuni Cj81-176_CP Clinical isolate Lab stock 
C. jejuni Cj1 wild-type Clinical isolate from Thailand Lab stock 
Cj1∆tssD(syn)::kanR_cas tssD in Cj1 wild-type was replaced with 
tssD(syn)::kanR_cas; kanamycin resistance  
This study 
Cj1∆tssM(syn)::kanR_cas tssM in Cj1 wild-type was  replaced with 
tssM(syn)::kanR_cas; kanamycin resistance 
This study 
E. coli Top10 Cloning strain used to hold plasmids Invitrogen 
Top10 pGEM_tssD(syn) Transformed pGEM_tssD(syn) into chemically 
competent E. coli Top10; ampicillin resistance 
This study 
Top10 pGEM_tssM(syn) Transformed pGEM_tssM(syn) into chemically 
competent E. coli Top10; ampicillin resistance 
This study 
Top10 pGEM_tssD(syn)::kanR_cas Transformed pGEM_tssD(syn)::kanR_cas into 
chemically competent E. coli Top10; ampicillin and 
kanamycin resistance 
This study 
Top10 pGEM_tssM(syn)::kanR_cas Transformed pGEM_tssM(syn)::kanR_cas into 
chemically competent E. coli Top10; ampicillin and 
kanamycin resistance 
This study 
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Table 2.3: List of eukaryotic strains 
 
Strains Descriptions Sources 
Mouse macrophage-like cells J774A.1 ATCC®TIB-67TM Lab stock 
Mouse macrophage-like cells 
RAW264.7 
ATCC®TIB-71TM Lab stock 
Danio rerio (zebrafish) WIK wild-
type 
Polymorphic relative to the TU line ARC, University of 
Exeter (UoE) 
Danio rerio (zebrafish) AB 
fms:nfsBmcherry transgenic 
mCherry expression in skin xanthphores and 
macrophages; constructed from AB wild-type 
University of Sheffield 
 
  
61 
 
Table 2.4: List of the primers 
Primers Sequences (5'→3') Application in this study 
fha_In_F TCAATGCTTTTTGCATCCAC Checking for fha expression in Cj1 wild-type 
and Cj1∆tssM(syn)::kanR_cas 
fha_In_R AGCGGTGATGATTGCACTTT Checking for fha expression in Cj1 wild-type 
and Cj1∆tssM(syn)::kanR_cas 
FIG_B_In_F CTCGCGATGAATTTGGAAGT Checking for FIG00469624 expression in 
Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas 
FIG_B_In_R TCGAAGTTCTTGCGGAAAAT Checking for FIG00469624 expression in 
Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas 
Kan_out_F CATCCTCTTCGTCTTGGTAGC Checking kanR_cas orientation in T6SS 
mutants with either tssD_Flank_F or tssM_F 
Kan_out_R TTGCCTTCTGCGTCCGGTCG Checking kanR_cas orientation in T6SS 
mutants with either tssD_Flank_F or tssM_F 
Southern_Probe_F TCATCTGCCTTTTCTTCTTCG Probe for southern blot 
Southern_Probe_R CAATTGCGGCTTTTGAAGAT Probe for southern blot 
tssD_Flank_F ATGCCTTCGATCAAGTCGAG 1) Check for double crossover in 
Cj1∆tssD(syn)::kanR_cas  
2) Checking kanR_cas orientation in T6SS 
mutants with Kan_out_F and Kan_out_R 
tssD_Flank_R ATGTGGGCGGTATTTCAATG Check for double crossover in 
Cj1∆tssD(syn)::kanR_cas 
tssD_In_F CAAGCGGTGCATCTACTGAA 1) Checking for deletion of tssD 
2) Checking for tssD expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
tssD_In_R GTTCAGATCCGCCACTTGTT 1) Checking for deletion of tssD 
2) Checking for tssD expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
tssL_In_F TTTCCGCCTAAAGTTTCATCA Checking for tssL expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
tssL_In_R TTTGGAGTTGCTTTTGCTTTC Checking for tssL expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
tssM_F TCAATGCTTTTTGCATCCAC Checking kanR_cas orientation in T6SS 
mutants with Kan_out_F and Kan_out_R 
tssM_Flank_F TTTTCCGCAAGAACTTCGAG Check for double crossover in 
Cj1∆tssM(syn)::kanR_cas  
tssM_Flank_R TTTGGAGTTGCTTTTGCTTTC Check for double crossover in 
Cj1∆tssM(syn)::kanR_cas 
tssM_In_F GGCATCTTTATTGCCTCCAA 1) Checking for deletion of tssM 
2) Checking for tssM expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
tssM_In_R CGCTTCATTGCAACCTGTTA 1) Checking for deletion of tssM 
2) Checking for tssM expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
VgrG_Contig_20_10_F TGAGCATGGAAGGGTTAAGG 1) Confirmation for scf_30956_20_contig_1 
joining to scf_30956_10_contig_1 
2) Checking for tssI expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
VgrG_Contig_20_10_R TGTCTTTGTTTTCTCCTACAAACTC 1) Confirmation for scf_30956_20_contig_1 
joining to scf_30956_10_contig_1 
2) Checking for tssI expression in Cj1 wild-
type and Cj1∆tssM(syn)::kanR_cas 
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2.2 Bacterial cell culture 
 
2.2.1 Escherichia coli 
 
E. coli strains were propagated on Luria Bertani (LB) agar or in LB broth.  When appropriate, 
the media were supplemented with either 50 µg/ml ampicillin or 50 µg/ml kanamycin.  The 
agar cultures were incubated at 37°C while broth cultures were incubated at 37°C with 
agitation at 200 revolution per minute (rpm).  The bacterial cells were revived from -80°C 
storage by streaking onto LB agar, passage one (P1); the cells were not propagated beyond 6 
passages. 
 
2.2.2  Salmonella Typhimurium 
 
S. Typhimurium SL1344 wild-type and fliC::gfp were propagated on LB agar or in LB broth.  
When appropriate, the bacterial were also propagated in Minimal media (MM) broth pH 5.8 
or LB broth where 70% of water was replaced by deuterium oxide (D2O).  The MM broth 
was made up of 1X M9 Minimal Salt (Sigma Product no. M6030), 10 µM Magnesium 
chloride, 0.16% (w/v) glycerol and 0.1% (w/v) casamino acid.  The agar cultures were 
incubated at 37°C while broth cultures were incubated at 37°C with agitation at 200 rpm.  
The bacterial cells were revived from -80°C storage by streaking onto LB agar, P1; the cells 
were not propagated beyond 6 passages.   
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2.2.3  Campylobacter jejuni 
 
C. jejuni Cj11168H, Cj81-176_CP and Cj1 wild-type and mutant strains were propagated on 
Columbia blood agar (Oxoid, Product code: CM0331) supplemented with 5% defibrinated 
horse blood (Oxoid, Product code: SR0050) (CBA) and Campylobacter selective supplement, 
Skirrow (CBA+), or in Muller Hinton broth (MHB).  When appropriate, the CBA+ media 
were supplemented with 50 µg/ml kanamycin.  The agar and broth cultures were incubated at 
either 42°C or 37°C in a microaerobic environment of 5% oxygen, 10% carbon dioxide (CO2) 
and 85% Nitrogen.  The bacterial cells were revived from -80°C storage by streaking onto 
CBA+, P1; the cells were not propagated beyond 4 passages. 
 
The quantification of C. jejuni cells were performed in serial dilutions; each dilution was 
spotted onto Muller Hinton Agar (MHA) plates in triplicate, 10 µl per spot.  The plates were 
then incubated at 37°C under a microaerobic environment for about 48 hours before counting. 
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2.3 Eukaryotic cell culture 
 
2.3.1 Mouse macrophage-like cells J774A.1 and Raw267.4 
 
The macrophage-like cells, J774A.1 and RAW264.7, were propagated in Dulbecco's 
modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS).  The cell line cultures were maintained in a humidified incubator aerated with 5% 
CO2.  The cell lines was sub-cultivated when they reached between 70-80% confluence, in a 
ratio of 1:3 to 1:6, and spent media was replaced with fresh media every two to three days.  
The macrophage-like cells were revived from -80°C storage by seeding into a T25 flask with 
10 ml of fresh media, P1; the cells were not propagated beyond 20 passages. 
 
2.3.2 Zebrafish WIK wild-type and AB fms:nfsBmCherry transgenic line 
 
The adult zebrafish were maintained by Aquarium Research Centre (ARC) at UoE.   
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2.4 Nucleic acid extraction 
 
2.4.1 Genomic DNA (gDNA)  
 
All gDNA used in this study was extracted using Promega's Wizard® Genomic DNA 
Purification kit according to the manufacturer's protocol with slight modifications.  When 
gDNA was extracted from C. jejuni cells, cells from CBA+ plates were picked up using a 
sterile cotton swabs moistened with sterile phosphate buffered saline (PBS) into 2 milli-litre 
(ml) micro-centrifuge tubes containing 1 ml of PBS.  Cells were dislodged from the swab into 
the solution.  Cells in suspension were collected to the bottom of each tube through 
centrifugation at 16.1 thousand times g-force (16,100 x g) for 5 minutes (min) at room 
temperature.  The cell pellets were dislodged into 600 microlitre (µl) of Nuclei Lysis Solution 
from the extraction kit.  The remaining steps of genomic DNA extraction were carried out 
according to the manufacturer's protocol.  The concentration of the extracted gDNA was 
determined by Nanodrop. 
 
2.4.2 Plasmid DNA 
 
All plasmid DNA used for electroporation in this study was extracted using Promega's 
PureYieldTM Plasmid Midiprep System according to the manufacturer's protocol.  The 
volume of overnight cultures used was 100 ml.  The extracted plasmid DNA was further 
concentrated by ethanol precipitation.  A 1/10 volume of 3M sodium acetate at pH 5.2 was 
added to the extracted plasmid DNA followed by addition of 2.5 volume (volume calculated 
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after addition of sodium acetate) of ice-cold 100% ethanol.  The mixture was then incubated 
at -20°C for a minimum of 30 min.  After this, the mixture was centrifugated at 20,000 x g at 
4°C for 15 min.  The supernatant was discarded and 1 ml of 70% ice-cold ethanol was added 
to rinse the plasmid DNA pellet.  The pellet was collected at the bottom of the tube by 
centrifugation at 20,000 x g at 4°C for 5 min.  The supernatant was discarded and the pellet 
was air dried.  Once dried, the pellet was resuspended in nuclease-free water.  The 
concentration of the extracted plasmid DNA was determined by Nanodrop. 
 
Plasmids used for ligation in this study were extracted using QIAprep Spin Miniprep Kit 
(Qiagen, Product code: 27104) according to the manufacturer's protocol 
 
2.4.3 RNA 
 
All RNA used in this study was extracted using MP Biomedicals Fast RNA® Pro Blue kit 
according to the manufacturer's protocol with slight modifications.  The bacterial cell 
suspensions in RNAproTM solution were transferred into a tube containing Lysing Matrix B 
and subjected to three beats in a Precellys machine set to 6500 rpm for 20 seconds each.  The 
cell suspensions were chilled on ice for 5 min between each beating.  The RNA pellet was 
resuspended in 100 µl of RNA storage solution (Ambion, Product code: AM7001) at room 
temperature for 5 min.  The concentration of the extracted RNA was determined by 
Nanodrop. 
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2.5  Mutant construction 
 
2.5.1 Transforming plasmids into E. coli Top10 cells 
 
The transformation of One Shot® Chemically Competent E. coli Top10 cells from Invitrogen, 
TOPO TA Cloning kit was performed according to the manufacturer's protocol with slight 
modifications.  Either 5 µl of plasmid DNA of pGEM_tssD(syn) or pGEM_tssM(syn) 
rehydrated according to manufacturer's protocol - or 10 µl of ligated product for 
pGEM_tssD(syn)::kanR_cas or pGEM_tssM(syn)::kanR_cas was used instead of PCR 
products.  When appropriate, the transformed cells were cultured on LB agar supplemented 
with either 50 µg/ml ampicillin or 50 µg/ml kanamycin.  The resulted strains were Top10 
pGEM_tssD(syn), Top10 pGEM_tssM(syn), Top10 pGEM_tssD(syn)::kanR_cas and Top10 
pGEM_tssM(syn)::kanR_cas. 
 
2.5.2 C. jejuni fluorescence reporters  
 
2.5.2.1 Making electro-competent C. jejuni cells 
 
Two to three colonies of C. jejuni grown on CBA+ passage 1 (P1) plates were picked and 
streaked onto fresh CBA+ plates, which is the second passage (P2) of the cells.  P2 plates 
were incubated under the same conditions, at 42°C for approximately a day.  Cells from P2 
plates were used to inoculate four fresh CBA+ plates as a third passage (P3) to obtain lawn 
growth after approximately a day.  Cells were harvested from four P3 plates cultured 
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overnight at 42 °C under microaerophilic conditions on CBA+ plates using sterile cotton 
swabs moistened with MHB into 2 ml micro-centrifuge tube containing 1.5 ml of MHB.  
Cells were then collected at the bottom of the tube by centrifugation at 11,000 x g for 5 min 
at 4 °C.  The cell pellet was washed three times with 1 ml of ice-cold 272 millimolar (mM) 
sucrose containing 15% (v/v) glycerol (filtered sterilised) and centrifuged at 11,000 x g for 10 
min at 4 °C.  After the final wash the cell pellet was re-suspended in 1 ml of sucrose-glycerol 
solution and aliquoted into ice-chilled 1.5 ml micro-centrifuge tubes, 50 µl each, and stored 
on ice ready for the electroporation reaction.   
 
2.5.2.2 Transformation of competent C. jejuni cells 
 
A total of 50 µg of plasmid DNA either pWM1015 (containing green fluorescent protein, 
GFP), pWM1018 (containing yellow fluorescent protein, YFP) or pWM1019 (containing 
cyan fluorescent protein, CFP), was added to 50 µl of electro-competent C. jejuni cells, 
mixed with gentle tapping and incubated on ice for 30 min.  After 30 min incubation the 
mixture was transferred to an ice-chilled electroporation cuvette (BioRad, Product code: 165-
2082).  The cells were pulsed at 2500 volt (V) with capacitance set to 25 micro-farad and 
resistance set to 200 ohms using the Gene Pulser XcellTM Total System (BioRad, Product 
code: 165-2660).  After pulsing the cuvette was returned immediately to ice and 100 µl of 
ice-cold S.O.C. medium (Invitrogen, Product code: 15544-034) was added to each cuvette.  
The transformed cells were transferred onto CBA plates.  The cuvette was rinsed with 
another 100 µl of S.O.C. media and transferred onto the same plate.  The cells were gently 
spread over the surface of the agar.  The agar plates were incubated in an upright position at 
42 °C, under microaerophilic conditions for 5 hr.   
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After 5 hr of incubation 500 µl of MHB was added to each plate and cells were gently 
scraped off the agar surface.  The cell suspension was transferred onto three CBA plates 
supplemented with 50 µg/ml of kanamycin (CBA-kan50 plates) with 120 µl of cell 
suspension each.  The plates were incubated at 42 °C under microaerophilic conditions until 
colonies were observed, or up to 5 days.  Transformed colonies formed on CBA-kan50 plates 
were picked and streaked on to CBA+ plates supplemented with 50 µg/ml of kanamycin 
(CBA+/kan50 plates) and incubated under similar conditions for 2 days.  The resulting strains 
were Cj11168H GFP reporter, Cj11168H YFP reporter and Cj11168H CFP reporter.  The 
fluorescence signals of transformed cells were checked under the fluorescence microscope. 
    
2.5.3 C. jejuni Cj1 T6SS mutants  
 
2.5.3.1 Digestion of pGEM_tssD(syn), pGEM_tssM(syn) and pJMK30 
 
The extracted plasmids DNA was digested in a 50 µl reaction containing 1 µl of 20U/µl 
BamHI (New England BioLabs, Product code: R0136S), 5 µl of NE Buffer 3, 0.5 µl of 10 
mg/ml bovine serum albumin (BSA), either 20 µg of pJMK30 or 5 µg of pGEM_tssD(syn) or 
pGEM_tssD(syn) and topped up with nuclease-free water to final volume.  The reaction mix 
was incubated at 37°C for an hour.  The digested products were separated in a 1% agarose gel 
electrophoretically.  Two bands were obtained from pJMK30, approximately 2.6 kilo-bases 
(kb) and 1.5 kb respectively.  The smaller band of approximately 1.5 kb, consisting of the 
kanR_cas was excised from the gel.  Single bands were obtained from pGEM_tssD(syn) and 
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pGEM_tssM(syn) respectively and were excised from the gel.  The excised bands were eluted 
from the gel using QIAquick Gel Extraction Kit (Qiagen, Product code: 28704) according to 
the manufacturer's protocol, with slight modifications.  An additional PE buffer wash step 
was incorporated and final elution was carried out with 30 µl of nuclease-free water.  Purified 
kanR_cas and digested pGEM_tssD(syn) and pGEM_tssM(syn) were quanititated using the 
NanoDrop 1000 spectrophotometer.   
 
2.5.3.2 Ligation of kanR_cas to pGEM_tssD(syn) and pGEM_tssM(syn) and 
transformation into E.coli Top10 cells 
 
The kanR_cas (insert) was ligated to digested plasmids (pGEM_tssD(syn) and 
pGEM_tssM(syn) respectively).  The amount of insert DNA required per 100 ng of plasmid 
DNA was 150 ng, calculation based on ratio of 4:1 (insert:plamid) according to the formula 
below: 
 
Amount of insert = 
(((100 ng of plasmid DNA) x (insert size: ~1.5 kb)) / (plasmid size: ~4 kb)) x 4 
 
The ligation reaction mixture of final volume 20 µl contained 1 µl of 1-3 U/µl of T4 DNA 
Ligase (Promega, Product code: M1801), 2 µl of 10X Ligase buffer, 172.5 ng of kanR_cas, 
100 ng of either digested pGEM_tssD(syn) or pGEM_tssM(syn) and topped up with 
nuclease-free water to final volume.  The positive control used digested pJMK30 vector and 
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kanR_cas, while the negative control was nuclease-free water.  The reaction mixtures were 
incubated at 16°C overnight.  After overnight ligation the resulting plasmids were 
pGEM_tssD(syn)::kanR_cas and pGEM_tssM(syn)::kanR_cas respectively.  10 µl of each 
plasmids was added to chemically competent E. coli Top 10 cells according to section 2.5.1. 
 
2.5.3.3 Transformation of competent C. jejuni cells 
 
50 µl of either pGEM_tssD(syn)::kanR_cas or pGEM_tssM(syn)::kanR_cas plasmid DNA was 
added to the electro-competent cells, then gently tapped to mix and incubated on ice for 30 
min.  The amount of plasmid DNA used was 6.6 µg for pGEM_tssD(syn)::kanR_cas and 10.6 
µg for pGEM_tssM(syn)::kanR_cas.  Electro-competent cells and electroporation were 
performed was described in section 2.5.2.1 and 2.5.2.2 respectively.  The resulting strains 
were Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas.   
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2.6 PCR 
 
2.6.1 PCR for products less than 1000 base-pairs (bp) 
 
All primers used in this study were designed using Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/).  PCR was performed in 
50 µl reactions containing 0.5 µl of 5 U/µl of Taq polymerase (NEB, Product code: M0273S), 
5 µl of 10X NEB Taq reaction buffer, 1 µl of 10 mM of deoxyribo-nucleotides (dNTPs), 2 µl 
of 10 µM of forward primer, 2 µl of 10 µM of reverse primer, 37.5 µl of nuclease-free water 
and 2 µl of 1/10 diluted gDNA (from wild-type or mutants), plasmid DNA or first strand 
complementary DNA (cDNA).  The PCR reaction mixture was subjected to initial 
denaturation at 94°C for 10 min, followed by 35 cycles of denaturation at 94°C for 30 
seconds (s), annealing at 56°C for 1 min and elongation at 72°C for 2 min, and final 
elongation at 72°C for 7 min.  gDNA from wild-type or plasmid DNA were used as positive 
controls; while nuclease-free water was used as negative controls.  The products were 
visualised under UV light after they were run electrophoretically through a 1% agarose gel.     
 
2.6.2 PCR for products more than 1000 bp 
 
PCR was performed in 50 µl reactions containing 1 µl of 1U/µl of KOD XtremeTM Hot Start 
DNA polymerase (Novagen®, Product code: 71975-3), 25 µl of 2X Xtreme buffer, 2 µl of 10 
mM of dNTPs, 1.5 µl of 10 µM of forward primer, 1.5 µl of 10 µM of reverse primer, 17 µl 
of nuclease-free water and 2 µl of 1/10 diluted gDNA (from wild-type or mutants) or plasmid 
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DNA.  The PCR reaction mixture was subjected to initial denaturation at 94°C for 2 min, 
followed by 35 cycles of denaturation at 98°C for 10 s, annealing at 56°C for 30 s and 
elongation at 68°C for 3 to 6.5 min (depending on product size).  gDNA from wild-type or 
plasmid DNA were used as positive controls - while nuclease-free water was used as negative 
controls.  The products were visualised under ultra-violet (UV) light after they were run 
electrophoretically through a 0.8% agarose gel.     
 
2.6.3 Reverse-transcription (RT)  PCR   
 
5 µg of RNA were pre-treated with TURBO DNA-freeTM kit (Ambion, Product code: 
AM1907) according to the manufacturer's protocol.  10 µl of TURBO treated RNA was used 
for reverse transcription to make first strand complimentary DNA (cDNA).  The first strand 
cDNA was made using SuperScriptTM III Reverse Transcriptase (Invitrogen, Product code: 
18080-093) according to the manufacturer's protocol.  The first strand cDNA was then used 
for PCR as described above in section 2.6.1.  RNA without SuperScriptTM III Reverse 
Transcriptase treatment was used as non-RT control.  
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2.7 Southern Blot 
 
2.7.1 Digestion of gDNA 
 
The extracted gDNA of Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas was digested in a 50 µl reaction containing 5 µl of 2U/µl BspCNI 
(New England BioLabs, Product code: R0624S), 5 µl of NE Buffer 4, 0.5 µl of 10 mg/ml 
BSA, 0.5 µl of 2 mM S-adenosylmethionine, 5 µg of gDNA and topped up with nuclease-free 
water to final volume.  The reaction mix was incubated at 25°C for an hour.  The enzyme was 
heat inactivated at 80°C for 20 min.  The digested products were separated electrophoretically 
in a 0.8% agarose gel. 
 
2.7.2 Depurination and denaturation DNA in gel 
 
The agarose gel was depurinated in 250 mM hydrochloric acid (HCl) until the bromophenol 
blue marker changed from blue to yellow at room temperature with gentle shaking.  After this, 
the gel was rinsed twice in Milli-Q (MQ) water.  The DNA in the gel was then denatured in 
two changes of solution containing 0.5M sodium hydroxide (NaOH) and 1.5M sodium 
chloride (NaCl) for 15 min each at room temperature with gentle shaking.  The gel was rinsed 
twice again using MQ water.  The denaturation process was neutralised by soaking the gel in 
two changes of 0.5M Tris-HCl at pH 7.5 and 1.5M NaCl for 15 min each at room temperature.  
Finally the gel was equilibrated in 20X saline-sodium-citrate (SSC) buffer for 10 min.   
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2.7.3 Blotting to membrane 
 
The denatured DNA in the gel were transferred onto a positively-charged nylon membrane, 
Hybond N+ (Amersham, Product code: RPN119B) according to the set-up illustrated in 
Figure 2.1. 
 
The DNA in the gel was transferred to the membrane overnight at room temperature.  After 
the overnight transfer, the membrane was baked at 80°C between two dry Whatman paper for 
two hours (hr) and the membrane was ready for hybridisation. 
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Figure 2.1: Set-up for transferring DNA from gel onto Hybond N+ membrane.  Four pieces of Whatman paper 
and Hybond N+ membrane were cut to the size of the gel.  A Whatman paper wick was cut to the 
width of the gel but extended in length, long enough to reach the 20X SSC reservior.  The gel-sized 
Whatman papers  were soaked with 20X SSC buffer.  The set-up was assembled as illustrated.  Any air 
bubbles between the gel, membrane and Whatman paper were removed. 
 
 
  
Support tray
Cling film
Absorbent paper
Whatman paper
Positively-charged 
nylon membrane
Agarose gel
Whatman paper wick 
into 20X SSC reservoir 
20X SSC reservoir 
Gel casting tray
Weight (200-500 g) 
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2.7.4 Construction of a probe for the Southern blot 
 
The probe was made using a PCR DIG Probe synthesis kit (Roche, Product code: 
11636090910).  The reaction mixture of final volume 50 µl contained 0.75 µl of Expand 
High Fidelity Enzyme mix, 5 µl of 10X DIG PCR buffer with magnesium chloride (MgCl2), 
2.5 µl of 10X DIG synthesis mix, 2.5 µl of 10X dNTPs stock, 2 µl of Southern_Probe_F, 2 µl 
of Southern_Probe_R, 34.25 µl of nuclease-free water and 1 µl of 1/10 gDNA extracted from 
Cj1 wild-type cells or 1 µl of nuclease-free water as negative control.  The reaction mixture 
was subjected to initial denaturation at 95°C for 2 min, followed by 40 cycles of denaturation 
at 95°C for 30 s, annealing at 56°C for 30 s and elongation at 72°C for 40 s, and final 
elongation at 72°C for 7 min.  The products were viewed under UV light after they were run 
electrophoretically through a 1% agarose gel. 
 
2.7.5 Hybridisation of DIG-labelled probe to blotted membrane 
 
The optimal hybridisation (hyb) temperature was 38.6°C, calculated based on the formula 
below:  
Tm = 49.82 + 0.41(%G+C) - 600/L 
Thyb = Tm - (20-25 °C) 
Tm:  melting point of probe-target hybrid 
(%G+C):  % of G and C residues in probe sequence [26% for Southern_Probe] 
L:  length of hybrid in base pairs [322 bp for Southern_Probe] 
Thyb:  optimal temperature for hybridisation of probe to target in DIG Easy Hyb 
buffer [33.6 – 38.6 °C for Southern_Probe, used 38.6 °C] 
 
The membrane  was placed inside a hybridisation chamber (cylindrical drum) with the DNA 
side facing up (inwards of drum) and soaked with 25 ml of pre-warm DIG Easy Hyb buffer 
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and then incubated with gentle rotation in a pre-warmed oven set to 38.6°C for 30 min.  20 µl 
of DIG-labelled Southern_Probe was added to 50 µl of nuclease-free water, heated to 100°C 
for 5 min, chilled immediately on ice and transferred to 10 ml of pre-warmed DIG Easy Hyb 
buffer.  After the 30 min incubation of pre-hyb the pre-hyb buffer was discarded and replaced 
with buffer containing the Southern_Probe.  The membrane was incubated at 38.6°C 
overnight with gentle mixing.  After overnight incubation the membrane was retrieved from 
the chamber into 200 ml of low stringency buffer made up of 2X SSC and 0.1% sodium 
dodecyl sulfate (SDS) and incubated at room temperature with shaking for 5 min.  The low 
stringency buffer was then discarded and replaced with fresh buffer.  The membrane 
continued to incubate in the fresh buffer for another 5 min at room temperature with shaking.  
After this, the membrane was transferred into high stringency buffer made up of 0.5X SSC 
and 0.1% SDS and pre-warmed to 65 °C.  The membrane was incubated in the warmed high 
stringency buffer for 15 min with shaking at 65°C.  The high stringency buffer was then 
discarded and replaced with fresh buffer.  The membrane continued to incubate in the fresh 
buffer for another 15 min at 65°C with shaking.                     
 
2.7.6 Detection of Southern_Probe hybridised to blotted membrane 
 
The hybridised membrane was washed and blocked using solution from the DIG Wash and 
Block Buffer Set (Roche, Product code: 11585762001).  The membrane was transferred into 
250 ml of 1X Washing Buffer with the DNA side facing up and incubated at room 
temperature with shaking for 2 min.  The Washing Buffer was then discarded and replaced 
with 250 ml of 1X Blocking Buffer.  The membrane was incubated in Blocking Buffer at 
room temperature for 30 min with shaking.  The detection antibody, anti-Digoxigenin-AP 
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(Roche, Product code: 11093274910) was diluted 1:10,000 using 1X Blocking Buffer to a 
final volume of 50 ml.  After the 30 min incubation in Blocking Buffer the buffer was 
discarded; the membrane was overlaid with 50 ml of the antibody solution and incubated for 
30 min with shaking at room temperature.  The antibody solution was discarded and the 
membrane was washed twice in 1X Washing Buffer, for 15 min each.  The membrane was 
then equilibrated in 50 ml of 1X Detection Buffer for 3 min.  After equilibration, the 
membrane was transferred onto a plastic film with the DNA facing up and CDP-Star (Roche, 
Product code: 12041677001) was added drop-wise onto the membrane till it was just 
sufficient to cover the entire surface.  A second sheet of plastic film was placed over the 
membrane to spread the substrate evenly.  The membrane sandwiched between the two 
plastic films was transferred to the BioRad gel imager with a ruler.  The Chemi Hi Sensitivity 
mode was selected and the filter slider was moved to the "no filter" position.  Images were 
captured and saved every minute between 600 and 1200 s of exposure.        
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2.8 SDS-Polyacrylamide gel electrophoresis (PAGE)  
 
2.8.1 Precipitation of proteins in culture supernatant 
 
Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas were cultured in 2 x 
50 ml of MHB.  After 24 hr incubation at 37°C, broth cultures from both flasks were pooled 
and transferred to two 50 ml centrifuge tubes; 47.5 ml of the culture each.  Cells were 
collected at the bottom of the tubes by centrifugation at 11,000 x g for 15 min at 4 °C.  
Culture supernatants were carefully decanted into a 50ml syringe attached to 0.20 µm filter 
disc, and filtered into clean 50 ml tubes.  Cell pellets were stored at -20°C.  Proteins present 
in culture supernatant filtrate were extracted using trichloroacetic acid (TCA).  The filtrate 
was split into four 50 ml centrifuge tubes, each containing 20 ml.  5 ml of 100% TCA was 
added to each tube and incubated on ice for 45 min to precipitate proteins present in the 
culture supernatant filtrate.  After incubation on ice, precipitated proteins were collected at 
the bottom of each tube by centrifugation at 20,000 x g for 5 minutes at 4°C.  The protein 
pellets were washed twice with ice-cold acetone, 10 ml per wash.  After the second wash the 
pellets were dislodged into 5 ml ice-cold acetone in each tube and pooled.  The precipitated 
proteins in the acetone suspension were collected with centrifugation.  A millilitre of protein 
suspension was transferred to a clean 1.5 ml micro-centrifuge tube  and centrifuged at 15,000 
x g for 30 s at 4°C - supernatant was discarded and another millilitre of protein suspension 
was added to the tube.  The process was repeated until the entire volume of protein 
suspension was spun down.  After the last centrifugation acetone was discarded and the 
protein pellet was dried at approximately 90°C on a heat block for 30 s to 1 min.  The protein 
pellet was rehydrated with 1 ml of PBS and stored at 4°C.  The concentrations of each protein 
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samples were quantified by PierceTM BCA Protein Assay kit (Thermo Scientific, Product 
code: 23227) according to the manufacturer's protocol with slight modifications.  The volume 
of the protein samples used was 10 µl and the volume of the BCA Working Reagent used per 
well was 180 µl.  Each protein samples was then adjusted to a concentration of 0.5 mg/ml. 
 
2.8.2 Extraction of protein in cell pellet 
 
The cell pellets (from 47.5 ml culture) of Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas were thawed and lysed in 2.5 ml of 1X BugBuster Protein 
Extraction Reagent (Novagen, Product code: 70750-3).  2.5 µl of Benzonase® (Novagen, 
Product code: 70750-3) was added followed by 2.5 µl of 1kU/µl of rLysozymeTM solution 
(Novagen, Product code: 71110-3).  The mixtures were incubated at room temperature for 20 
min on a rocking platform.   
 
2.8.3 Separation of proteins in gel 
 
The protein samples from culture supernatant and cell pellets were mixed with 4X NuPAGE 
LDS Sample Buffer (Invitrogen, Product code: NP0008) prior to loading.  The final 
concentration of LDS Sample Buffer in each sample was 1X.  The mixture was then heated at 
95°C for 5 min and chilled on ice.  10-15 µl of each mixtures was loaded into individual 
wells on pre-cast NuPAGE 4-12% Bis-Tris Gel 1.0 mm x 12 well (Novex, Product code: 
NP0322Box) assembled into a XCell SureLock® Mini-Cell according to the manufacturer's 
instructions.  Protein markers, Perfect Protein™ Markers 10-225 kilo-Dalton (kDa) (Novagen, 
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Product code: 69079-3), were loaded into the first and last well on each gel, 5 µl per well.  
The gels were set to run at 185 V for 35 minutes in 1X NuPAGE MES SDS Running Buffer 
(Invitrogen, Product code: NP0002) or until the blue dye reached the end of the gel.  After 
electrophoresis the gel was rinsed three times in MQ water.  The gel was stained with 
SimplyBlue™ SafeStain (Invitrogen, Product code: LC6060) according to the manufacturer's 
protocol.  The microwave procedure was used for culture supernatant protein samples and the 
basic protocol was used for cellular protein samples.  The images of the gel were captured 
using Odyssey CLx imaging system (LI-COR). 
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2.9 Mass spectrometry  
 
2.9.1 Protein samples from culture supernatant 
 
The culture supernatant protein samples were analysed by the UoE, Biosciences - Mass 
Spectrometry Facility.  The samples were put through nano-liquid chromatography (LC) in-
line with quadrupole time-of-flight (Q-TOF) 6520 (Agilent) mass spectrometer coupled to a 
1200 series HPLC-Chip interface system.  1µl of each sample was loaded onto a high 
capacity micro C18 reverse phase analytical column (Agilent Protein Identification Chip, 
75µm x 150mm).  The enrichment column flow rate was 3 µl/min and the analytical column 
flow rate was 0.3 µl/ min.  Buffer A was 2% acetonitrile with 0.1% formic acid in water and 
buffer B was 95% acetonitrile with 0.1% formic acid in water.  The peptides were separated 
using the following gradient, 0 min – 0% Buffer B, 9 min – 70% Buffer B, 12mins – 100% 
Buffer B.   
 
Peak extraction and protein identification were carried out using Spectrum Mill MS 
Proteomics Workbench software (Agilent).  Databases were obtained from NCBI or ExPASy, 
and searches were restricted to relevant species. 
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2.9.2 Protein samples from cell pellet 
 
The stained gel containing cellular proteins was de-stained in MQ water overnight.  A region 
on the gel containing proteins between 15 to 35 kDa was excised and sent to UoE 
Biosciences - Mass Spectrometry Facility for mass spectrometry analysis.  As the samples 
were complex the digested solutions were separated using the following gradient: 0 min – 2 % 
Buffer B, 65 min – 30% Buffer B, 100 min – 60% Buffer B, 120 min – 100% Buffer B, 122 
min – 2% Buffer B with a 7 min equilibration time.   
 
  
85 
 
2.10 Whole genome sequencing 
 
A fraction of extracted genomic DNA was run on 1% agarose gel to ensure that there was no 
degradation of the extracted genomic DNA.  After quality of extracted genomic DNA was 
ascertained the materials were handed over to UoE Bioscience - Sequencing Facility, where 
they performed library preparation and ran the samples through Illumina high-
throughput HiSeq 2500 with paired-end reads of 100 bp.   
 
In brief, library preparation involved shearing genomic DNA into fragments of 200-600 bp 
using Covaris, ligating adaptors on to the end of each strand and attaching each strand on to 
an Illumina flow cell.  Each strand on the flow cell was then amplified by bridge PCR on the 
Illumina cBot to generate a cluster of identical sequence, after which, sequencing primers 
were annealed and DNA was synthesised to 100 bp using fluorescent nucleotides.  The 
incorporated nucleotide was read and bases called.  When the first read was completed, the 
DNA clusters on the flow cell were re-generated to proceed with the sequencing of 
complementary strands for paired-end reads.      
 
Data from Illumina was analysed in a standard Illumina pipeline to generate 100 bp 
fragments and was subjected to de-novo assembly to create contigs.  The contigs were 
uploaded onto MG-RAST metagenomics analysis server (http://metagenomics.anl.gov/) for 
annotation.   
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2.11 Growth curve 
 
2.11.1 S. Typhimurium SL1344 wild-type 
 
Two to three colonies of S. Typhimurium grown on LB agar plates were inoculated into LB 
broth and incubated overnight.  The optical density of the overnight culture was determined 
at 590 nm (OD590).  The overnight culture was then diluted to obtain 40 ml of OD590 
approximately 0.1.  3 ml of the diluted culture were aliquoted into universal tubes and 
incubated.  At each time-point, a tube was retrieved from the incubator and OD590 was 
determined.   
 
2.11.2 C. jejuni Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssD(syn)::kanR_cas 
 
Two to three colonies of C. jejuni grown on CBA+ passage 1 (P1) plates were picked and 
streaked onto fresh CBA+ plates - which is second passage (P2) of the cells.  P2 plates were 
incubated under the same conditions for approximately a day.  Cells from P2 plates were used 
to inoculate third passage (P3) plates to obtain a lawn growth on fresh CBA+ plates after 
culturing under the same conditions for approximately a day.  Cells harvested from P3 plates 
were dislodged into 1 ml of MHB and OD590 was determined.  The cell suspensions were 
then diluted to obtain 50ml of OD590 approximately 0.1.  MHB was used for the adjustment 
of the cell suspension, which was pre-incubated overnight at 37°C under microaerophilic 
conditions.  The 50 ml culture was marked as fourth passage (P4).  The OD590 of the P4 
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cultures were read at the various time points.  The growth curve was performed with three 
biological replicates. 
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2.12 Bacterial-host interaction assays 
 
2.12.1 S. Typhimurium - macrophages infection assays 
 
2.12.1.1 Preparation of J774A.1 cells for infection 
 
J774A.1 macrophage-like cells were harvested from standard T75 culturing flasks using a 
cell scraper.  The cells were stained with trypan blue and viable cell density was determined 
using a haemocytometer.  The cells were then seeded into 35 mm diameter µ-Dish, with 
either a glass bottom (Ibidi, Product code: IB-81158) or a standard bottom (Ibidi, Product 
code: IB-81156) at density of 4x105 cells per dish.  The glass bottom µ-Dishes were used for 
SRS imaging while the standard bottom µ-Dishes were used for Confocal imaging.   
 
The cells were allowed to attach to the bottom of the dish overnight.  After overnight 
incubation, the cells were washed twice using L-15 media pre-warmed to 37°C.   
 
2.12.1.2 Preparation of S. Typhimurium for infection 
 
SL1344 wild-type or SL1344 fliC::gfp were grown in LB broth or LB-D2O broth overnight.  
The overnight cultures were diluted to OD590 of approximately 0.1 using the appropriate 
media, and incubated for another 2 hr, until OD590 was approximately 0.5.  The bacterial cell 
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density at OD590 of 1 is equivalent to 5x108 CFU/ml.  The bacterial suspension was adjusted 
to density of 4x107 cfu/ml in L-15 media pre-warmed to 37°C.   
 
2.12.1.3 Infection of J774A.1 cells with S. Typhimurium 
 
The L-15 media in the µ-Dishes was discarded and the monolayer J774A.1 cells were 
overlaid with 1 ml of bacterial suspension at density of 4x107 CFU/ml; the multiplicity of 
infection (MOI) was 100.  The cells were incubated at 37°C for an hour after which the 
bacterial cell suspension was aspirated out and the J774A.1 monolayer was overlaid with 2 
ml of L-15 media containing 100 µg/ml gentamicin.  At this point, the time point was set at 
T0.  The cells were returned to the incubator for another hour.  At T1 the L-15 media with 
100 µg/ml gentamicin was discarded and was replaced with 2 ml of L-15 media containing 
10 µg/ml gentamicin.  The cells were imaged at T2 by SRS or fixed for Confocal imaging 
(refer to section 2.12.1.4).   
 
2.12.1.4 Fixing of infected J774A.1 cells 
 
At T2, the media was discarded and the cells were rinsed three times with sterile PBS and 
overlaid with 4% para-formaldehyde (PFA) for 10 min to fix the cells.  After this, the cells 
were then rinsed twice with PBS and washed three times in PBS with shaking for 5 min each.  
After the last wash, Vectashield-DAPI (Vector Laboratories, H-1200) was dropped over the 
cells and the µ-Dishes were stored in the dark at 4°C ready for Confocal imaging. 
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2.12.2 C. jejuni - macrophages infection assays 
 
2.12.2.1 Preparation of RAW264.7 cells for infection 
 
RAW264.7 macrophage-like cells were harvested from standard T75 culturing flasks using a 
cell scraper.  The cells were stained with trypan blue and viable cell density was determined 
using a haemocytometer.  The cells were then seeded into each well of two 24-well plates at a 
density of 2x105 cells per well.  The cells were allowed to attach to the bottom of the wells 
overnight.  After overnight incubation the cells were washed twice using DMEM 
supplemented with 1% FBS (DMEM-1%FBS), pre-warmed to 37°C. 
 
2.12.2.2 Preparation of Cj1 cells for infection 
 
Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssD(syn)::kanR_cas cells harvested from 
P3 plates and dislodged into 1 ml of MHB and OD590 was determined.  The cell suspension 
were then diluted to obtain 28 ml of OD590 approximately 0.1.  MHB was used for the 
adjustment of the cell suspension, which was pre-incubated overnight at 37 °C under 
microaerophilic conditions.  The 28 ml culture was marked as fourth passage (P4) and was 
aliquoted into a 24-well plate; 1 ml per well and 1 plate per strain.  The P4 cultures were 
incubated at 37°C under microaerophilic conditions for approximately 24 hours.  After 24 
hours of incubation the broth cultures from each well of the same plate were pooled.  The 
bacterial cells were collected at the bottom of the tube by centrifugation at 11,000 x g for 5 
min at room temperature.  The cell pellets were resuspended in 2 ml of pre-warmed DMEM 
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supplemented with 1% FBS (DMEM-1% FBS).  The cell suspension was then adjusted to 
density of 2x106 CFU/ml.  The bacterial cell density at OD590 of 1 is equivalent to 1x109 
cfu/ml.  The bacterial cells suspension was diluted serially and spotted on MHA plates. 
 
2.12.2.3 Infection of RAW264.7 cells with Cj1 wild-type and T6SS mutants 
 
The DMEM-1% FBS in each well of the 24-well plates was discarded and the monolayer 
RAW264.7 cells were overlaid with 1 ml of bacterial suspension at density of 2x106 CFU/ml; 
the multiplicity of infection (MOI) was 10.  The cells were incubated at 37°C under 5% CO2.   
 
After four hours of incubation a plate of infected RAW264.7 cells was rinsed 5 times using 
pre-warmed 1X PBS.  The RAW264.7 cells were lysed in 0.5 ml of 1% saponin (prepared in 
water) for 15 min.  The saponin treatment released all bacterial cells adhering to and invading 
the RAW264.7 cells into the saponin solution.  The bacterial cell suspensions was then 
diluted serially and spotted on MHA plates. 
 
After four hours of incubation another plate of infected RAW264.7 cells was rinsed three 
times using pre-warmed 1X PBS.  After the last rinse, the RAW264.7 cells in each well were 
overlaid with 2 ml of DMEM-1%FBS containing 250 µg/ml of gentamicin.  The cells were 
returned to the incubator and were further incubated at 37°C with 5% CO2.  The gentamicin 
treatment killed all bacterial cells that were on the exterior of the macrophage cells.  After 
two hours, the cells were rinsed three times using pre-warmed 1X PBS.  The RAW264.7 cells 
were lysed in 0.5 ml of 1% saponin for 15 min.  The saponin treatment released all bacterial 
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cells that had invaded the RAW264.7 cells into the saponin solution.  The bacterial cell 
suspension was then diluted serially and spotted on MHA plates.  The assays were performed 
with three biological replicates, each in triplicate.        
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2.12.3 C. jejuni - ZFE challenging assays 
 
2.12.3.1 Preparation of ZFE for bacterial challenge 
 
ZF eggs were collected from the ARC in the morning and tank water was replaced with 
aerated 1X marine salt solution (MSS).  WIK eggs were incubated in MSS with 0.000001% 
methylene blue while AB fms:nfsB.mCherry transgenic line eggs were incubated in MSS 
without methylene blue.  The eggs were incubated at 28°C and unfertilised eggs were 
removed at 5-6 hours post-fertilisation (hpf) stages.  The remaining embryos were returned to 
incubation till 24 hpf.  At 24 hpf the chorion of the embryos was mechanically removed.  
After removal of chorion WIK wild-type embryos were placed into MSS while AB 
fms:nfsB.mCherry transgenic embryos were placed into MSS containing 75 µM of 1-phenyl 
2-thiourea (PTU).  The addition of PTU was to stop pigment development.  The MSS with 
PTU was refreshed daily.  At the desired stages of development (28, 30 or 52 hpf) the 
embryos were anaesthetised in 0.03% Tricane made in MSS.  The embryos were then 
transferred onto a slide covered with a layer of 3% methy-cellulose.   
 
2.12.3.2 Preparation of C. jejuni cells for challenging ZFE 
 
C. jejuni cells harvested from P3 plates were dislodged into 1 ml of MHB and OD590 was 
determined.  Cells harvested from P3 were either used for ZFE challenge or for preparing P4 
cultures.  For ZFE challenge the cell suspension was adjusted to OD590 of approximately 10.  
The bacterial cell suspensions were diluted serially and spotted on MHA plates. 
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For P4 cultures, the cell suspensions were diluted to obtain 28 ml of OD590 approximately 0.1.  
The bacterial suspension was aliquoted into a 24-well plate, 1 ml per well and 1 plate per 
strain.  MHB was used for the adjustment of the cell suspension, which was pre-incubated 
overnight at 37°C under microaerophilic conditions.  The P4 cultures were incubated at 37°C 
under microaerophilic conditions for approximately 24 hours.  After 24 hours of incubation 
the broth cultures from each well of the same plate were pooled.  The bacterial cells were 
collected at the bottom of the tube by centrifugation at 11,000 x g for 5 min at room 
temperature.  The cell pellets were resuspended in 2 ml of PBS.  The cell suspension was 
then adjusted to OD590 of approximately 1 or 10.  The bacterial cell suspensions were diluted 
serially and spotted on MHA plates. 
          
2.12.3.3 Microinjection of ZFE with C. jejuni cells 
 
The needle for microinjection was loaded with a bacterial suspension and was calibrated on a 
stage micrometer.  The injection pressure or time, was adjusted to obtain a droplet size of 
between 1-2 nl.  The needle was then inserted into either the embryo's yolk sac or yolk sac 
circulation valley as illustrated in Figure 2.2.  Two pulses were delivered per embryo.  After 
inoculation, the embryos were rinsed out from the methyl-cellulose matrix using MSS into a 
clean petri dish.  In general a minimum of 20 embryos were injected per set.  For each 
experiment, two controls were incorporated: i) uninjected control - the ZFE were de-
chorionated but not injected, a minimal of 5 ZFE per experiment; ii) PBS injected control - 
the ZFE were de-chorionated and injected with 2 pulses of PBS, a minimal of 20 ZFE per 
experiment.  The embryos were incubated at 28°C and scored at 24 hours post-infection (hpi) 
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for survival or maintained up to a maximum of 5 days post-fertilisation.  Embryos with 
observable heart beat were scored as alive  - regardless of edema formation.  The embryos 
were then killed in 70% ethanol.  The actual inoculated dose was determined by delivering 50 
pulses into 50 µl PBS.  The bacterial suspension were diluted serially and spotted on MHA 
plates.              
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Figure 2.2: Site of inoculation in 28 hpf ZFE.  Bacterial cells were delivered into yolk sac (A) or yolk sac 
circulation valley (B) via microinjection.  The yellow arrows indicate the tip of the needle used for 
microinjection.  
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2.12.4 C. jejuni - piglet challenging assays 
 
This study was performed by Dr Paul Everest from the Institute of Infection, Immunity and 
Inflammation at University of Glasgow using C. jejuni Cj1 wild-type, 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssD(syn)::kanR_cas.  Competitive index challenge was 
performed on two groups of animals, each consisting of 9 newborn piglets.  In each group the 
piglets were inoculated with equal amounts of wild-type and a mutant.  The wild-type strain 
was grown on CBA+ and mutant strains were grown on CBA+ were supplemented with 50 
µg/ml kanamycin, both strains were incubated at 37 °C in a VAIN cabinet for 48 hr.  The 
bacteria cells from each strain was then scraped off into PBS with its optical density adjusted 
to 1x108 CFU/ml.  The piglets were inoculated orally with an inoculation dose of 
approximately 1x108 CFU.  Faecal samples were collected daily up to Day 5 post-infection.  
Faecal samples were quantified for wild-type and respective T6SS mutant by culturing.   
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2.13 Raman spectroscopy 
 
2.13.1 Raman analysis of SL1344 wild-type grown in LB, LB with 70% D2O and MM 
 
At each time point of the growth curve 50 ml of SL1344 wild-type cells were collected at the 
bottom of the tube by centrifugation at 11,000 x g for 5 min.  The culture supernatant was 
discarded and the cell pellet was resuspended in 1 ml PBS.  The cell suspension was then 
spun at 16,100 x g for 3 min and cells were collected at the bottom of the tube.  The cell 
pellet was washed twice more in PBS.  After the last wash, the cell pellet was placed on ice 
and transferred to the Raman spectrometer laboratory.  Approximately 10 µl of the moist cell 
pellet was spotted onto an aluminium coated glass slide.  Raman shift spectra were collected 
between 400-4000 cm-1 using Raman spectrometer Reinshaw RM1000.  The settings used for 
spectrum collection were 785 nm notch, 50% laser power, 10s acquisition and 40x objective.  
Raman spectra were collected from a minimum of three different biological replicates and a 
minimum of three different focal points each. 
 
2.13.2 Raman analysis of J774A.1 
 
J774A.1 macrophage-like cells were harvested from standard T75 culturing flasks using cell 
scraper into 5ml of PBS.  The cells were collected at the bottom of the tube by centrifugation 
at 1,000 x g for 3 min.  The cell pellet was washed three times in PBS.  After the last wash, 
the cell pellet was placed on ice and transferred to the Raman spectrometer laboratory.  
Approximately 10 µl of the moist cell pellet was spotted onto an aluminium coated glass slide.  
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Raman shift spectra were collected between 400-4000 cm-1 using Raman spectrometer 
Reinshaw RM1000.  The settings used for spectrum collection were 785 nm notch, 50% laser 
power, 10s acquisition and 40x objective.  Raman spectra were collected from a minimum of 
three different biological replicates and a minimum of three different focal points each. 
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2.14 SRS and Confocal imaging 
 
The J774A.1 cells infected with SL1344 wild-type or SL1344 fliC::gfp were imaged under 
SRS microscope and Confocal microscope respectively.  The SRS system was built in-house 
by the Physics Department at UoE.  The Stokes beam was fixed at 1064 nm while the pump 
beam was tuned to achieve as close as possible to four of the selected wavenumbers.  The 
operation of the SRS microscope and taking of cell images were performed with help from 
Dr Julian Moger of Physics Department.  The Confocal microscope used was ZEISS LSM 
510 META.  The laser was set for visualisation of GFP and DAPI. 
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2.15 Imaging of ZFE 
 
2.15.1 Staining of C. jejuni Cj11168H with 5-(6)-carboxyfluorescein-succinylester 
(FITC)   
 
Cj11168H wild-type cells were harvested from P4 cultures.  The cells were collected at the 
bottom of the tube by centrifugation at 11,000 x g for 5 min.  The cell pellet was then 
resuspended in 200 µl of 0.4 µg/ml FITC for 15 minutes at room temperatur in the dark and 
with constant mixing (Agerer et al., 2004).  After 15 min of incubation the cells were washed 
5 times with PBS or until the supernatant no longer looked yellowish.  After the final wash, 
the cells were resuspended in 100 µl of PBS and used for inoculation into AB 
fms:nfsB.mCherry transgenic embryos at 28 hpf. 
 
2.15.2 Imaging of AB fms:nfsB.mCherry transgenic embryos inoculated with fluorescing 
Cj11168H   
 
The AB fms:nfsB.mCherry transgenic embryos were inoculated with either Cj11168H GFP 
reporter or Cj11168H stained with FITC.  The embryos were visualised at various time-points 
post-infection using an upright fluorescence microscope, equipped with a filter where 
excitation is at 472 nm, and emission at 520 nm, emission for GFP detection and another 
filter with excitation at 543 nm and emission at 593 nm for mCherry detection.   
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2.16 Electron microscopy (EM) for visualisation of C. jejuni capsule 
 
Cj11168H wild-type and Cj1 wild-type were cultured under two different growth conditions; 
i) 37 °C in MHB for 24 hr, and ii) 37 °C on CBA+ for 48 hr.  Cells were then harvested for 
capsule detection by EM.  Bacterial cells on agar cultures were picked up with a cotton swab 
and dislodged into 1 ml PBS.  The cell suspensions from agar culture were spun down at 
11,000 x g for 5 min and supernatant was discarded.  2 ml of each broth culture were spun 
down at 11,000 x g for 5 min, and supernatant was discarded.  The cell pellets were passed to 
Dr Massimo Micaroni from Bio-imaging Centre at UoE for further processing and imaging 
under transmission EM.  The samples were processed according to the protocol illustrated in 
Karlyshev et al (Karlyshev et al., 2001).  
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Chapter 3:  Raman microscopy of S. Typhimurium SL1344 
within mouse macrophage-like cells J774A.1  
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3.1 Introduction 
 
3.1.1 Raman microspectroscopy 
 
Raman microspectrometry has been shown to discriminate between bacterial species and 
differentiates between different stages of growth within each species tested (Huang et al., 
2004).  These properties could enable the use of Raman microscopy for the interrogation of 
metabolically active and domant cells during host-pathogen interactions.  This could be 
potentially exploited for imaging based on specific chemicals in a complex matrix such as, 
for example, in demonstrating lipids in fresh tissues (Mansfield et al., 2013).  Raman 
spectroscopy has been used in the detection and identification of Campylobacter (Lu et al., 
2012).  Hence, we would like to explore the possibility of using the Campylobacter specific 
chemical signature to perform label-free live imaging of bacteria within host cells.  This 
study was initially performed using model organisms, Salmonella Typhimurium strain 
SL1344 and mouse macrophage-like cells J774A.1.           
 
3.1.2 Aim of study 
 
The aim of this study was to determine the molecular make-up of bacteria and host cells 
based on Raman spectroscopy and to use the information for interrogation of host-pathogen 
interactions.  An established model, mouse macrophage-like cells infected with Salmonella 
Typhimurium was chosen for method development and testing. 
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3.2 Results 
 
3.2.1 Methodologies developed for Raman spectra collection and processing 
 
Salmonella Typhimurium strain SL1344 cells were grown in LB broth overnight at 37°C with 
shaking at 200 rpm.  Mouse macrophage-like cells were cultured in T75 tissue culture flask 
till 70-80% confluence at 37°C with 5% CO2.  Bacterial and macrophage cells were harvested 
from the growth vessel and washed three times in PBS.  The cell pellets were spotted onto 
aluminium coated glass slides.   
 
The Raman spectra of S. Typhimurium strain SL1344 wild-type and mouse macrophage-like 
cells J774A.1 were collected between 400-4000 cm-1 using a Reinshaw RM1000 Raman 
spectrometer, equipped with a 785 nm laser, Figure 3.1.  The settings used for spectrum 
collection were 785 nm notch, 50% laser power, 10s acquisition and 40x objective.  Raman 
spectra were collected from a minimum of three different biological replicates and for each 
replicate, spectra were collected at a minimum of three different focal points.  All the spectra 
collected were then averaged before they were used in comparisons. 
 
The raw spectra obtained were very noisy and were smoothed using software from the Raman 
spectra-microscope, WIRE2.0.  The smoothing algorithm in WIRE 2.0 removed most of the 
noise, Figure 3.1. 
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The baseline of each spectrum needed to be removed as well, but the smoothing algorithm 
was not able to perform this function.  The baseline attributed to each spectrum differs 
according to cell types and preparations, hence, baseline subtraction was essential before 
different samples could be compared.  This was achieved by applying an in-house developed 
algorithm, a Bayesian Whittaker–Henderson (BWH) smoother (Lau et al., 2012), onto 
smoothed spectra.  The BWH algorithm was developed together with Dr Ron Yang (College 
of Life and Environmental Sciences, UoE).  Figure 3.2 illustrates spectra before and after 
baseline subtraction. 
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Figure 3.1: Raw and smoothed Raman spectrum collected from (A) S. Typhimurium SL1344 wild-type and (B) mouse macrophage-like cells J774A.1.  Y-axis = Raman intensity 
(arbitrary units).  X-axis = Wavenumbers (cm-1).  Left: Raw (blue) and smoothed (red) Raman spectrum from S. Typhimurium cultured overnight in LB broth. Right: 
Raw (magenta) and smoothed (green) Raman spectrum from mouse macrophage-like cells J774A.1 at passage 5.  Raw spectra were smoothed using WIRE 2.0.  
A B 
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Figure 3.2: Smoothed and baseline subtracted Raman spectrum collected from (A) S. Typhimurium SL1344 wild-type and (B) mouse macrophage-like cells J774A.1.  Y-axis = 
Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Left: Smoothed (red) and baseline subtracted (purple) Raman spectrum from S. Typhimurium 
cultured overnight in LB broth. Right: Smoothed (green) and baseline subtracted (brown) Raman spectrum from mouse macrophage-like cells J774A.1 at passage 5.  
Raw spectra were smoothed using WIRE 2.0.  Baseline subtracted from smooth spectra using Bayesian Whittaker–Henderson smoother. 
A B 
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Raman peak intensities can be affected by the number of cells in each focal volume.  Spectra 
collected from the same sample could result in different intensities as the cell suspension did 
not spread uniformly when spotted and dried on the slide.  Figure 3.3 (A) provides an 
illustration of baseline subtracted spectra collected from a sample at different focal points.  
These variations between the spectra were corrected by normalisation.  Each intensity value 
was normalised through division by total intensity integrated over the whole spectrum.  
Normalised spectra of the same sample are presented in Figure 3.3 (B); demonstrating that 
this normalisation has compensated for differences in cell concentration in the sampling 
volume.  The normalised data could therefore be used for comparison between samples. 
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Figure 3.3: Raman spectra of S. Typhimurium SL1344 collected at different focal point, (A) before and (B) after normalisation.  Y-axis = Raman intensity (arbitrary units).  X-
axis = Wavenumbers (cm-1).  Left: 5 spectra collected from same S. Typhimurium sample at different focal point before normalisation.  Right: Same spectra as chart 
on the left but after normalisation by division of each intensity value by total intensities value of respective spectrum.     
A B 
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3.2.2 Raman spectra of S. Typhimurium at different stages of growth 
 
For these experiments an overnight culture of S. Typhimurium in LB broth was diluted and 
inoculated into fresh LB broth.  The growth profile of the bacteria is illustrated in Figure 3.4. 
 
At various stages of growth bacterial cells were harvested for Raman spectroscopy.  The 
spectra obtained from various growth stages are illustrated in Figure 3.5.  Profiles of cells at 
different growth stages were similar, but the intensities of some peaks varied.  For example, 
cells at mid log phase gave the highest intensities at 724 cm-1 and 781 cm-1, while cells at 
early log phase gave the highest intensities at 810 cm-1, 1477 cm-1 and 1569 cm-1. 
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Figure 3.4: Growth curve of S. Typhimurium SL1344 wild-type in LB broth.  The optical density of the culture was monitored at 30 min interval up to 240 minutes.   
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Figure 3.5: Raman spectra of S. Typhimurium SL1344 wild-type at various growth phases.  Spectra plotted were average of all spectra collected (both technical and biological 
replicated).  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Red: Mean normalised spectrum from SL1344_T30 representing 
lag phase.  Green: Mean normalised spectrum from SL1344_T90 representing early log phase.  Orange: Mean normalised spectrum from SL1344_T120 representing 
mid log phase.  Blue: Mean normalised spectrum from SL1344_T150 representing late log phase.  Purple: Mean normalised spectrum from SL1344_T360 representing 
stationary phase.  Magenta: Mean normalised spectrum from SL1344_ON, an overnight culture, representing late stationary phase.  The blue arrows indicate peaks at 
which the wavenumbers could be selected for Raman based imaging.  The maroon arrows indicate other peaks that had shown differences in intensities at different 
growth stages. 
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3.2.3 Analysis of normalised spectra and identification of wavenumbers to be used for 
Raman based imaging  
 
After normalisation, spectra from each sample type collected (technical and biological 
replicates, minimal of 3 each) were compared by one-way ANOVA using an R programme 
(http://www.r-project.org/).  Wavenumbers that had P-value <0.0001 between two sample 
types compared were represented by vertical blue lines in Figures 3.6-10. 
 
115 
 
 
 
 
 
 
 
 
 
Figure 3.6: Comparison of normalised Raman spectrum collected from S. Typhimurium SL1344 wild-type grown in LB broth at lag phase with mouse macrophage-like cells 
J774A.1.  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Black: Normalised spectrum from J774A.1.  Red: Normalised 
spectrum from SL1344.  Blue: Wavenumbers at which ANOVA analysis had determine normalised intensities between J774A.1 and SL1344 to be significantly 
different, P-value ≤0.0001. 
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Figure 3.7: Comparison of normalised Raman spectrum collected from S. Typhimurium SL1344 wild-type grown in LB broth at early log phase with mouse macrophage-like cells 
J774A.1.  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Black: Normalised spectrum from J774A.1.  Red: Normalised 
spectrum from SL1344.  Blue: Wavenumbers at which ANOVA analysis had determine normalised intensities between J774A.1 and SL1344 to be significantly 
different, P-value ≤0.0001. 
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Figure 3.8: Comparison of normalised Raman spectrum collected from S. Typhimurium SL1344 wild-type grown in LB broth at mid log phase with mouse macrophage-like cells 
J774A.1.  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Black: Normalised spectrum from J774A.1.  Red: Normalised 
spectrum from SL1344.  Blue: Wavenumbers at which ANOVA analysis had determine normalised intensities between J774A.1 and SL1344 to be significantly 
different, P-value ≤0.0001. 
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Figure 3.9: Comparison of normalised Raman spectrum collected from S. Typhimurium SL1344 wild-type grown in LB broth at stationary phase with mouse macrophage-like 
cells J774A.1.  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Black: Normalised spectrum from J774A.1.  Red: Normalised 
spectrum from SL1344.  Blue: Wavenumbers at which ANOVA analysis had determine normalised intensities between J774A.1 and SL1344 to be significantly 
different, P-value ≤0.0001. 
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Figure 3.10:  Comparison of normalised Raman spectrum collected from S. Typhimurium SL1344 wild-type grown in minimal media pH 5.8 broth for 120 min with mouse 
macrophage-like cells J774A.1.  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  Black: Normalised spectrum from J774A.1.  
Red: Normalised spectrum from SL1344.  Blue: Wavenumbers at which ANOVA analysis had determine normalised intensities between J774A.1 and SL1344 to be 
significantly different, P-value ≤0.0001. 
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In order to establish whether it would be possible to distinguish features of the bacterial 
spectrum in the complex environment of the host cell, comparision spectra were obtained 
from a representative host cell.  Normalised spectra from mouse macrophage-like cells 
J774A.1 were compared with spectra collected from S. Typhimurium SL1344 wild-type cells.  
SL1344 spectra were collected at different growth stages in LB broth.  Spectra were also 
collected from cells grown in MM pH 5.8 broth for 120 min.  LB mimicked the extracellular 
environment of intestine lumen (Balbontin et al., 2006) while MM broth mimicked the 
macrophage phagosomal environment (Manes et al., 2007).  Figure 3.11 showed the 
differences in spectra obtained from SL1344 after 120 min growth in LB and MM broth with 
reference to J774A.1 spectrum. 
 
Wavenumbers at which Raman signals were determined to be significantly different between 
macrophage cells and S. Typhimurium SL1344 cells are tabulated in Table 3.1. 
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Figure 3.11: Comparison of Raman spectra from S. Typhimurium SL1344 wild-type grown for 120 min in LB and MM broth with mouse macrophage-like cells J774A.1.  Spectra 
plotted were average of all spectra collected (both technical and biological replicated).  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers 
(cm-1).  Blue: Mean normalised spectrum from J774A.1.  Red: Mean normalised spectrum from SL1344 grown in LB broth for 120 min.  Green: Mean normalised 
spectrum from SL1344 grown in MM broth for 120 min.  The arrows indicate differences between spectra of SL1344 grown in LB broth and MM broth.  
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Table 3.1: List of wavenumbers ranges at which Raman signals between J774A.1 cells and SL1344 cells from 
different growth phases were determined to be significantly different.  SL1344_T30: SL1344 at lag 
phase. SL1344_T90: SL1344 at early log phase. SL1344_T120: SL1344 at mid-log phase. 
SL1344_T360: SL1344 at stationary phase.  SL1344_MM_T120: SL1344 grown in minimal media pH 
5.8 for 120 min. 
 
J774A.1 vs 
SL1344_T30 
J774A.1 vs 
SL1344_T90 
J774A.1 vs 
SL1344_T120 
J774A.1 vs 
SL1344_T360 
J774A.1 vs 
SL1344_MM_T120 
2839-2858 2843-2845 2838-2861 2841 1706-1712 
2826-2837 1699-1714 1700-1718 1565-1574 1671-1677 
1557-1577 1646-1667 1639-1672 1558-1559 1636-1668 
1468-1488 1597-1598 1550-1595 1475-1480 1632 
1428-1446 1551-1594 1467-1493 1433-1434 1553-1578 
1384-1392 1468-1493 1426-1461 1376-1398 1469-1493 
1368-1379 1426-1452 1343-1408 1367-1372 1431-1459 
1324-1339 1353-1406 1332-1337 1332-1347 1342-1408 
1308-1319 1334-1336 1264-1273 1090-1101 1262-1272 
1235-1246 1198-1202 1087-1106 774-790 1129-1131 
1085-1112 1088-1106 1000-1005 756-758 1123-1125 
1011-1012 1053-1055 772-955 712-717 1086-1115 
976-979 1043-1051 764-767  1000-1003 
918-969 998-1035 744  947-954 
774-820 985-991 717-730  932 
774 975-979 707-709  755-822 
720-727 918-969 661-673  724-727 
664-670 831-905 594-599  664-671 
575-582 774-821 572-586  578-583 
 743-744 503-506  543-548 
 718-727 434-439  525-526 
 707-708    
 662-672    
 596-597    
 575-584    
 545-547    
 520-521    
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Spectral data were collected from at least three independent samples and a minimum of three 
spectra for each sample.  Biological and technical replicates were performed to increase the 
confidence in differences observed from spectra comparison.  Spectra from different growth 
stages and conditions of SL1344 were compared against J774A.1 statistically by one-way 
ANOVA.  Spectra from SL1344 at different growth stages and growth media and spectra 
from J774A.1 cells were then overlaid and visually compared.  Six peaks were selected at 
which SL1344 cells had higher signal compared to J774A.1 cells.  All wavenumbers 
shortlisted for Raman based imaging were where signals were highest for each of the selected 
peaks.  The higher signal coming from bacterial cells could hopefully aid in discriminating 
bacteria cells from macrophages during imaging.  The shortlisted wavenumbers and their 
Raman vibration attribution (if available) are summarised in Table 3.2 and indicated on 
spectra in Figure 3.12.   
 
Another peak of interest was at 2844 cm-1, representing a C-H vibration mode which gave a 
strong signal from both SL1344 and J774A.1 cells.  This signal could potentially be used to 
provide background contrast without distinguishing between cells and bacteria. 
 
The last peak selected was the peak at 1444 cm-1 from J774A.1 cells, because coherent 
Raman at low frequencies is expected to visualise the larger scale host cells rather than 
bacteria and hence might be used to provide control images.   
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Table 3.2:  List of wavenumbers selected for Raman based imaging.  Ticks represent distinctive Raman signals 
were present in either mouse macrophage-like cells J774A.1 and S. Typhimurium at various growth 
stages and when cultured in MM. 
 
Cell types 
with 
higher 
signal 
Raman 
vibration 
attribution 
Wavenumbers 
(cm-1) 
J774A.1 SL1344 
Lag 
phase 
SL1344 
Early 
log 
phase 
SL1344 
Mid 
log 
phase 
SL1344 
Stationary 
phase 
SL1344 
Grown in 
minimal 
media pH 5.8 
for 120 min 
SL1344 
and 
J774A.1 
CH2 
symmetrical1 
2844.40       
SL1344  1568.92       
SL1344 Protein marker 
band2 
1476.98       
J774A.1  1443.96       
SL1344 Carbohydrate 
range3 
1095.78       
SL1344 Nucleic acids 
(C-O-P-O-C 
in RNA 
backbone)2 
809.75       
SL1344 Cytosine, 
uracil (ring, 
str)2 
780.66       
SL1344  723.98       
1
 (Davis et al., 2003),2 (Huang et al., 2010), 3 (Brehm-Stecher and Johnson, 2004)  
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Figure 3.12: Overlay Raman spectra of mouse macrophage-like cells J774A.1 and S. Typhimurium SL1344 wild-type at early-log growth phase in LB broth.  Spectra plotted were 
average of all spectra collected (both technical and biological replicated).  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = Wavenumbers (cm-1).  
Black: Mean normalised spectrum from J774A.1.  Red: Mean normalised spectrum from SL1344.  The arrows indicates peaks at which the wavenumbers were 
selected for Raman based imaging.   
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3.2.4 Coherent Raman based imaging 
 
Images of S. Typhimurium SL1344 wild-type cells were taken at some of the selected 
wavenumbers using SRS microscopy.  The Stokes beam was fixed at 1064 nm while the 
pump beam was tuned to achieve, as close as possible, to four of the selected wavenumbers.  
Representative images are shown in Figure 3.13, demonstrating good contrast particularly at 
2841 cm-1.     
 
Next; mouse macrophage-like J774A.1 cells were infected with either the S. Typhimurium 
SL1344 wild-type or a S. Typhimurium SL1344 fliC::gfp mutant.  The fliC::gfp mutant 
enabled visualisation of bacteria cells within macrophages under Confocal microscopy, and 
was used to confirm the spectral identification of the bacteria.  As shown in Figure 3.14, the 
images obtained showed that under the culture conditions employed the bacteria had invaded 
the host cells.  Some host cells had shown to habour one or more bacteria. 
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Figure 3.13: SRS images of S. Typhimurium SL1344 wild-type at various wavenumbers.  SL1344 wild-type cells (arrowed) were at mid log phase (T120) when harvested for 
imaging.  The cell suspension was diluted to OD590 of 0.01 for imaging. 
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Figure 3.14: Confocal images of mouse macrophage-like cells J774A.1 infected with S. Typhimurium SL1344 fliC::gfp mutant at MOI of 100.  J774A.1 cells were overlaid with 
SL1344 fliC::gfp mutant for 1 hours before extracellular bacteria cells were killed by gentamicin.  Macrophage cells were unstained except for nucleus stained with 
DAPI and fluoresced blue (red arrow).  SL1344 fliC::gfp mutant cells fluoresced green (white arrowed).  Images were taken 2 hr post-infection.  Hours post-infected 
started together with gentamicin treatment.  
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Having shown that the bacteria resides within host cells by Confocal, SRS images of J774A.1 
cells infected with SL1344 wild-type were taken by SRS microscopy, as shown in Figure 
3.15.  At each of the wavenumbers identified above features could be identified in the cells of 
the size expected for bacteria.  However, the features were insufficiently sharp to constitute 
positive identification and so an alternative approach of labelling the bacteria cells with 
deuterium oxide was employed.   
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Figure 3.15: SRS images of mouse macrophage-like cells J774A.1 infected with S. Typhimurium SL1344 wild-type 
at MOI of 100.  Images were taken between 2 to 6 hours post-infection.  Stokes beam was fixed as 1064 
nm while pump beam (values in brackets) was tuned to achieve closest possible to selected 
wavenumbers.  Signals possibly coming from bacteria cells were indicated with arrows. 
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3.2.5 SRS imaging of deuterated bacteria 
 
The lack of contrast between bacteria and host cells arises because no spectral peaks could be 
found in the bacteria which were not also present in the host cell.  This problem was 
addressed by replacing C-H bond with C-D bonds which have a different vibrational 
frequencies.  This was effected by incubating SL1344 wild-type in media where water was 
replaced by deuterium oxide to a percentage of 70%.  The Raman spectra of SL1344 wild-
type cells grown in LB or MM broth made up with 70% D2O were collected.  The spectra 
were compared to spectra from J774A.1 cells and SL1344 cells grown in LB and MM, as 
shown in Figure 3.16. 
 
The results obtained showed that culturing of SL1344 wild-type in media containing D2O 
gave an additional peak at 2148 cm-1.  This frequency could only be found in bacterial cells 
grown in D2O media and not in macrophages; so it was used for SRS imaging.  SRS images 
of SL1344 wild-type cells grown in LB made up of 70% D2O were taken at selected 
wavenumbers and are shown in Figure 3.17.   
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Figure 3.16: Comparison of Raman spectra from S. Typhimurium SL1344 wild-type grown in media with and without deuterium oxide with mouse macrophage-like cells J774A.1.  
Spectra plotted were average of all spectra collected (both technical and biological replicated).  Y-axis = Normalised Raman intensity (arbitrary units).  X-axis = 
Wavenumbers (cm-1).  (A) Blue: Mean normalised spectrum from J774A.1.  Red: Mean normalised spectrum from SL1344 grown in LB broth for 120 min.  Green: 
Mean normalised spectrum from SL1344 grown in LB broth consisting of 70% D2O for 120 min.  (B) Blue: Mean normalised spectrum from J774A.1.  Red: Mean 
normalised spectrum from SL1344 grown in MM broth for 120 min.  Green: Mean normalised spectrum from SL1344 grown in LB broth consisting of 70% D2O for 
120 min.  The arrows indicate peaks from carbon-deuterium (C-D) vibration (2147.51 cm-1), which is only present in cells grown in media containing D2O. 
A B 
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Figure 3.17: SRS images at various wavenumbers of S. Typhimurium SL1344 wild-type grown in LB broth made 
up with 70% Deuterium oxide and 30% water.  SL1344 wild-type cells were at mid log phase (T120) 
when harvested for imaging.  Stokes beam was fixed as 1064 nm while pump beam was tuned to 
achieve closest possible to selected wavenumbers.  Cell density was 5x107 cfu/ml.  At 2844 cm-1 (C-H 
vibration frequency) and 2418 cm-1 (C-D vibration frequency), the signals were high and cell 
suspension was too dense and led to overexpose images.  Due to the high cell density, individual cells in 
the remaining images were marked by arrows.  
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The images show that culturing of the bacteria cells in media containing D2O did not affect 
SRS imaging: a point to note is that although at 1444 cm-1, J774A.1 cells were shown to have 
a higher signal than SL1344 cells, the signal from the bacteria was strong too.  Hence, it was 
still possible to capture bacterial images at this frequency. 
 
SL1344 fliC::gfp mutant was also grown in LB consisting of 70% D2O and was used to infect 
J774A.1 cells.  Confocal images in Figure 3.18 show that culturing in D2O containing media 
had not affected its ability to infect macrophages.  In parallel, SL1344 wild-type cells grown 
in LB consisting of 70% D2O was also used to infect J774A.1 cells.  Images of macrophages 
infected with SL1344 wild-type were captured at carbon-deuterium (C-D) frequency (Figure 
3.18).    
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Figure 3.18: Mouse macrophage-like cells J774A.1 infected with S. Typhimurium SL1344 wild-type and fliC::gfp 
mutant grown in LB broth made up with 70% Deuterium oxide and 30% water.  A: Confocal image of 
J774A.1 cells infected with SL1344 fliC::gfp mutant (indicated by the yellow arrows) at 30 min post-
infection.  B: SRS image at C-D frequency (2148 cm-1) of J774A.1 cells infected with SL1344 wild-type 
(indicated by the white arrows) at 30 min post-infection.  Outlines of macrophage cells were visible 
and cell nuclei were the dimmer region within the macrophage cells.  C: Confocal image of J774A.1 
cells infected with SL1344 fliC::gfp mutant at 120 min post-infection (indicated by the yellow arrows).  
D: SRS image at C-D frequency (2148 cm-1) of J774A.1 cells infected with SL1344 wild-type (indicated 
by the white arrows) at 120 min post-infection.  In Confocal images, bacteria cell fluoresced green and 
in SRS images, bacteria cells signal are brighter red against the baseline.      
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In Figure 3.18 (A), the bacterial cells appeared to be inside macrophage cell cytoplasm and 
distributed around the nucleus.  Similarly, SRS images from the same time point (Figure 3.18 
(B)) also showed stronger signals within the macrophage cells and around the nucleus.  At 
120 min post-infection, bacterial cells seemed to be sparsely distributed in both Confocal and 
SRS images - as shown in Figure 3.18 (C) and (D).  Fewer bacterial cells were detected in 
SRS image (Figure 3.18 (D)).     
 
SRS images of J774A.1 cells infected with SL1344 wild-type grown in LB consisting of 70% 
D2O were then taken at selected wavenumbers, as shown in Figure 3.19.   
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Figure 3.19: SRS images of mouse macrophage-like cells J774A.1 infected with S. Typhimurium SL1344 wild-type 
grown in LB broth made up with 70% Deuterium oxide and 30% water, at MOI of 100.  Images were 
taken between 2 to 6 hours post-infection.  Stokes beam was fixed as 1064 nm while pump beam was 
tuned to achieve closest possible to selected wavenumbers.  A macrophage cell was enclosed within the 
yellow circle.  Arrows pointing to potential signals from bacteria cells within the macrophage cell.  
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Regions of the size and shape expected of the bacteria were visible in images at 2148 cm-1.  
The same regions were also visible at 1569 cm-1, 1444 cm-1 and 781 cm-1 and so these modes 
were most likely also to be from bacteria cells, confirming the preliminary identification 
made above.      
 
Unfortunately, subsequent attempts of imaging did not yield similar outcomes.  Images could 
only be captured at the high frequency C-H stretching region. This was due to an ongoing 
technical fault with the laser system which caused it to become unstable when the pump 
wavelength was tuned to the longer wavelengths required to access lower vibrational 
frequencies.        
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3.3 Discussion 
 
A raw Raman spectrum collected from the spectrometer requires smoothing and background 
subtraction before useful information can be extracted from it.  The smoothing process helps 
to reduce noise collected during the Raman spectrum acquisition and enables better resolution 
of spectral peaks (Ferraro et al., 2003).  Spectral smoothing here were initially performed 
using the instrument software WIRE2.0, where Savitsky-Golay smoothing was applied.  In 
Savitsky-Golay smoothing a weighted average of adjacent points of each point in the original 
spectrum was used to plot the smoothed spectrum (Ferraro et al., 2003).  The smoothing 
process only reduced noise but not the baseline.  Hence, in order for comparison of spectra 
collected from different samples, the baseline in each spectrum was removed.   
 
There are several approaches available for baseline removal.  It can be done either manually 
or automatically with an algorithm.  Manual baseline removal requires user input in 
identifying which is a baseline and which is a signal.  This is user dependent, subjective and 
often non-reproducible (Lau et al., 2012).  The baselines of spectra collected here were 
subjected to baseline removal through application of an algorithm the BHW smoother, was 
developed in-house together with Dr Ron Yang (Lau et al., 2012).   
 
The BHW algorithm is a Bayesian interpretation of Whittaker-Henderson’s with revised 
fidelity.  The latter is a typical Least-square error model commonly used in baseline 
estimation (Lau et al., 2012).  The Bayesian interpretation is a learning process applied to 
estimate parameters for the model used (Lau et al., 2012).  The BHW algorithm had been 
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shown to perform better than other commonly used algorithm such as Peaks, Spline, 
msProcess and airPLS on simulated data (Lau et al., 2012).  BHW had also been shown to 
perform better than Spline when applied to real spectra (Lau et al., 2012). 
 
Beside baseline issues of spectra collected, the intensity of each peak was dependent on the 
amount of material available in each focal volume. Within the same sample materials were 
distributed unevenly across the surface while drying and hence peak intensities differs 
between focal points.  Before spectra could be combined or compared, it was important that 
the intensity range of each spectrum to be normalised (Ferraro et al., 2003).  Each spectrum 
collected was normalised to achieve total area under the spectrum as 1.  This is a commonly 
used normalisation approach especially when the spectra do not shared a common peak 
(Ferraro et al., 2003).  The spectral processing protocol was applied to all spectra collected.   
 
The Raman spectrum provides a chemical fingerprint of the cell being interrogated (Huang et 
al., 2010).  This information enables differentiation between cell types (Huang et al., 2010) 
and is likely to be influenced by gene expression and may be regulated by factors such as: 
temperature, pH and nutrient availability (Huang et al., 2010).  It has previously been 
reported that closely related species could be differentiated based on their Raman spectrum, 
for example different Bacillus species (Hutsebaut et al., 2004), Staphylococcus epidermidis 
strains and E. coli strains (Almarashi et al., 2012).   
 
When the bacteria cells were actively growing, intensities at proteins (1477 cm-1) and nucleic 
acids (781 cm-1 and 810 cm-1) wavenumbers were highest.  However, as it entered stationary 
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phase, two peaks were lost, one at 810 cm-1.  The 810 cm-1 peak was assigned to "Cytosine, 
uracil (ring, str)" (Huang et al., 2010).   This observation coincided with previous reported 
work on Acinetobacter sp., E. coli and Pseudomonas fluorescens (Huang et al., 2004).  The 
"Cytosine, uracil (ring, str)" peak was observed in the exponential phase of these cells but not 
at stationary phase (Huang et al., 2004).  The spectra of bacteria cells collected at various 
growth stages differs and such information could potentially be used in future to determine 
physiological stages of bacteria cells.  However, more work would be required to investigate 
further into the potential of this application.  It would also require building up of spectra 
libraries of different bacteria, in different growth conditions and at different growth stages .    
 
In order to achieve Raman based imaging of bacteria cells within macrophages, the 
differences in Raman spectrum between the two cell types were exploited.  Raman spectra 
were collected from S. Typhimurium strain SL1344 grown at different growth stages and 
under different growth conditions.  Raman spectra were also collected from mouse 
macrophage-like cells J774A.1, as a representative host cell.   
 
In the initial attempt to image J774A.1 cells infected with SL1344, images were obtained at 
each of the selected wavenumbers, except for 1443.96 cm-1.  Images obtained showed that 
signals higher than background were detected in two of the macrophage cells  (Figure 3.15).  
The signals were detected in all the images captured at 724 cm-1, 781 cm-1, 810 cm-1, 1095 
cm-1, 1477 cm-1 and 1569 cm-1.  These were the wavenumbers where signals were thought to 
be coming more strongly from bacterial cells rather than macrophage cells.  The images 
captured suggested that the signal observed were likely to be from bacterial cells within 
macrophages.  However, this could not be validated.  Hence, although the objective of Raman 
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based imaging was label-free imaging, for validation, bacteria cells were required to be 
labelled.   
 
In order to validate the images, the bacterial cells were required to be specifically labelled 
and be detectable by Raman microscopy.  For this reason the approach used was to culture 
the bacterial cells in broth media made up with 70% of D2O.  The deuterium atom will 
replaced the hydrogen atom.  This resulted in an additional molecular vibration frequency, C-
D vibration.  This additional peak was unique to the bacteria grown in the deuterium oxide 
media, and was not present in macrophage cells.  When images obtained from the selected 
wavenumbers coincided with images from C-D frequency, it strongly suggested that the 
images obtained were truly from the bacteria cells.   
 
It has been reported that microorganisms are more tolerant to deuterium oxide as compared to 
multicellular organisms (Hirai et al., 2010).   For example, Vibrio phorphorescens was able to 
survive in prolong contact with heavy water (Harvey, 1934).  Deuterium oxide had been used 
in Raman based imaging to prevent heating of sample (Zumbusch et al., 1999), but not for 
image validation.  Here, SL1344 were able to grow in media containing 70% D2O.  The 
Raman spectra obtained showed some variations between cells grown in LB broth and in LB 
broth media made up with 70% of D2O; the most distinct difference is the addition of a peak 
at 2148 cm-1 for cells grown in media containing D2O.  This additional peak corresponded to 
C-D vibration.  Although variations were observed in the Raman profile, the ability of the 
bacteria cells grown in media containing D2O to infect macrophages was not affected - 
rendering it to be suitable for imaging work.   
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SRS imaging of deuterium treated SL1344 in Figure 3.19 showed again that signals were 
detected at the same spot within macrophage cells across the selected wavenumbers.  In this 
set of images the spot was also detected in the wavenumbers for C-D vibration.  This 
validated the signals detected in those selected wavenumbers.   
 
The results obtained showed that the selected wavenumbers were able to provide 
discriminative imaging of bacteria cells within macrophages.  This is the first time that 
bacterial cells were distinctly imaged by SRS within macrophages based on carefully selected 
wavenumbers.  It successfully demonstrated the potential of SRS microscopy in 
discriminative imaging for bacterial cells within macrophages with the selected wavenumbers.  
However, the quality of images was limited and further development of this approach was not 
possible, largely because of the instability of the laser system when operated at low 
frequencies which I found to be necessary.  Further development of laser technology should 
overcome this problem and imaging of bacteria interacting with live cells in real-time and in 
a label-free manner could then provide more insight into bacteria and host cell interactions.  It 
could also potentially be used to image bacteria cells within a whole organism, such as 
optically clear zebrafish embryos, in a label-free manner. 
 
As reproducible results could not be obtained at present, this study was terminated and did 
not proceed to explore its potential use in interrogating Campylobacter molecular make-up 
for Raman based imaging.  However, the ZFE infection model was established in this study 
as discussed in Chapter 4.  Attempts in making reporter Campylobacter strains using 
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fluorescence makers had shown to be difficult (refer to Chapter 4).  The resultant strains were 
weak in fluorescence signals, making it unsuitable to perform live-imaging to investgate 
interraction between the bacteria and host cells.  Hence, it is important to continue to 
develope a label-free live-imaging technique for Campylobacter; the Raman based imaging 
provides the potential to perform live-imaging of Campylobacter in its native form.  When 
the laser system for Raman based imaging matures, it could be used in the interrogation of 
the interaction of Campylobacter with host immune cells in vivo in a label-free manner.     
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Chapter 4:  Development of ZFE as an optically transparent 
infection model for Campylobacter jejuni  
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4.1 Introduction 
 
4.1.1 Animal models for Campylobacter 
 
A good animal model is essential in the understanding of disease and the patho-physiology of 
infection.  In order to study disease an animal model should ideally be able to reproduce the 
disease as it would in a human host. The route of challenge used should be physiologically 
relevant, mimicking the natural route of infection in humans and the challenge dosage should 
be low.  The model should produce robust, reproducible results and ideally be low cost and 
ethically acceptable (Ruiz-Palacios et al., 1981).  Bovine, canine, feline, avian, murine and 
swine models have been explored for understanding Campylobacteriosis (Babakhani et al., 
1993; Janssen et al., 2008; Jones and Little, 1931a, b; Jones et al., 1931; Prescott et al., 1981; 
Prescott and Karmali, 1978; Ruiz-Palacios et al., 1981; Sanyal et al., 1984; Young et al., 
2007).  However, none of these models met all the criteria stated above.  For example, they 
are either high maintenance / cost for calves and piglets models (Jones and Little, 1931a, b; 
Jones et al., 1931), they do not reproduce disease outcomes observed in humans, such as in 
canine, feline and murine models (Prescott et al., 1981; Prescott and Karmali, 1978) or the 
route of infection used is not the natural route for human infection, for example in murine 
model (Janssen et al., 2008; Young et al., 2007). 
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4.1.2 ZFE as infection model 
 
ZFE have been widely used in developmental studies.  This is largely because of their optical 
transparency properties.  However, ZFE are gaining popularity in pathogen studies as model 
organisms for the study of disease caused by Mycobacterium, Pseudomonas and Salmonella, 
(Clatworthy et al., 2009; Davis et al., 2002; van der Sar et al., 2003; Wang, 2010).  There are 
currently no reports on the use of ZFE as a model for Campylobacteriosis studies.  
 
There are several advantages to ZFE as a model for infectious diseases studies, namely; i) 
low cost and maintenance; ii) minimal lab space requirement; iii) ease of handling; iv) ex vivo 
embryo development; v) transparency and most importantly; vi) similar immune system 
(innate and adaptive) to human and other vertebrates (Phelps and Neely, 2005).  These 
features can be exploited to gain a better understanding of the interaction of Campylobacter 
with innate immunity cells, such as macrophages, in vivo.     
 
 
 
4.1.3 Aim of study 
 
The aim of this study was to develop a ZFE infection model for Campylobacter.      
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4.2 Results 
 
4.2.1 Determining the site of inoculation in ZFE for Campylobacter infection model  
 
In this study C. jejuni strain Cj11168H was first inoculated into the ZFE yolk sac's circulation 
valley (CV) in embryos at 30 or 52 hpf.  The bacteria were grown at 37°C or 42°C on CBA+ 
or in MHB.  Each embryo was inoculated with approximately 2-4 nl of bacterial suspension 
adjusted to OD590 of approximately 10.  The cell density for Cj11168H wild-type cells from 
24 hr broth culture at 37°C, at OD590 1 was, on average, 5x108 CFU/ml (calculated from 17 
different dilution spots counts).  The mean inoculum volume was set as 3 nl, hence the 
number of bacteria cells inoculated into each embryo was approximately 15,000 CFU.  The 
survival of challenged embryos at 24 hpi are summarised in Table 4.1.   
 
The conditions in which Campylobacter was grown had previously been shown to affect 
killing of G. mellonella (Champion et al., 2010), therefore, bacteria were cultured under 
different conditions; i.e. at 37°C or 42°C in broth or on agar before challenging ZFE.  The 
results obtained showed that for CV inoculation, almost all of the embryos remained alive at 
24 hpi regardless of the culturing conditions.   
 
Next, another route of infection was investigated.  Bacteria were inoculated into the yolk sac 
(YS) of the embryos instead of its CV.  When 28 hpf embryos were challenged with OD590 
~10 of Cj11168H grown at 37°C in MHB, all but one out of 93 challenged embryos were 
dead at 24 hpi (Table 4.2), while embryos challenged at 28 or 52 hpf with Cj11168H grown 
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at 42°C on CBA+ had 55% and 70% survival respectively (Table 4.2).  The results obtained 
showed that ZFE were more susceptible when C. jejuni was inoculated into the YS.  Hence, 
for all subsequent infection assays the bacteria cells were inoculated into the embryo's yolk 
sac.    
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Table 4.1: ZFE were challenged with C. jejuni Cj11168H wild-type cells that were inoculated into CV of 30 or 52 
hour post-fertilisation (hpf) embryos.  The bacteria were cultured at either 37°C or 42°C either on 
CBA+ or in MHB.  Optical density of bacteria cells were adjusted to approximately OD590 10 for 
inoculation.  A total of 4 different batches of ZFE were used.  Survival percentage of challenged ZFE 
at 24 hpi was as tabulated. 
 
Bacterial 
culture 
temperature 
(°C) 
Culture 
media 
Stage of 
development 
(hpf) 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Survival 
percentage 
at 24 hpi (%) 
37 
CBA+ 
30 10.25 25 1 100 
52 10.6 24 2 96 
MHB 
30 10 25 1 100 
52 9.6 25 2 100 
42 
CBA+ 
30 10.6 20 3 100 
52 9.6 21 4 100 
MHB 
30 9.8 20 3 100 
52 10.2 21 4 100 
 
Table 4.2: ZFE were challenged with C. jejuni Cj11168H wild-type cells that were inoculated into YS of 28 or 52 
hour post-fertilisation embryos.  The bacteria were cultured at either 37°C or 42°C either on CBA+ or 
in MHB.  Optical density of bacteria cells were adjusted to approximately OD590 10 for inoculation.  A 
total of 6 different batches of ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was as 
tabulated. 
 
Bacterial 
culture 
temperature 
(°C) 
Culture 
media 
Stage of 
development 
(hpf) 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Mean 
survival 
percentage 
at 24 hpi (%) 
37 
CBA+ 
28 
Not Tested 
52 
MHB 
28 10 93 5 to 9 2 
52 Not Tested 
42 
CBA+ 
28 9.9 46 10 & 11 55 
52 9.65 47 10 & 11 70 
MHB 
28 
Not Tested 
52 
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4.2.2 Determining the developmental stage of ZFE for Campylobacter infection model  
 
 
In order to develop a ZFE infection model for Campylobacter embryos were challenged with 
bacteria at 28 hpf or 52 hpf.  These developmental stages were chosen based on the expected 
presence of macrophages, and both macrophages and neutrophils in the organism respectively.   
 
The ZFE were challenged with C. jejuni, strain Cj11168H or strain Cj81-176_CP.  The 
bacterial cell suspensions at an optical density of approximately 10 were inoculated into YS 
of 28 hpf or 52 hpf embryos.  The percentage survival of the embryos at 24 hpi is 
summarised in Table 4.3.  The results from Batch number 10 & 11 (previously presented in 
Table 4.2) was re-presented here for comparison with results obtained from Cj81-176_CP. 
 
The number of infected embryos alive at 24 hpi was lower for embryos challenged at 28 hpf 
as compared to those challenged at 52 hpf.  This result indicates that embryos at 28 hpf were 
more susceptible to the infection, hence they were used for subsequent infection assays. 
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Table 4.3: ZFE were challenged with C. jejuni Cj11168H or Cj81-176_CP wild-type cells that were inoculated 
into YS of 28 or 52 hour post-fertilisation embryos.  The bacteria were cultured at 42°C either on 
CBA+ or in MHB.  Optical density of bacteria cells were adjusted to approximately OD590 10 for 
inoculation.  A total of 4 different batches of ZFE were used.  Survival percentage of challenged ZFE 
at 24 hpi was as tabulated. 
 
C. jejuni strain Culture 
media 
Stage of 
development 
(hpf) 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Mean 
survival 
percentage 
at 24 hpi (%) 
Cj11168H 
CBA+ 
28 9.9 46 10 & 11 55 
52 9.65 47 10 & 11 70 
MHB 
28 
Not Tested 
52 
Cj81-176_CP 
CBA+ 
28 11 40 12 & 13 40 
52 10.5 40 12 & 13 80 
MHB 
28 11 40 12 & 13 48 
52 10 35 12 & 13 60 
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4.2.3 Effects of culture conditions on infection of ZFE by C. jejuni 
 
C. jejuni was cultured at 42°C (mimicking the chicken host environment) or 37°C 
(mimicking human host environment) and tested using ZFE infection model.  The bacteria 
were also grown using two different media CBA+ and MHB.     
 
The survival percentages of ZFE challenged at 28 or 52 hpf with agar grown or broth grown 
Cj81-176_CP (Table 4.4, the data on Cj81-176_CP was extracted from Table 4.3) were 
analysed by one-way ANOVA followed by uncorrected Fisher's least significant difference 
(LSD) test, at 95% confidence level.  The results showed that differences between the 
survival percentages of the four groups were not significant.  Based on prior observations in 
the G. mellonella model (when challenged with 106 CFU agar grown Campylobacter cells 
some larvae survived, but when challenged with same amount of broth grown Campylobacter 
cells all larvae died (Champion et al., 2010)), Campylobacter cells grown in broth culture 
were selected as the culturing condition for subsequent assays. 
 
The results obtained showed a higher mortality when bacteria were grown at 37°C than at 
42°C (Table 4.5).  The data obtained was a tested using t-test and the results showed the 
difference between the survival percentages was significant at 95% confidence (P-value = 
0.016).  Thus, in subsequent assays, the bacteria cells were cultured at 37°C prior to infecting 
ZFE. 
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All the results obtained were used to define the parameters for using the ZFE as an infection 
model for Campylobacter studies.  The optimised ZFE infection model uses embryos at 28 
hpf and Campylobacter cells pre-grown at 37°C in broth and inoculated into the embryo's YS.         
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Table 4.4:  ZFE were challenged with C. jejuni Cj81-176_CP wild-type cells that were inoculated into YS of 28 or 
52 hour post-fertilisation embryos.  The bacteria were cultured at 42°C either on CBA+ or in MHB.  
Optical density of bacteria cells were adjusted to approximately OD590 10 for inoculation.  A total of 2 
different batches of ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was as 
tabulated. 
 
C. jejuni strain 
Stage of 
development 
(hpf) 
Culture 
media 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Mean 
survival 
percentage 
at 24 hpi (%) 
Cj81-176_CP 
28 
CBA+ 11 40 12 & 13 40 
MHB 11 40 12 & 13 48 
52 
CBA+ 10.5 40 12 & 13 80 
MHB 10 35 12 & 13 60 
 
 
Table 4.5: ZFE were challenged with C. jejuni Cj11168H wild-type cells that were inoculated into YS of 28 hour 
post-fertilisation embryos.  The bacteria cells cultured at either 37°C or 42°C in MHB.  Optical density 
of bacteria cells were adjusted to approximately OD590 1 for inoculation.  A total of 3 different batches of 
ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was as tabulated. 
 
Bacterial 
culture 
temperature 
(°C) 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Mean 
survival 
percentage 
at 24 hpi (%) 
37 1.02 60 14 to 16 32 
42 0.97 60 14 to 16 57 
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4.2.4 Effects of inoculation dose on infection of ZFE by C. jejuni 
 
With the above mentioned parameters determined for the ZFE infection model, Cj11168H 
wild-type cells at various optical densities were used to challenge the embryos.  It required 
approximately 4 hours to inoculate an entire set of embryos consisting of a minimum of 80 
embryos.  Hence, the embryos were inoculated at stages between 28-32 hpf.   
 
Table 4.6 showed the numbers of embryos challenged for each of the inoculation dose tested.  
Mortalities of challenged embryos at 24 hpi are shown in Figure 4.1.   
 
The ZFE at 28 hpf were challenged with Cj11168H wild-type cells at OD590 0.1 to 10.  The 
cell density for Cj11168H wild-type cells at OD590 1 was, on average, 5x108 cfu/ml.  At 
OD590 10, with mean inoculum volume as 3 nl, the number of bacterial cells inoculated into 
each embryo was approximately 15,000 CFU.  Hence the challenge doses tested were 150 
CFU per ZFE (for OD590 0.1), 750 CFU per ZFE (for OD590 0.5), 1,500 CFU per ZFE (for 
OD590 1) and 15,000 CFU per ZFE (for OD590 10).   
 
The mortality of the embryos increased with increasing challenge dose.  Almost 100% 
mortality was achieved by 24 hpi when bacteria cell suspension at OD590 10 was used for 
inoculation.  When the infection dose was reduced 100-fold to OD590 0.1, the mortality was 
2.5%.   
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Based on the results an inoculation dose of OD590 at approximately 1 caused approximately 
50% death and was selected for subsequent studies.   
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Table 4.6: List of the number of ZFE tested for each infection dose.  ZFE were challenged with C. jejuni 
Cj11168H wild-type cells that were inoculated into YS of 28-32 hour post-fertilisation embryos.  The 
bacteria cells were cultured at 37°C in Muller Hinton broth (MHB).  Optical density of bacteria cells 
were adjusted to approximately OD590 0.1, 0.5, 1.0 and 10 for inoculation.  A total of 5 different 
batches of ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was tabulated. 
 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Survival 
percentage 
at 24 hpi (%) 
0.1 40 6 & 7 98 
0.5 40 8 & 9 68 
1 100 5 to 9 43 
10 93 5 to 9 2 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Mortality chart of ZFE challenged with C. jejuni strain Cj11168H wild-type at 24 hpi.  ZFE at stages 
between 28-32 hpf were used.  Cj11168H wild-type was cultured in MHB at 37°C for 24 hr.  The 
optical densities of the bacterial cells were adjusted to OD590 0.1, 0.5, 1.0 and 10 respectively and were 
delivered into embryo's yolk-sac through micro-injection.  The mortality of ZFE was dependent on the 
inoculation dose.  Higher mortality was obtained with higher inoculation dose.  At OD590 of 
approximately 10, 99% of challenged embryos were dead by 24 hpi and at OD590 of approximately 1, 
57% of challenged embryos were dead by 24 hpi.   
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4.2.5 Testing of Campylobacter strains and mutants using the ZFE infection model 
 
The Cj11168H strain was used as the reference strain in the development of the ZFE 
infection model for Campylobacter studies.  The model was then used to test C. jejuni strain 
Cj1, a clinical isolate from Thailand.   
 
A total of 57 ZFE were challenged with Cj1 grown at 37°C in MHB, at OD590 1.0.  The 
percentage of embryos survived at 24 hpi was 40%, while those challenged with Cj11168H 
was 33% (Table 4.7).  The difference in survival percentages was tested using t-test at 95% 
confidence; the test result showed that the difference was not significant.   
 
Four previously constructed Cj11168H mutants were also tested using the ZFE infection 
model.  The four mutants were i) CDT mutant (∆cj0079); ii) acapsular mutant (∆cj1413); iii) 
aflagellate mutant (∆cj1339); iv) mutant lacking the LOS biosynthesis cluster - LOS mutant 
(∆cj1132c to cj1152c).    
 
Table 4.8 and Figure 4.2 show the percentage survival of ZFE at 24 hpi with wild-type or 
mutants.  The survival percentages were analysed by one-way ANOVA followed by 
uncorrected Fisher's LSD.  The statistical analysis at 95% confidence showed that the 
survival percentages of the CDT mutant and the acapsular mutant were not significantly 
different from wild-type.  ZFE challenged with the aflagellate mutant and the LOS mutant, 
had higher survival percentages compared to those challenged with wild-type.  Statistical 
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analysis showed that the differences in the survival percentages were significantly different, 
with P-values of 0.0083 and <0.0001 respectively.   
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Table 4.7: ZFE were challenged with C. jejuni Cj1 or Cj11168H wild-type cells that were inoculated into YS of 
28-32 hour post-fertilisation embryos.  The bacteria were cultured at 37°C in MHB.  Optical density of 
bacteria cells were adjusted to approximately OD590 1 for inoculation.  A total of 2 different batches of 
ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was as tabulated. 
 
C. jejuni strain 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Batch 
number 
Mean survival 
percentage at 
24 hpi (%) 
Cj1 1.0 57 17 to 18 40 
Cj11168H 1.05 48 17 to 18 33 
 
 
 
 
Table 4.8: ZFE were challenged with C. jejuni Cj11168H wild-type and mutants cells that were inoculated into 
YS of 28-32 hour post-fertilisation embryos.  The bacteria were cultured at 37°C in MHB.  Optical 
density of bacteria cells were adjusted to approximately OD590 1 for inoculation.  A total of 9 different 
batches of ZFE were used.  Survival percentage of challenged ZFE at 24 hpi was as tabulated. 
 
C. jejuni strain / 
mutants 
Mean optical density 
of bacteria cell 
suspension (OD590) 
Number of 
embryos 
challenged 
Number 
embryos 
alive at 24 
hpi 
Batch 
number 
Mean 
survival 
percentage at 
24 hpi (%) 
Cj11168H 
wild-type 1.01 189 50 19 to 27 26 
Cj11168H 
CDT mutant 1.03 68 18 19 to 21 26 
Cj11168H 
acapsular mutant 0.98 60 21 24, 26 & 27 35 
Cj11168H 
aflagellate mutant 0.995 80 36 22, 25 to 27 45 
Cj11168H 
LOS mutant 1.03 60 57 23, 26 & 27 95 
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Figure 4.2: Survival chart of ZFE challenged with C. jejuni strain Cj11168H wild-type and four mutants at 24 hpi.  
ZFE at stages between 28-32 hpf were used.  Cj11168H wild-type and mutants were cultured in MHB 
at 37°C for 24 hr.  The optical densities of the bacterial cells were adjusted to approximately OD590 1 
and were delivered into embryo's yolk-sac through micro-injection.  Survival percentages of CDT 
mutant and acapsular mutant were not significantly different from wild-type.  The survival 
percentages of aflagellate mutant and LOS mutant were significantly different from wild-type, with P-
value of 0.0083 and <0.0001 respectively.  The statistical analysis performed was one-way ANOVA 
followed by uncorrected Fisher's LSD.    
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4.2.6 Imaging of ZFE challenged with C. jejuni 
 
4.2.6.1 Bright-field imaging 
 
At 28 hpf the ZFE still resides within its chorion.  Prior to delivering the bacteria cell 
suspension by micro-injection into its YS the chorion was mechanically removed.  Figure 4.3 
shows an image of a ZFE at 28 hpf - the insert is an embryo at the same development stage 
residing within it chorion.  An image of uninfected embryos at 52 hpf is shown in Figure 4.4.  
The heart cavity and yolk sac were normal and more pigmentation could be observed on the 
embryo surfaces.   
 
Most ZFE challenged with C. jejuni showed signs of edema in the heart cavity, YS or both by 
24 hpi.  Figure 4.5 provides an illustration of the various forms of edema observed in ZFE 
challenged with C. jejuni.  All embryos with observable heartbeat at 24 hpi were recorded as 
alive.  The survival data recorded includes infected embryos that had edema.  Edema 
formation was observed in ZFE challenged with C. jejuni wild-type or mutant strains, with 
the exception of Cj11168H LOS mutant.  ZFE challenged with the latter were observed to be 
similar to uninfected ZFE at 52 hpf.  Beside edema formation, another commonly observed 
featured in the challenged ZFE (except for ZFE infected with Cj11168H LOS mutant) was 
the presence of a dark spot.  It was observed to be either in the YS or at the junction of the 
YS and the heart cavity.      
  
164 
 
 
 
 
 
  
Figure 4.3: ZFE at 28 hpf with (insert) and without chorion.  The de-chorinated embryos was embedded in 3% 
methyl-cellulose and glass capillary needle (indicated by the yellow arrow) was inserted into the yolk 
sac.  2 pulses of bacteria cell suspension, of approximately 2-4 nl were then delivered into the yolk sac 
through the glass capillary needle.   
 
 
 
 
 
 
 
 
Figure 4.4: Uninfected ZFE at 52 hpf.  More pigmentations (indicated by the red arrows) were observed over its 
surfaces, heart cavity and yolk sac is normal. 
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Figure 4.5: Images showing various ZFE infected with C. jejuni, at 24 hpi.  Edema (indicated by black arrows) 
were observed in the infected embryos at the heart cavity, yolk sac or both.  Dark spots (indicated by 
blue arrows) were also observed in the yolk sac or at the junction of the yolk sac and the heart cavity.    
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4.2.6.2 Fluorescence images 
 
4.2.6.2.1 Reporter C. jejuni Cj11168H cells 
 
Cj11168H cells were transformed by electroporation with a plasmid encoding either CFP, 
GFP or YFP protein (Miller et al., 2000).       
 
In Figure 4.6 images of Cj11168H wild-type, CFP, GFP and YFP reporter are presented.  The 
signals from the reporters in Cj11168H are very weak compared to the signals in an E. coli 
background (Figure 4.7).  In both Cj11168H and E. coli, CFP signals crossed over and were 
detected in the GFP filter.  In Cj11168H, the GFP signals also crossed over and were 
detectable in the CFP filter.  However, in E. coli GFP signals were detected in both CFP and 
YFP filters.  YFP signals in both Cj11168H and E. coli crossed over and were detected in 
both CFP and GFP filters.       
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Figure 4.6: C. jejuni Cj11168H wild-type, CFP reporter, GFP reporter and YFP reporter cells.  The bacteria were 
grown on CBA+ agar and a single colony was dislodged into 10 µl of water on glass slide.  The cells 
were heat fixed onto the slide.  Overall, the reporter signals were weak.  CFP reporter was detected 
under both CFP and GFP filter.  GFP reporter was detected both GFP and CFP filters.  YFP reporter 
was detected in all three filters.  
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Figure 4.7: E. coli strains expressing CFP, GFP and YFP.  The bacteria were grown on LB agar and a single 
colony was dislodged into 10 µl of water on glass slide.  The cells were heat fixed onto the slide.  
Overall, the reporter signals were strong.  CFP reporter was detected under both CFP and GFP filter.  
GFP reporter and YFP reporter was detected in all three filters. 
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A transgenic line of zebrafish expressing mCherry as a reporter in macrophages, was kindly 
provided by University of Sheffield (Gray et al., 2011).  The transgenic line with 
fluorescently tagged immune cells (mCherry-expressing macrophages) was used to track 
interaction between the bacteria and the immune cells in real-time.   
 
The mCherry-macrophage ZFE were inoculated at 28 hpf with GFP-Cj11168H (Figure 4.8).  
The images were taken using live embryos between 0-3 hpi.  This set of embryos was 
inoculated with a higher infection dose at OD590 ~13.  As fluorescent signals from Cj11168H 
GFP reporter were not strong.  The higher inoculation dose was used to enable better 
visualisation of the inoculated bacteria.  During the first hour after inoculation a cloud of 
green fluorescence was visible within the yolk sac of the infected embryo (Figure 4.8, B).  
However, between the first and second hour, the green fluorescent cloud had dispersed 
(Figure 4.8, C) and by the third hour it could not be detected (Figure 4.8, D and E).  It was 
observed that after the first hours more mCherry-macrophages were located towards the 
middle of the yolk sac.  This was not observed in unchallenged embryos. 
 
A second set of mCherry-macrophage ZFE were inoculated with GFP-Cj11168H at OD600 1.  
This set of infected embryos was incubated overnight and images were taken at 22 hpi, 
(Figure 4.9).  The images of live embryos were taken using an upright fluorescent microscope.  
High magnification objectives, such as 40X and above, could not be used as it would result in 
crushing of the live embryos.  Auto-fluorescence from the embryos interfered with imaging 
of the GFP-Cj11168H and the use of low magnification objective did not allow detailed 
features to be imaged.  However, there were regions within the yolk sac that showed higher 
fluorescent signals compared to background fluoresence.  These regions coincide with the 
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dark spot observed under bright-field.  It was also observed that mCherry macrophages were 
located within the vicinity of the dark spots.  This is an indication that macrophages were 
recruited to the dark spot where the bacterial cells were potentially located.  The current 
imaging approach was not able to determine if the macrophages were interacting with the 
bacterial cells or if the bacterial cells within the dark spot observed were still viable.   
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Figure 4.8: Images of Cj11168H GFP reporter cells and yolk sac of infected mCherry-macrophage ZFE. A: C. jejuni 
Cj11168H GFP reporter cells at OD600 13, image taken with 100X objective.  B:  Transgenic ZFE with 
mCherry-expressing macrophages infected with C. jejuni Cj11168H GFP reporter cells at OD600 13, 
image taken between 0-1 hpi with 20X objective.  Green - Cj11168 GFP reporter cells and Red 
(indicated by white arrows) - mCherry macrophages.  C: Transgenic ZFE with mCherry-expressing 
macrophages infected with C. jejuni Cj11168H GFP reporter cells at OD600 13, image taken between 1-2 
hpi with 10X objective. Green - Cj11168 GFP reporter cells and Red (indicated by white arrows) - 
mCherry macrophages.  D and E: Transgenic ZFE with mCherry-expressing macrophages infected with 
C. jejuni Cj11168H GFP reporter cells at OD600 13, image taken between 1-3 hpi with 10X objective.  
Red (indicated by white arrows) - mCherry macrophages. 
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Figure 4.9: Images of yolk sac regions taken at 22 hpi of mCherry-macrophage ZFE infected with C. jejuni 
Cj11168H GFP reporter cells at OD600 1. A, D, G and J: Imaged taken at bright-field.  Dark regions 
within yolk sac were indicated by blue arrows.  B, E, H and K: Images taken using GFP filter.  Regions 
with stronger green fluorescence were indicated by yellow arrows.  C, F, I and L: Images taken using 
mCherry filter.  mCherry macrophages were indicated by white arrows.  A-C: images taken using 10X 
objective.  D-L: Images taken using 20X objective.  
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4.2.6.2.2 FITC labelled C. jejuni Cj11168H cells 
 
As the Cj11168H GFP reporter did not have a strong fluorescent signal staining of 
Campylobacter cells was explored.  Cj11168H wild-type cells were stained in 0.4 µg/ml of 
FITC for 15 minutes at room temperature with constant mixing (Agerer et al., 2004).  The 
FITC stained bacteria cells gave a strong fluorescent signal, Figure 4.10.  
 
A total of 24 ml of Cj111668H wild-type broth culture were stained with FITC.  After 
washing, the cells were re-suspended in 100 µl of PBS and were used to inoculate mCherry-
macrophages ZFE.  The infected ZFE were monitored for up to 52 hpi (Figure 4.11).  The 
FITC signal was strong and dispersed within the yolk sac.  However, this staining approach 
could not be used to address the issue of determining if the bacteria are still viable or not.  
Furthermore, it is not a good approach for studying bacteria and macrophage interactions as 
the binding of the dye to the bacterial cell would have modified or masked the structures on 
the bacteria cell surfaces that might be important for interaction with host cells.  In Figure 
4.11 (G and I) the bright-field image showed a dark spot was present in the embryo's YS and 
the mCherry images showed that mCherry expressing macrophages gathered around the dark 
spot.  This was, as previously observed when Cj11168H GFP reporter images were taken. 
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Figure 4.10: Broth grown Cj11168H wild-type cells (OD600 ~10) were stained with 0.4 µg/ml 5-(6)-
carboxyfluorescein-succinylester for 15 min, with constant mixing at room temperature.  The stained 
cells were washed thrice in PBS before visualisation under fluorescence microscope using 100X 
objective. 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: mCherry-macrophage ZFE infected with Cj111668H wild-type cells stained with FITC.  A-C: Images 
taken at 1 hpi using 20X objective.  A - Bright-field, B - GFP filter and C - mCherry filter.  D-F: 
Images taken at 22 hpi using 10X objective.  D - Bright-field, E - GFP filter and F - mCherry filter.  G-
I: Images taken at 52 hpi using 10X objective.  G - Bright-field, H - GFP filter and I - mCherry filter.  
mCherry macrophages were indicated by white arrows.  Dark regions within yolk sac were indicated 
by blue arrows.  Regions with stronger green fluorescence were indicated by yellow arrows.         
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4.3 Discussion 
 
ZFE infection models have been established for several pathogens.  In these studies the 
pathogen of interest was inoculated into the ZFE by micro-injection into the axial vein (van 
der Sar et al., 2003), yolk sac circulation valley (Clatworthy et al., 2009) or yolk sac (Prajsnar 
et al., 2008).  Inoculation into the yolk sac could be done at any ZFE developmental stage.  
However, injection into the circulation valley, was only possible when the blood circulation 
system was established - which is around 30 hpf.  Inoculation into the circulation valley 
would potentially allow the bacteria to travel within the blood circulation to other parts of the 
body, whereas inoculation into the yolk sac should result in the bacteria remaining localised.   
 
Campylobacter is not a natural pathogen for zebrafish, hence it was important to determine if 
the pathogen was able to establish an infection in ZFE.  The yolk sac's circulation valley is a 
point where blood returning from the body and tail of the embryo flows freely to the heart 
and is re-circulated (Clatworthy et al., 2009).  When bacteria were injected into the 
circulation valley, it enter the circulation, thereby mimicking bacteraemia (Prajsnar et al., 
2008).  It was reported that P. aeruginosa inoculated into the circulation valley of 28 hpf ZFE 
was lethal to the embryos.   
 
Unlike the P. aeruginosa ZFE infection model inoculation of C. jejuni into circulation valley 
was not lethal.  Nonetheless, the results obtained were similar to those seen in a S. aureus 
ZFE infection model.  In the study, it was reported that 100% of the infected embryos were 
alive at 48 hpi when S. aureus was inoculated into the circulation valley of the embryo 
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(Prajsnar et al., 2008).  However, when it was inoculated into the yolk sac, 100% mortality 
was achieved at a lower infecting dose (Prajsnar et al., 2008).  It was suggested that survival 
of embryos inoculated into the circulation valley could be due to the ZFE host defence 
mechanism either controlling or clearing the challenge (Prajsnar et al., 2008).  When 
inoculated into the yolk sac S. aureus grew within the site of inoculation, and injection into 
the circulation valley led to systemic infection (Prajsnar et al., 2008).     
 
It is not clear what happens to C. jejuni after inoculation into the circulation valley or the yolk 
sac.  Attempts to recover Campylobacter cells post-infection were not successful.  A problem 
faced was the presence of other bacteria from the embryos that were able to grow on selective 
agar that contained Skirrow supplement.  The other challenge was low or no recovery of 
Campylobacter cells from infected embryos.  It could either be due to the bacteria being 
killed by the embryo's defence mechanism, or the bacteria switching into VBNC state and 
thereby were not quantifiable by cfu counts.   
 
The ex vivo embryo allows disease pathogenesis to be studied at different developmental 
stages as the immune system becomes established in the organism (Phelps and Neely, 2005).  
Macrophage-like cells are found within the yolk-sac after ~22 hpf (Herbomel et al., 1999); 
primitive granulocytes circulate the embryo by 48 hpf (Lieschke et al., 2001), while mature 
neutrophils are found in tissues by 72 hpf (Willett et al., 1999).  Macrophages and neutrophils 
form an important part of the innate immunity system and macrophages in ZFE have been 
shown to be involved in the clearing of bacteria inoculated into the embryo (Herbomel et al., 
1999).   
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The ZFE were tested at 2 different stages of development (28 hpf and 52 hpf) and results 
obtained were similar to ZFE infected with P. aeruginosa at 28 hpf and 50 hpf (Clatworthy et 
al., 2009).  The survival rates of embryos when challenged at 52 hpf were higher compared to 
those infected at 28 hpf.  This is because at 52 hpf the embryos were potentially more 
immuno-competent since both macrophages and granulocytes (neutrophils) had appeared and 
were functional (Clatworthy et al., 2009; Herbomel et al., 1999; Le Guyader et al., 2008; 
Lieschke et al., 2001).  The interaction of C. jejuni with monocytes in vivo is still an 
unanswered question (Young et al., 2007).  Hence, ZFE at 28 hpf, where only macrophages 
are present, is a good developmental stage at which to study this interaction.              
 
Campylobacter is exposed to different temperatures, from chickens to humans, throughout its 
infection cycle.  While inside the chicken intestine, bacteria is exposed to 42°C.  Upon entry 
into human host, the temperature will be at 37°C.  The temperature in which bacteria reside 
will affect its cellular process (Hurme and Rhen, 1998) - some genes might be switched either 
on or off to adapt to the new environment.   
 
In this study Cj11168H wild-type cells were grown at 37°C or 42°C prior to inoculating into 
ZFE.  It was recorded that embryos infected with Campylobacter grown at 37°C had a higher 
mortality rate.  The difference in mortality rate observed could be due to differential gene 
expression when the bacteria were exposed to the two different temperatures.   
 
178 
 
A proteomic study conducted on Campylobacter grown at 37°C or 42°C both on agar and in 
broth showed that various categories of proteins were differentially expressed (Zhang et al., 
2009).   The proteins shown to be differentially expressed were either involved in; i) 
metabolism; ii) stress defences; iii) iron acquisition; iv) regulator system or v) cell structures 
(Zhang et al., 2009).  It was reported that some proteins were uniquely expressed when 
Campylobacter was grown at 37°C and might play a part in human host adaptation (Zhang et 
al., 2009).  This might explain the observations made in ZFE infection.   
 
Besides, the proteomics study, the effect of culturing temperature on growth, chemotaxis, 
motility and adherence/invasion of epithelial cells has also been reported.  Culturing of 
Campylobacter at 37°C was shown to be more favourable for growth and chemotaxis 
(Khanna et al., 2006).  The motilities of Campylobacter grown at 37°C or 42°C were reported 
to be strain dependent.  Cj81116 was more motile at 42°C, whereas environmental isolate C. 
jejuni M1 showed no significant differences in motility between the two temperatures tested 
(Aroori et al., 2013).  Campylobacter grown at 37°C has also been demonstrated to exhibit 
enhanced adherence/invasion of human epithelial cells (Aroori et al., 2013; Konkel et al., 
1992).  In order to investigate further the difference observed in ZFE, motilities, 
transcriptomics and proteomics studies could be performed on Cj1168H wild-type grown 
under the two different temperatures.     
 
The percentage of embryo death post challenged was dependent on the inoculation dose.  
When comparing the inoculation dose of C. jejuni used to challenged ZFE to a S. aureus ZFE 
infection model (bacteria inoculated into yolk sac), the ZFE were more susceptible to S. 
aureus.  However, when compared to a P. aeruginosa infection model (bacteria inoculated 
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into yolk sac's circulation valley), the ZFE were more susceptible to C. jejuni.  The infection 
dose of different bacteria will be different.  It has been reported that infection doses of 
bacteria are dependent on the molecules the pathogen use to facilitate its infection in each 
host (Leggett et al., 2012).  If the molecules work in close proximity of the bacteria, then 
fewer bacteria will be required to establish an infection (Leggett et al., 2012).  Contrary to 
this, when the molecules act on sites at a distance away from the bacteria, then a higher 
number of the bacteria would be required to establish an infection - a matter of concentration 
over distance (Leggett et al., 2012).   
 
An important outcome from the infection dose study was that ZFE could be killed in a dose 
dependent manner.  With that knowledge, this model could be used to screen Campylobacter 
isolates or mutants for its virulence or attenuation in ZFE.  An additional advantage to the 
ZFE model was its ability to use organismal death as the hard end-point (Prajsnar et al., 2008).  
This is often not possible in other model organisms.   
 
The ZFE model was used to screen four C. jejuni Cj11168H mutants.  These mutants were 
previously tested using the G. mellonella model (Champion et al., 2010).   
 
In the ZFE model the CDT mutant was not attenuated.  Survival percentage between this 
mutant and wild-type strain was the same.  This is different from observations made in the G. 
mellonella model where CDT mutant had shown significant attenuation (Champion et al., 
2010).  It suggests that CDT does not have any role in establishing infection in ZFE.   
 
180 
 
The acapsular mutant although showed a higher percentage of survival when compared to 
wild-type, the difference was not significant.  Similarly, in the G. mellonella model, enhance 
survival of this mutant was observed but was not significant (P>0.5) when compared to wild-
type strain (Champion et al., 2010).  The slight increase in survival observed in both model 
suggests that capsule might play a role in infection.  It has been reported that it is unusual for 
Campylobacter, an intestinal pathogen, to have capsule and its actual role was not well 
defined (Guerry et al., 2012) although it has a role in serum resistance (Keo et al., 2011) and 
modulates host immune responses (Maue et al., 2013). 
 
The aflagellate mutants tested had showed a significant higher percentage of survival when 
compared to wild-type.  In the G. mellonella model, the survival percentage of larvae 
challenged with this mutant was also significant higher (P<0.5) when comapred to wild-type 
(Champion et al., 2010).  This indicates that flagella in Campylobacter play a role in 
establishing infection in both ZFE and G. mellonella.  The flagella is an important export 
apparatus for Cia (Campylobacter invasion antigens) proteins which play a role in invasion of 
epithelial cells (Konkel et al., 2004).     
 
The LOS mutant was highly attenuated in the ZFE and this is similar to observations in the G. 
mellonella model (Champion et al., 2010).  This indicates that LOS plays a vital role in 
virulence in both model organisms.  LOS of Campylobacter has been reported to play a part 
in serum resistance and adherence and invasion of epithelial cells (Young et al., 2007).  
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The variation in survival observed when the embryos were infected with different 
Campylobacter mutants shows the potential of using ZFE as an infection model for screening 
mutants.  The ZFE has been used as an infection model for mutant screening in other 
pathogens such as Salmonella Typhimurium (van der Sar et al., 2003) and Listeria 
monocytogenes (Levraud et al., 2009).  Besides these various advantages stated previously, 
the ability to perform high throughput screening makes ZFE an attractive model for 
Campylobacter studies (Phelps and Neely, 2005; Wang et al., 2007).     
 
However, before going full scale into using the ZFE model, an important point to note is that 
ZFE could not be maintained at 37°C; hence, upon inoculation into the embryo the bacteria 
will be incubated inside the embryo at 28°C.  As Campylobacter is able to grow at 
temperatures between 30°C to 47°C (Aroori et al., 2013) its ability to survive at 28°C will 
need to be addressed.  It has also been observed that quality of the embryos varies from batch 
to batch.  For example, when tested at OD590 of 1 in Batch 16-20 the survival rate of the 
embryo was 43%.  When different batches were tested with the same input the survival 
percentages changed.  For example, for Batches 21 to 22, it was 31.25% and for Batches 23-
31, it dropped to 26.46%.  In order to overcome the batch to batch issue, a reference strain, 
such as Cj11168H wild-type, should always be included in each infection assay involving 
strains or mutants screening. 
 
An important advantage of ZFE was that it stays optically transparent during the first three 
weeks of its development (Phelps and Neely, 2005).  This property allows images of embryos 
to be taken.  Real-time imaging to track bacteria injected in ZFE had been reported for 
various pathogens (Clatworthy et al., 2009; Davis et al., 2002; Rounioja et al., 2012; van der 
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Sar et al., 2003).  In all these real-time imaging studies a strong fluorescent reporter strain 
was made to allow tracking of the bacteria inside the embryo.  A major challenge faced in the 
imaging of Campylobacter within the embryo was the lack of a strong fluorescent reporter 
strain.   
 
Plasmids comprising of CFP, GFP or YFP reporter gene fused with Campylobacter promoter 
were obtained from its USDA-ARS laboratory (Miller et al., 2000) and transformed into 
Cj11168H.  Unfortunately, the fluorescence signal in Cj11168H reporter were not strong.  In 
order to obtain a stronger reporter Cj11168H wild-type cells were stained with FITC prior to 
inoculation into ZFE.  Although the FITC signal was strong, it was dispersed inside the yolk 
sac and remained strong after 2 days.  The images obtained were not able to determine if the 
bacteria were still alive with the dye bound to them, or dead with the dye freely dispersed 
inside the yolk sac.       
 
The bright-field images showed formation of edema at either the yolk or heart cavity or both 
in infected embryos.  Edema formation had not been reported in other pathogens using ZFE 
as an infection model.  It will be interesting to investigate further to determine what bacterial 
or host factors caused this phenomenon.   
 
Another observation was that infected embryos developed a dark spot in the yolk sac or at the 
junction of yolk sac and heart cavity.  In fluorescent-based imaging mCherry macrophages 
were seen at the same location as the dark spot seen in bright-field images.  In Figure 4.9 the 
GFP signal was also stronger at the same location as the dark spot and the mCherry 
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macrophages.  This suggests that the dark spot observed in bright-field images may be 
aggregations of bacteria and macrophages.  What is happening within the dark spot?  This is 
an important question that still needs to be addressed.  It is unfortunate that higher 
magnification could not be achieved with the upright fluorescent microscope used.  However, 
this demonstrated the potential of using ZFE to interrogate the interaction of Campylobacter 
with macrophages in vivo.                
 
Real-time imaging to monitor interaction of macrophages with bacteria cells might be 
possible with a different microscope system, for example a multi-photon inverted microscope.  
The multi-photon microscope will be able to perform optical sectioning of thick tissues (such 
as ZFE) and due to its laser system, will be less detrimental to the cells (Masters and So, 
2004).  An inverted microscope would allow higher magnification objectives to be used 
without the fear of crushing the live embryos.   However, before that could be done a stronger 
Campylobacter reporter will be needed.   
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Chapter 5:  Identification of T6SS and construction of T6SS 
mutants in Campylobacter jejuni 
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5.1  Introduction 
 
5.1.1 Identification of T6SS 
 
A component of the T6SS, Hcp, was reported as early as 1996 in V. cholerae (Williams et al., 
1996) and since then other components such as the icmGCDJBF locus in Legionella 
pneumophilia (Purcell and Shuman, 1998), and icmF in Salmonella enterica (Folkesson et al., 
2002), have also been reported.  The classification of the secretion system as Type VI 
secretion system was in 2006 after the vas genes cluster was found in Vibrio cholerae 
(Pukatzki et al., 2006).  The T6SS is found mainly in Proteobacteria, with the exception of 
the epsilon sub-group.  Around a third of genomes harbouring the T6SS were found to have 
multiple copies (Boyer et al., 2009).  For example, Yersinia species can have 5 to 6 copies of 
T6SS loci, Burkholderia species between 2 to 6 copies and Pseudomonas species 2 to 3 
copies (Boyer et al., 2009).   
 
A functional T6SS in Campylobacter was first suspected when 4 components of T6SS (tssJ, 
tssK, tssC and tssD) were detected after mass spectrometry analysis of C. concisus cellular 
proteins (Kaakoush et al., 2011).  However, no further work on the potential T6SS in 
Campylobacter was reported until Lertpiriyapong et al presented their work on a functional 
T6SS in C. jejuni (Lertpiriyapong et al., 2012).  To date, there are only two reports on 
functional T6SS in C. jejuni - and both report a single copy of T6SS (Bleumink-Pluym et al., 
2013; Lertpiriyapong et al., 2012).   
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The identification of a potentially functional T6SS was based on the presence of 13 COGs of 
protein on a single locus.  The 13 COGs were identified by Boyer et al after screening a total 
of 506 complete genome sequences. The 506 complete genome consist of 176 T6SS loci 
from 92 different bacteria (Boyer et al., 2009).  The 13 core COGs were present within T6SS 
loci at a frequency of more than 70 percent, which was significantly higher than other COGs 
screened (Boyer et al., 2009).  A hallmark indicator for functional T6SS in bacteria 
harbouring T6SS locus is the presence of TssD in culture media (Pukatzki et al., 2007).   
 
5.1.2 Mutagenesis in Campylobacter 
 
Early work on Campylobacter was handicapped by a lack of tools to make mutants.  
However, a breakthrough was made when Labigne-Roussel et al constructed the shuttle 
vector, pILL550.  This allowed the introduction of foreign DNA into Campylobacter via 
conjugation (Labigne-Roussel et al., 1987).  Subsequently, a conjugative suicide vector, 
pILL560, was constructed. It was similar to pILL550 but was unable to replicate in 
Campylobacter after the removal of Campylobacter replication sequences (Labigne-Roussel 
et al., 1988).  The suicide plasmid was constructed to include a C. jejuni 16s rRNA gene at 
the multiple cloning site (MCS). A kanamycin resistance cassette was inserted within the 16s 
rRNA gene to disrupt it.  The suicide plasmid containing the disrupted 16s rRNA gene, 
pILL545, was transferred into C. jejuni via conjugation.  The kanamycin resistance cassette  
was shown to have integrated into the chromosome at the target gene region (a double 
crossover event) and the plasmid was lost in cells when grown on selective plates (Labigne-
Roussel et al., 1988).  The work of Labigne-Roussel et al set the background for 
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Campylobacter mutagenesis, and Miller et al demonstrated its ability to be transformed by 
electroporation (Miller et al., 1988).   
 
5.1.3 Aim of study 
 
The aim of this study was to identify a T6SS in C. jejuni strains isolated from Thailand and to 
construct T6SS mutants for future work. 
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5.2   Results 
 
5.2.1:  Identification of T6SS in Campylobacter jejuni strain Cj1 
 
C. jejuni strains isolated from patients in Thailand were sequenced using the Illumina HiSeq 
2500 with 100 bp paired end reads.  The 100 bp reads were subjected to de-novo assembly to 
create contigs.  The contigs were then uploaded onto MG-RAST metagenomics analysis 
server (http://metagenomics.anl.gov/) for annotation.  Annotation of contigs from the various 
C. jejuni strains being sequenced revealed that strain Cj1 harbours a cluster of genes 
consisting of T6SS core orthologs (Pukatzki et al., 2006).   
 
Two contigs from Cj1 were found to include genes that could encode components of a T6SS.  
Contig  scf_30956_20_contig_1 (20905 bps in length) contained 12 genes which are likely to 
be components of a T6SS.  Contig scf_30956_10_contig_1 (963 bps) had a partial gene 
which could encode for a T6SS component, tssI.  The stop codon of tssI was within this 
contig but not its start codon.  Table 5.1 is the annotation output from MG-RAST for the two 
contigs. 
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Table 5.1: Summary of C. jejuni strain Cj1 contig scf_30956_10_contig_1 and contig scf_30956_20_contig_1 
annotation from MG-RAST. 
 
    
  
Contig ID Location Start Stop Strand Function Evidence codes 
scf_30956_
10_contig_1 
scf_30956_10_co
ntig_1_12_908 
12 908 + VgrG protein isu;USS-DB-7 
isu;Type_VI_secretion_syste
ms 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_47_3469 
47 3469 + FIG00470311: 
hypothetical protein 
ff 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_3480_478
1 
3480 4781 + FIG00469624: 
hypothetical protein 
ff 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_5684_478
5 
5684 4785 - hypothetical protein  
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_9208_568
1 
9208 5681 - IcmF-related 
protein 
isu;Type_VI_secretion_syste
ms 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_9326_984
1 
9326 9841 + hypothetical protein  
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_10869_10
096 
10869 10096 - Outer membrane 
protein ImpK/VasF, 
OmpA/MotB 
domain 
icw(2);USS-DB-7 
icw(3);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_12263_10
866 
12263 10866 - Uncharacterized 
protein ImpJ/VasE 
icw(5);USS-DB-7 
icw(6);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_12719_12
273 
12719 12273 - Type VI secretion 
lipoprotein/VasD 
icw(7);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_12845_14
092 
12845 14092 + Uncharacterized 
protein ImpA 
icw(3);USS-DB-7 
icw(3);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_14161_14
646 
14161 14646 + Uncharacterized 
protein ImpB 
isu;USS-DB-7 
isu;Type_VI_secretion_syste
ms 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_14648_16
102 
14648 16102 + Uncharacterized 
protein ImpC 
icw(5);USS-DB-7 
icw(5);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_16105_16
497 
16105 16497 + Uncharacterized 
protein similar to 
VCA0109 
icw(2);USS-DB-7 
icw(2);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_16494_18
215 
16494 18215 + Protein ImpG/VasA icw(1);USS-DB-7 
icw(1);Type_VI_secretion_s
ystems 
scf_30956_
20_contig_1 
scf_30956_20_co
ntig_1_18212_19
120 
18212 19120 + Uncharacterized 
protein ImpH/VasB 
icw(4);USS-DB-7 
icw(4);Type_VI_secretion_s
ystems 
190 
 
Two genes encoded in contig scf_30956_20_contig_1 were annotated as hypothetical 
proteins.  Sequences of these two proteins were search against the National Centre for 
Biotechnology Information Conserved Domains Database 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).  The search showed that 
Scf_30956_20_contig_1_5684_4785 consisted of T6SS forkhead-associated (Fha) domain 
(E-value = 4.87e-14). Scf_30956_20_contig_1_9326_9841 was identified as T6SS hemolysin 
co-regulated protein (Hcp) (E-value: 3.32e-68).   
 
T6SS components of Cj1 annotated by MG-RAST were assigned to a standardised 
nomenclature for T6SS and COGs, Table 5.2. 
 
The scf_30956_10_contig_1 contig that comprised a partial tssI gene was aligned in silico 
with contig scf_30956_20_contig_1 using Clone Manager version 7 
(http://www.scied.com/pr_cmbas.htm).  The alignment showed a homology block of 42 bps 
between the two contigs. The homology block was at the 3' end of contig 
scf_30956_20_contig_1 and 5' end of contig scf_30956_10_contig_1, as illustrated in Figure 
5.1. 
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Table 5.2: Assignment of T6SS components in C. jejuni strain Cj1 as annotated by MG-RAST to standardised 
T6SS nomenclature.  
 
Contig and Location Function tss 
assignment 
COGs 
scf_30956_10_contig_1_12_908 VgrG protein tssI 3501 
scf_30956_20_contig_1_47_3469 FIG00470311: hypothetical 
protein 
-  
scf_30956_20_contig_1_3480_4781 FIG00469624: hypothetical 
protein 
-  
scf_30956_20_contig_1_5684_4785 hypothetical protein; fha 
domain 
- 3456 
scf_30956_20_contig_1_9208_5681 IcmF-related protein tssM 3523 
scf_30956_20_contig_1_9326_9841 hypothetical protein; hcp tssD 3157 
scf_30956_20_contig_1_10869_10096 Outer membrane protein 
ImpK/VasF, OmpA/MotB 
domain 
tssL 3455 
scf_30956_20_contig_1_12263_10866 Uncharacterized protein 
ImpJ/VasE 
tssK 3522 
scf_30956_20_contig_1_12719_12273 Type VI secretion 
lipoprotein/VasD 
tssJ 3521 
scf_30956_20_contig_1_12845_14092 Uncharacterized protein ImpA tssA 3515 
scf_30956_20_contig_1_14161_14646 Uncharacterized protein ImpB tssB 3516 
scf_30956_20_contig_1_14648_16102 Uncharacterized protein ImpC tssC 3517 
scf_30956_20_contig_1_16105_16497 Uncharacterized protein similar 
to VCA0109 
tssE 3518 
scf_30956_20_contig_1_16494_18215 Protein ImpG/VasA tssF 3519 
scf_30956_20_contig_1_18212_19120 Uncharacterized protein 
ImpH/VasB 
tssG 3520 
 
 
 
 
 
 
 
Figure 5.1: Alignment of C. jejuni strain Cj1 contig scf_30956_10_contig_1 with contig scf_30956_20_contig_1 in 
Clone Manager version 7.  The comparison showed a region of 42 bps overlap between the two contigs.  
The last 42 bps of contig scf_30956_20_contig_1 is in homology with the first 42 bps of contig 
scf_30956_10_contig_1.    
  
Cj1_scf_30956_10_contig_1 (1 to 963) Homology Block: 1 to 42
5' 3'
Partial - tssI [COG3501 9vgrG)]
Cj1 scf_30956_20_contig_1 (1 to 20905) Homology Block: 20864 to 20905
5' 3'
FIG00470311FIG00469624COG3456 (fha)TssM [COG3523 (icmF-related)]TssD [COG3157 (hcp)]L 455 mpK/vasF/ompA_motB domain/dotU)]TssK [COG3522 (impJ/vasE)]Ts J [COG3521 (vasD)]TssA [COG3515 (impA)]TssB [COG3516 (impB)]Tss [COG3517 (impC)]TssE [COG3518 (VC_A0109-like)]TssF [COG3519 (ImpG/VasA)]TssG [COG3520 (impH/vasB)]
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Sequences from both contigs were joined in silico.  The start codon of tssI was identified 
within contig scf_30956_20_contig_1 and the complete tssI gene was mapped.  The in silico 
fusion of the two contigs was verified with PCR.  A forward primer binding to contig 
scf_30956_20_contig_1 and a reverse primer binding to contig scf_30956_10_contig_1 
generated a product of 701 bps, which is the correct size (Figure 5.2).  These results verified 
that the fusion of the two contigs in silico was correct.       
 
The putative T6SS locus in Cj1 included 12 out of 13 T6SS core COGs (Table 5.2).  
However, COG0542 corresponding to tssH (also known as clpV), which belongs to a sub-
type of the ATPase AAA+ family (Schlieker et al., 2005), was missing from the Cj1 T6SS 
genes cluster. 
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Figure 5.2: PCR confirmation of the fusion of contig scf_30956_10_contig_1 with contig scf_30956_20_contig_1 as 
predicted in silico.  A: Position of primers pair used; forward primer - VgrG_Contig_20_10_F on Cj1 
scf_30956_20_contig_1 (at position 20661bp) and reverse primer - VgrG_Contig_20_10_R on 
Cj1cscf_30956_10_contig_1 (at position 498C bp).  B: PCR products of the primers pair used.  Lane 1 
and 7: GeneRulerTM 1kb DNA ladder (Fermentas); Lane 2 and 6: GeneRulerTM 100 bp DNA ladder; 
Lane 3: No template control; Lane 4: C. jejuni strain 11168H genomic DNA; Lane 5: C. jejuni strain 
Cj1 genomic DNA.  An expected product of 701 bps was obtained from Cj1 genomic DNA.       
 
   
A 
B 
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5.2.2 Gene organisation of T6SS in Campylobacter jejuni strain Cj1 
 
Sequence information from the fusion of two contigs was used to map the gene organisation 
of the Cj1 putative T6SS locus using Clone Manager (Figure 5.3).   
 
The gene organisation of T6SS locus in Cj1 was similar to the two reported C. jejuni strains, 
ATCC 43431 and 108 (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012). 
 
195 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Gene organisation of putative T6SS locus in C. jejuni strain Cj1.  The genes on the locus were assigned with standardised T6SS nomenclature; COGs number and 
alternative gene name were provided in brackets.   
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5.2.3 Functionality of T6SS in Campylobacter jejuni strain Cj1 
 
The genomic DNA sequence of Cj1 tssD was translated in silico into an amino acid sequence.  
The TssD protein sequence was provided to commercial company Perbio.  They input the 
sequence into their Antigen Profiler software and identified three regions within the protein 
sequence as likely antigenic peptides.  The results from the Antigen Profiler are presented in 
Figure 5.4.     
 
Among the three peptides identified by Antigen Profiler, DKTELLKVSMSYRK, was 
recommended as the best option for Western Blot and immuno-fluorescence applications.  
The selected peptide for Cj1 TssD was synthesised and used as an antigen for immunisation 
in a rabbit host.   
 
Unfortunately, after additional boosting and extension of the immunisation protocol, the 
highest titre obtained was only 1:3200.  The failure to generate antibodies against Cj1 TssD 
peptide led to an inability to use Western Blot for detection of TssD in Cj1 culture 
supernatant as a functionality test for T6SS in Cj1. 
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Figure 5.4: Report from Antigen Profiler provided by Perbio.  Cj1 TssD protein sequence was analysed for 
peptides suitable for generation of antibodies that could be used for both Western blot and immuno-
fluorescence applications.  The location of the peptides within the sequence was shown in the section 
on Protein Sequence and Features.  Three peptides were identified as suitable candidates and their 
sequences were shown in the Antigen Peptide Candidates table.  The hydrophobicity and 
hydrophilicity chart of the Cj1 TssD was presented in the Graphical Analysis section.  The regions of 
suitable candidates were highlight in blue.     
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In view of the fact that no antibodies were available for Western blot, mass spectrometry was 
used instead to detect secreted T6SS components in culture supernatant.  Complex protein 
extracts would not be suitable for direct mass spectrometry analysis without fractionation.  
Hence, proteins precipitated from culture supernatant were run on SDS-PAGE (Figure 5.5).  
The gel image was shown to Dr Hannah Florance from UoE - Mass Spectrometry Facility 
and the proteins were confirmed to be suitable for nano-LC coupled to QTOF mass 
spectrometry analysis.  The mass spectrometry output data was analysed using Spectrum Mill 
MS Proteomics Workbench software by Agilent.   
 
A total of 14 C. jejuni proteins were identified in Cj1 culture supernatant sample (Table 5.3).  
The proteins detected were mostly flagellar associated proteins.  TssD was also among the 14 
proteins detected but no other T6SS components were detected.  The TssD detected had a 
calling of 5 distinct peptides and coverage of 40.9% of its amino acid sequence (Table 5.3).  
The presence of TssD in culture media is a hallmark indicator that the T6SS in bacteria 
harbouring T6SS genes cluster is functional (Pukatzki et al., 2007).  Hence, the detection of 
TssD in Cj1 culture supernatant strongly suggests that the secretory mechanism of T6SS in 
Cj1 is functional.   
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Figure 5.5: Analysis of C. jejuni strain Cj1 culture supernatant by SDS-PAGE.  Proteins in Cj1 24 hr old culture 
media were precipitated using TCA and run on NuPAGE® 4-12% Bis-Tris Gel (Novex®), at 200 V for 
35 minutes in MES buffer.  The gel was stained with SimplyBlue™ SafeStain (Invitrogen) and imaged 
with Odyssey® CLx infra-red imager (LI-COR).  Lane M: Perfect Protein™ Markers, 10-225 kDa 
(Novagen®); Lane 1: 3.75 µg Cj1 culture supernatant TCA protein precipitate; and Lane 2: 1.875 µg 
Cj1 culture supernatant TCA protein precipitate.      
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Table 5.3: Mass spectrometry data on the analysis of C. jejuni strain Cj1 culture supernatant TCA protein precipitate. 
 
Group 
number 
Spectra 
number 
Distinct 
peptides 
number 
Distinct 
summed 
MS/MS search 
score 
% amino 
acid 
coverage 
Mean 
peptide 
spectral 
intensity 
Protein 
molecular 
weight (da) 
Species Database 
accession 
number 
Protein Name 
1 15 11 160.6 29.2 3.15E+05 59337 CAMJU I6ZA17 Flagellin A (Fragment) 
2 9 6 77.33 12.4 1.51E+05 69981 CAMJU H8BLU8 Flagellar capping protein 
3 9 5 76.65 40.9 3.66E+05 18807 CAMJU B5QJ70 Secreted protein Hcp 
4 5 3 47.02 28.0 5.65E+05 11023 CAMJU H7X9T0 Putative periplasmic cytochrome C 
5 5 3 36.72 7.4 2.03E+05 46406 CAMJU A5KG76 Major outer membrane protein 
6 3 2 34.41 10.4 1.77E+05 21925 CAMJU H7X5W9 Putative uncharacterized protein 
7 3 2 25.17 10.4 3.30E+05 26574 CAMJJ A1VZ75 Flagellin subunit protein FlaC 
8 2 2 19.48 16.5 1.25E+05 13620 CAMJU A5KF91 Possible flagellar protein 
9 1 1 17.1 2.2 1.25E+05 58409 CAMJU D2N0U0 Flagellar hook protein flgE 
10 1 1 16.84 4.8 1.42E+05 27527 CAMJU H7ZT60 Putative uncharacterized protein 
11 1 1 16.51 10.3 1.81E+05 12192 CAMJU H7XE85 Putative uncharacterized protein 
12 2 1 16.43 15.7 4.34E+05 14179 CAMJU A5KGY8 Putative uncharacterized protein 
13 2 1 13.11 2.9 1.03E+05 45098 CAMJU A5KF24 Elongation factor Tu 
14 1 1 12.4 4.9 1.26E+04 28820 CAMJU A5KH72 Probable ABC-type amino-acid 
transporter periplasmic solute-binding 
protein 
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5.2.4 T6SS mutants in Campylobacter jejuni strain Cj1 
 
5.2.4.1 Construction of tssD and tssM mutants in Cj1    
 
The genes encoding two components of the T6SS system in Cj1, tssD and tssM, were 
selected for inactivation and replacement with a gene cassette conferring kanamycin 
resistance.   
 
A synthetic construct was designed for each of the target genes.  It consisted of 7 sections; i) 
restriction enzyme site 1 (RE1) - SpeI, for sub-cloning into pGEM-Teasy vector; ii) TG flank 
5': 450 bp region flanking 5' end of target gene; iii) TG 5': 50 bp region of target gene at 5' 
end; iv) restriction enzyme site 3 (RE3) - BamHI, for insertion of kanamycin resistance 
cassette; v) TG 3': 50 bp region of target gene at 3' end; vi) TG flank 3': 450 bp region flaking 
3' end of target gene; vii) restriction enzyme site 2 (RE2) - NdeI, for sub-cloning into pGEM-
Teasy.  The design of the construct is illustrated in Figure 5.6.  The detailed descriptions of 
the designed cloning fragments, i) tssD(syn) and ii) tssM(syn), are tabulated in Table 5.4.   
 
The cloning fragments were synthesised by GenScript using their standard vector, pUC57 
and sub-cloned into the multiple cloning site (MCS) of pGEM-Teasy, at SpeI and NdeI sites.  
The resulting plasmids were pGEM_tssD(syn) and pGEM_tssM(syn).   
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A plasmid (pJMK30) containing a kanamycin resistance cassette  (kanR_cas) was kindly 
provided by Dr Mark Reuter from the Institute of Food Research, UK (van Vliet et al., 1998).  
The kanR_cas was digested from pJMK30 using BamHI (Karlyshev and Wren, 2005) and 
cloned into the suitably digested pGEM_tssD(syn) and pGEM_tssM(syn) respectively.  The 
resultant plasmids pGEM_tssD(syn)::kanR_cas and pGEM_tssM(syn)::kanR_cas had a 
kanR_cas sandwiched between the 50 bp from start codon and 50 bp to stop codon of the 
respective target genes - as illustrated by in the mutant genome in Figure 5.6.  The list of 
plasmids used in this study is tabulated in Table 5.5.    
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Figure 5.6: Construction of Cj1tssD and tssM mutants.  A synthetic construct was made up of 7 sections: i) RE1 - 
SpeI restriction enzyme site (for sub-cloning into pGEM-Teasy vector); ii) TG flank 5' - 450 bp region 
flanking 5' end of target gene; iii) TG 5' - 50 bp region of target gene at 5' end; iv) RE3 - BamHI 
restriction enzyme site (for insertion of kanR_cas); v) TG 3' - 50 bp region of target gene at 3' end; vi) 
TG flank 3' - 450 bp region flaking 3' end of target gene; and vii) RE2 - NdeI restriction enzyme site (for 
sub-cloning into pGEM-Teasy).  The construct was synthesised and dropped into pGEM-Teasy vector.  
A kanR_cas could be dropped into the construct at RE3.  The construct carrying a kanR_cas could then 
be integrated into the genome in a double crossover event.  The resulted genome of the mutant will be as 
illustrated in Campylobacter genome (mutant).  Four primers pairs were designed to check for 
orientation of kanamycin resistance cassette inserted and successful occurrence of double crossover 
event. 
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Table 5.4: List of cloning fragments used in this study. 
 
Cloning fragments Descriptions Sources 
tssD(syn) SpeI:450 bp flanking 5' end of tssD:50 bp of tssD from start 
codon:BamHI:50 bp of tssD to stop codon:450 bp flanking 
3'end of tssD:NdeI 
GenScript 
tssM(syn) SpeI:450 bp flanking 5' end of tssM:50 bp of tssM from start 
codon:BamHI:50 bp of tssM to stop codon:450 bp flanking 
3'end of tssM:NdeI 
GenScript 
kanR_cas Kanmycin resistance cassette (consisting of its own promoter 
and aphAIII gene) were digested from pJMK30 at BamHI 
sites, cassette size is 1499 bp 
pJMK30 
tssD(syn)::kanR_cas 450 bp flanking 5' end of tssD:50 bp of tssD from start 
codon:kanR_cas:50 bp of tssD to stop codon:450 bp flanking 
3'end of tssD 
This study 
tssM(syn)::kanR_cas 450 bp flanking 5' end of tssM:50 bp of tssM from start 
codon:kanR_cas:50 bp of tssM to stop codon:450 bp flanking 
3'end of tssM 
This study 
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Table 5.5: List of plasmids used in this study. 
 
Plasmids Descriptions Sources 
pUC57 Ampicillin resistance, multiple cloning site (MCS) 
within lacZ gene, plasmid size is 2710bp 
GenScript 
pUC_tssD(syn) Cloning of tssD(syn) into MCS of pUC57 by EcoRV  GenScript 
pUC_tssM(syn) Cloning of tssM(syn) into MCS of pUC57 by EcoRV GenScript 
pGEM-Teasy Ampicillin resistance, multiple cloning site (MCS) 
within lacZ gene, plasmid size is 3015bp 
Promega 
pGEM_tssD(syn) Cloning of tssD(syn) into MCS of pGEM-Teasy by SpeI 
and NdeI 
GenScript 
pGEM_tssM(syn) Cloning of tssM(syn) into MCS of pGEM-Teasy by SpeI 
and NdeI 
GenScript 
pJMK30 Ampicillin resistance, contains a kanR_cas within 
BamHI sites (source of kanR_cas) 
Institute of Food 
Research, UK 
pGEM_tssD(syn)::kanR_cas Cloning of kanR_cas into tssD(syn) in pGEM_tssD(syn) 
by BamHI 
This study 
pGEM_tssM(syn)::kanR_cas Cloning of kanR_cas into tssM(syn) in pGEM_tssM(syn) 
by BamHI 
This study 
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The two suicide plasmids: pGEM_tssD(syn)::kanR_cas and pGEM_tssM(syn)::kanR_cas, 
were delivered into electro-competent Cj1 cells via electroporation.  The wild-type target 
genes were then replaced by the cloning fragments tssD(syn)::kanR_cas and 
tssM(syn)::kanR_cas (Table 5.4) respectively, through a double crossover event.  This 
resulted in two T6SS mutants in Cj1, i) Cj1∆tssD(syn)::kanR_cas and ii) 
Cj1∆tssM(syn)::kanR_cas.  The list of strains used in this study is tabulated in Table 5.6. 
 
The total number of transformants obtained for each mutant was not determined.  However, a 
total of four Cj1∆tssD(syn)::kanR_cas isolates and three Cj1∆tssM(syn)::kanR_cas were 
screened by PCR. 
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Table 5.6: List of strains used in this study. 
 
Strains Descriptions Sources 
E. coli Top10 Cloning strain used to hold plasmids Invitrogen 
Top10 pGEM_tssD(syn) Transformed pGEM_tssD(syn) into chemically 
competent Top10 
This study 
Top10 pGEM_tssM(syn) Transformed pGEM_tssM(syn) into chemically 
competent Top10 
This study 
Top10 pGEM_tssD(syn)::kanR_cas Transformed pGEM_tssD(syn)::kanR_cas into 
chemically competent Top10 
This study 
Top10 pGEM_tssM(syn)::kanR_cas Transformed pGEM_tssM(syn)::kanR_cas into 
chemically competent Top10 
This study 
C. jejuni strain Cj1 wild-type Clinical isolate from Thailand Lab stock 
Cj1∆tssD(syn)::kanR_cas tssD in Cj1 wild-type was replaced with 
tssD(syn)::kanR_cas  
This study 
Cj1∆tssM(syn)::kanR_cas tssM in Cj1 wild-type was  replaced with 
tssM(syn)::kanR_cas 
This study 
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5.2.4.2 PCR screening of tssD and tssM mutants in Cj1    
 
Potential Cj1∆tssD(syn)::kanR_cas isolates generated from two different plasmid sources 
were tested with 4 different sets of primer.  Regions amplified by each set of primers are 
illustrated in Figure 5.7.  The results obtained from primer set 1: tssD_Flank forward and 
reverse (F+R) are shown in Figure 5.8; primer set 2: tssD_In F+R in Figure 5.9; primer set 3: 
tssD_Flank forward and Kan_Out forward in Figure 5.10; and primer set 4: tssD_Flank 
forward and Kan_Out reverse in Figure 5.11.   
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Figure 5.7: Illustration on regions primed by each primer sets in C. jejuni strain Cj1 (A) wild-type and two possible constructs of tssD mutant: (B) kanR_cas inserted in the same 
orientation as tssD and (C) kanR_cas inserted in the opposite orientation as tssD.  Primer set 1: tssD_Flank forward and reverse; primer set 2: tssD_In forward and 
reverse; primer set 3: tssD_Flank forward and Kan_out forward; and primer set 4: tssD_Flank forward and Kan_out reverse. 
   
A 
B C 
210 
 
 
 
  
 
 
 
 
Figure 5.8:  PCR screening of C. jejuni strain Cj1 tssD replacement mutant, Cj1∆tssD(syn)::kanR_cas with 
tssD_Flank forward and reverse primer.  Lane 1 and 8: GeneRulerTM 1kb DNA ladder (Fermentas); 
Lane 2: No template control; Lane 3: Cj1∆tssD(syn)::kanR_cas isolate 1 genomic DNA; Lane 4: 
Cj1∆tssD(syn)::kanR_cas isolate 2 genomic DNA; Lane 5: Cj1∆tssD(syn)::kanR_cas isolate 3 genomic 
DNA; Lane 6: Cj1∆tssD(syn)::kanR_cas isolate 4 genomic DNA; and Lane 7: C. jejuni strain Cj1 wild-
type genomic DNA.  Cj1 wild-type yielded a product of 2547 bps and Cj1∆tssD(syn)::kanR_cas yielded 
a product of 3626 bps.    
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Figure 5.9: PCR screening of C. jejuni strain Cj1 tssD replacement mutant, Cj1∆tssD(syn)::kanR_cas with tssD_In 
forward and reverse primer.  Lane 1 and 8: GeneRulerTM 100 bp DNA ladder (Fermentas); Lane 2: 
No template control; Lane 3: Cj1∆tssD(syn)::kanR_cas isolate 1 genomic DNA; Lane 4: 
Cj1∆tssD(syn)::kanR_cas isolate 2 genomic DNA; Lane 5: Cj1∆tssD(syn)::kanR_cas isolate 3 genomic 
DNA; Lane 6: Cj1∆tssD(syn)::kanR_cas isolate 4 genomic DNA; and Lane 7: C. jejuni strain Cj1 wild-
type genomic DNA.  Cj1 wild-type yielded a product of 273 bps and Cj1∆tssD(syn)::kanR_cas yielded 
no product.   
 
 
 
 
 
 
 
Figure 5.10: PCR screening of C. jejuni strain Cj1 tssD replacement mutant, Cj1∆tssD(syn)::kanR_cas with 
tssD_Flank forward and Kan_Out forward to determine orientation of kanamycin resistance cassette  
inserted.  Lane 1 and 8: GeneRulerTM 1kb DNA ladder (Fermentas); Lane 2: No template control; 
Lane 3: Cj1∆tssD(syn)::kanR_cas isolate 1 genomic DNA; Lane 4: Cj1∆tssD(syn)::kanR_cas isolate 2 
genomic DNA; Lane 5: Cj1∆tssD(syn)::kanR_cas isolate 3 genomic DNA; Lane 6: 
Cj1∆tssD(syn)::kanR_cas isolate 4 genomic DNA; and Lane 7: C. jejuni strain Cj1 wild-type genomic 
DNA.  Cj1 wild-type yielded no product.  Cj1∆tssD(syn)::kanR_cas isolates with kanamycin resistance 
cassette  inserted in same orientation as tssD yielded a product of 1207 bps.  Cj1∆tssD(syn)::kanR_cas 
isolates with kanamycin resistance cassette inserted in opposite orientation as tssD yielded no product.  
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Figure 5.11: PCR screening of C. jejuni strain Cj1 tssD replacement mutant, Cj1∆tssD(syn)::kanR_cas with 
tssD_Flank forward and Kan_Out reverse to determine orientation of kanamycin resistance cassette  
inserted.  Lane 1 and 8: GeneRulerTM 100 bp DNA ladder (Fermentas); Lane 2: No template control; 
Lane 3: Cj1∆tssD(syn)::kanR_cas isolate 1 genomic DNA; Lane 4: Cj1∆tssD(syn)::kanR_cas isolate 2 
genomic DNA; Lane 5: Cj1∆tssD(syn)::kanR_cas isolate 3 genomic DNA; Lane 6: 
Cj1∆tssD(syn)::kanR_cas isolate 4 genomic DNA; and Lane 7: C. jejuni strain Cj1 wild-type genomic 
DNA.  Cj1 wild-type yielded no product.  Cj1∆tssD(syn)::kanR_cas isolates with kanamycin resistance 
cassette  inserted in opposite orientation as tssD yielded a product of 1223 bps.  
Cj1∆tssD(syn)::kanR_cas isolates with kanamycin resistance cassette inserted in same orientation as 
tssD yielded no product. 
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Potential Cj1∆tssM(syn)::kanR_cas isolates were also tested with 4 different sets of primers.  
Regions amplified by each set of primers are illustrated in Figure 5.12.  The results obtained 
from primer set 1: tssM_Flank forward and reverse (F+R) are shown in Figure 5.13; primer 
set 2: tssM_In F+R in Figure 5.14; primer set 3: tssM forward and Kan_Out forward in Figure 
5.15; and primer set 4: tssM forward and Kan_Out reverse in Figure 5.16.   
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Figure 5.12: Illustration on regions primed by each primer sets in C. jejuni strain Cj1 (A) wild-type and two possible constructs of tssM mutant: (B) kanR_cas inserted in the same 
orientation as tssM and (C) kanR_cas inserted in the opposite orientation as tssM.  Primer set 1: tssM_Flank forward and reverse; primer set 2: tssM_In forward and 
reverse; primer set 3: tssM forward and Kan_out forward; and primer set 4: tssM forward and Kan_out reverse. 
 
A 
B C 
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Figure 5.13: PCR screening of C. jejuni strain Cj1 tssM replacement mutant, Cj1∆tssM(syn)::kanR_cas with 
tssM_Flank forward and reverse primer.  Lane 1 and 7: GeneRulerTM 1kb DNA ladder (Fermentas); 
Lane 2: Cj1∆tssM(syn)::kanR_cas isolate 1 genomic DNA; Lane 3: Cj1∆tssM(syn)::kanR_cas isolate 2 
genomic DNA; Lane 4: Cj1∆tssM(syn)::kanR_cas isolate 3 genomic DNA; Lane 5: C. jejuni strain Cj1 
wild-type genomic DNA; and Lane 6: No template control.  Cj1 wild-type yielded a product of 6060 
bps and Cj1∆tssM(syn)::kanR_cas yielded a product of 4136 bps. 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: PCR screening of C. jejuni strain Cj1 tssM replacement mutant, Cj1∆tssM(syn)::kanR_cas with 
tssM_In forward and reverse primer.  Lane 1 and 7: GeneRulerTM 100 bp DNA ladder (Fermentas); 
Lane 2: Cj1∆tssM(syn)::kanR_cas isolate 1 genomic DNA; Lane 3: Cj1∆tssM(syn)::kanR_cas isolate 2 
genomic DNA; Lane 4: Cj1∆tssM(syn)::kanR_cas isolate 3 genomic DNA; Lane 5: C. jejuni strain Cj1 
wild-type genomic DNA; and Lane 6: No template control.  Cj1 wild-type yielded a product of 421 bps 
and Cj1∆tssM(syn)::kanR_cas yielded no product. 
  
216 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: PCR screening of C. jejuni strain Cj1 tssM replacement mutant, Cj1∆tssM(syn)::kanR_cas with tssM 
forward and Kan_Out forward to determine orientation of kanamycin resistance cassette  inserted.  
Lane 1 and 7: GeneRulerTM 1 kb DNA ladder (Fermentas); Lane 2: Cj1∆tssM(syn)::kanR_cas isolate 1 
genomic DNA; Lane 3: Cj1∆tssM(syn)::kanR_cas isolate 2 genomic DNA; Lane 4: 
Cj1∆tssM(syn)::kanR_cas isolate 3 genomic DNA; Lane 5: pGEM_tssM(syn)::kanR_cas plasmid DNA; 
and Lane 6: No template control.  pGEM_tssM(syn)::kanR_cas plasmid DNA with kanamycin cassette 
inserted in the same orientation as tssM yield no product.  Cj1∆tssM(syn)::kanR_cas isolates with 
kanamycin resistance cassette inserted in opposite orientation as tssM yielded a product of 558 bps.  
Cj1∆tssM(syn)::kanR_cas isolates with kanamycin resistance cassette inserted in same orientation as 
tssM yielded no product. 
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Figure 5.16: PCR screening of C. jejuni strain Cj1 tssM replacement mutant, Cj1∆tssM(syn)::kanR_cas with tssM 
forward and Kan_Out reverse to determine orientation of kanamycin resistance cassette  inserted.  
Lane 1 and 7: GeneRulerTM 1 kb DNA ladder (Fermentas); Lane 2: Cj1∆tssM(syn)::kanR_cas isolate 1 
genomic DNA; Lane 3: Cj1∆tssM(syn)::kanR_cas isolate 2 genomic DNA; Lane 4: 
Cj1∆tssM(syn)::kanR_cas isolate 3 genomic DNA; Lane 5: pGEM_tssM(syn)::kanR_cas plasmid DNA; 
and Lane 6: No template control.  pGEM_tssM(syn)::kanR_cas plasmid DNA with kanamycin cassette 
inserted in the same orientation as tssM yield a product of 574bp.  Cj1∆tssM(syn)::kanR_cas isolates 
with kanamycin resistance cassette inserted in same orientation as tssM yield a product of 574 bps.  
Cj1∆tssM(syn)::kanR_cas isolates with kanamycin resistance cassette inserted in opposite orientation 
as tssM yield no product. 
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Primer sets tssD_Flank and tssM_Flank, which annealed to regions on the chromosome 
flanking the synthetic construct, generated products of different sizes between wild-type and 
mutants.  In Cj1 wild-type, tssD_Flank and tssM_Flank generated products of 2547bp and 
6060bp respectively.  However, in Cj1∆tssD(syn)::kanR_cas, a larger product of 3626bp was 
generated.  The increase in size was because the kanR_cas used to replace tssD was larger 
than the latter.  In Cj1∆tssM(syn)::kanR_cas, the product generated was 4136bp.  This is a 
smaller product as compared to the wild-type.  Here, the reduction in size was because the 
size of kanR_cas was smaller than the tssM it replaced.  
 
A second set of primers, tssD_In and tssM_In, prime to regions within the target genes.  This 
set of primers was used in the screening to ensure that the target genes were no longer present 
in the genome of the mutants.  There was no product from both mutants when this set of 
primers was used. This indicated that each target gene was lost in its respective mutant. 
 
The PCR results obtained confirmed that double crossover had taken place in all 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas isolates.   
 
In Cj1∆tssD(syn)::kanR_cas, two out of four isolates, isolate 2 and 3, had the kanR_cas 
inserted in the same orientation as tssD.  The Cj1∆tssD(syn)::kanR_cas isolate 2 was selected 
for use in subsequent work. 
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In Cj1∆tssM(syn)::kanR_cas, all isolates had the kanR_cas inserted in the same orientation as 
tssM.  The Cj1∆tssM(syn)::kanR_cas isolate 1 was selected for use in subsequent work. 
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5.2.4.3 Checking of tssD and tssM mutants in Cj1 by Southern Blot  
 
Southern blotting was also used to confirm the identity of Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas.  The restriction enzymes sites within the T6SS gene cluster of Cj1 
wild-type and the two T6SS mutant strains were predicted.  BspCNI and SpeI were not 
predicted to cut within the tssD or tssM or kanR_cas (Figure 5.17 and Table 5.7).  The in 
silico analysis indicated that digestion of wild-type DNA with BspCNI would generate a 
fragment of 8217 bp that contained tssD and tssM.  In Cj1∆tssD(syn)::kanR_cas, the fragment 
containing tssD(syn)::kanR_cas would be 9296 bp while in Cj1∆tssM(syn)::kanR_cas, the 
fragment containing tssM(syn)::kanR_cas would be 6293 bp.  The difference in the size of the 
fragments generated between wild-type and T6SS mutants was due to the insertion of 
kanR_cas that had replaced the target genes. 
 
The digested gDNA of wild-type and T6SS mutants were separated in an agarose gel (Figure 
5.18) and Southern blotted using a DIG labelled probe.  The probe was generated from fha, 
which is downstream to tssM, but within the BspCNI cutting sites, as illustrated in Figure 
5.19.  The results showed that a fragment of approximately 8217 bp in digested wild-type 
gDNA reacted with the probe (Figure 5.20).  The probe also reacted with digested 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas gDNA (Figure 5.20).  However, the 
size of the fragment reacting with the probe in Cj1∆tssD(syn)::kanR_cas was approximately 
9296 bp while in Cj1∆tssM(syn)::kanR_cas, it was approximately 6293 bp.  The results 
obtained were similar to the in silico analysis and thus confirmed the identities of 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas.     
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Figure 5.17: Illustration on cutting sites for BspCNI and SpeI along C. jejuni strain Cj1 T6SS locus.  
 
Table 5.7: List of fragments generated from C. jejuni strain Cj1 wild-type T6SS locus after digestion by 
restriction enzymes, BspCNI and SpeI, repectively.  Fragment in bold will comprise of both tssD and 
tssM. 
 
Fragment BspCNI SpeI 
1 2103 bp (730-2832) 14531 bp (807-
15337) 
2 8217 bp (2833-
11049) 
 
3 974 bp (11050-
12023) 
 
4 18 bp (12024-12041)  
5 948 bp (12042-
12989) 
 
6 211 bp (12990-
13200) 
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Figure 5.18: Digested of genomic DNA of C. jejuni strain Cj1 wild-type and T6SS mutants separated on 0.8% 
agarose gel and stained with SYBR® Safe stain post-electrophoresis.  Lane 1 and 8: GeneRulerTM 1kb 
plus DNA ladder (Fermentas); Lane 2 and 3: BspCNI digested Cj1 wild-type genomic DNA; Lane 4 
and 5: BspCNI digested Cj1∆tssM genomic DNA; and Lane 6 and 7: BspCNI digested Cj1∆tssD 
genomic DNA.   
 
 
 
 
 
 
 
 
 
 
Figure 5.19: Illustration on location of Southern blot probe along C. jejuni strain Cj1 T6SS locus (green box). 
  
223 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.20: Southern blot of BspCNI digested genomic DNA of C. jejuni strain Cj1 wild-type, 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas.  DIG-labelled probe hybridised to fragments 
within the T6SS genes cluster that consist of both tssD and tssM.  The fragment hybridised by the 
probe in Cj1 wild-type was 8217 bps.  The fragment hybridised by the probe in 
Cj1∆tssM(syn)::kanR_cas was 6293 bps.  The fragment hybridised by the probe in 
Cj1∆tssD(syn)::kanR_cas was 9296 bps. 
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5.2.4.4 Checking of tssD and tssM mutants in Cj1 by sequencing 
 
Genomic DNA of Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas 
were sent for whole genome sequencing at UoE - Sequencing Facility.  Similarly, sequence 
data were input into MG-RAST for annotation.  Contigs containing genes of interest tssD and 
tssM were illustrated in Figure 5.21.  Sequence data confirmed deletions of each target gene 
and the kanR_cas was also inserted in the same transcription orientation as its respective 
target gene.  
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Figure 5.21: Comparison of Sequence data of C. jejuni strain Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas.  Sequence information confirmed that kanR_cas had replaced bulk of the 
target genes and was inserted in the same transcription orientation as its respective target gene. 
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5.2.4.5 Mass spectrometry of Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas 
culture supernatants 
 
The supernatants from 24 hr cultures of Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas were analysed by mass spectrometry.  Similarly, protein 
precipitated from culture supernatant of the two mutants was run on SDS-PAGE (Figure 
5.22).   
 
TssD was not detected in either culture supernatant protein samples.  To demonstrate that 
TssD was being made, but not secreted in Cj1∆tssM(syn)::kanR_cas, its cellular proteins were 
analysed for the presence of TssD.  A cell pellet lysate of Cj1∆tssM(syn)::kanR_cas was 
separated by SDS-PAGE and the gel area between 15-35 kDa excised for analysis by mass 
spectrometry, Figure 5.23.  A cell pellet lysate of Cj1∆tssD(syn)::kanR_cas, prepared in the 
same way as Cj1∆tssM(syn)::kanR_cas, was also analysed.  
 
TssD was only detected in Cj1∆tssM(syn)::kanR_cas cellular protein fraction with a calling of 
8 distinct peptides.  The amino acid coverage was 78.3 percentage, Table 5.8.  No TssD was 
detected in Cj1∆tssD(syn)::kanR_cas cell pellet.   
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Figure 5.22: Analysis of C. jejuni strain Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas culture supernatant 
by SDS-PAGE.  Proteins from 24 hr old culture media were precipitated using TCA and run on 
NuPAGE® 4-12% Bis-Tris Gel (Novex®), at 200 V for 35 minutes in MES buffer.  The gel was stained 
with SimplyBlue™ SafeStain (Invitrogen) and imaged with Odyssey® CLx infra-red imager (LI-COR).  
Lane M: Perfect Protein™ Markers, 10-225 kDa (Novagen®); Lane 1: 3.75 µg 
Cj1∆tssM(syn)::kanR_cas culture supernatant TCA protein precipitate; Lane 2: 1.875 µg 
Cj1∆tssM(syn)::kanR_cas culture supernatant TCA protein precipitate; Lane 3: 3.75 µg 
Cj1∆tssD(syn)::kanR_cas culture supernatant TCA protein precipitate; and Lane 4: 1.875 µg 
Cj1∆tssD(syn)::kanR_cas culture supernatant TCA protein precipitate. 
 
 
 
 
 
 
Figure 5.23: SDS-PAGE of C. jejuni strain Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas cell pellet lysates.  
Cellular protein were separated on NuPAGE® 4-12% Bis-Tris Gel (Novex®), at 200 V for 35 minutes in 
MES buffer.  The gel was stained with SimplyBlue™ SafeStain (Invitrogen) and imaged with Odyssey® 
CLx infra-red imager (LI-COR).  Lane M: Perfect Protein™ Markers, 10-225 kDa (Novagen®); Lane 1: 
neat Cj1∆tssM(syn)::kanR_cas cell pellet lysate; Lane 2: 1:10 Cj1∆tssM(syn)::kanR_cas cell pellet lysate; 
Lane 3: neat Cj1∆tssD(syn)::kanR_cas cell pellet lysate; and Lane 4: 1:10 Cj1∆tssD(syn)::kanR_cas cell 
pellet lysate.  Lane 1 and 3 between the sizes of 15 to 35 kDA were excised for mass spectrometry 
analysis (between blue dash line).  
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Table 5.8: An extract of mass spectrometry data on the analysis of C. jejuni strain Cj1∆tssM cell pellet lysate. 
 
Group 
number 
Spectra 
number 
Distinct 
peptides 
number 
Distinct summed 
MS/MS search score 
% amino acid 
coverage 
Mean peptide 
spectral intensity 
Protein 
molecular 
weight (da) 
Species Database 
accession 
number 
Protein Name 
31 16 8 115.23 78.3 1.46E+06 18806.6 CAMJU B5QJ70 Secreted protein 
Hcp 
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5.2.4.6 Checking the expression of other T6SS components by reverse transcription PCR 
(RT-PCR) in Cj1∆tssM(syn)::kanR_cas  
 
Total RNA extracted from 24 hr or 48 hr cultures of Cj1 wild-type or 
Cj1∆tssM(syn)::kanR_cas were reverse-transcribed and first strand complimentary DNA 
(cDNA) were analysed by PCR.  The cDNA was checked against 6 genes on the T6SS locus; 
i)FIG00469624, ii) fha, iii) tssM, iv) tssD, v) tssL, and vi) tssI (Figure 5.24 to 5.29). 
 
The results obtained showed that all genes tested were expressed by Cj1 wild-type under the 
culturing conditions tested.  Similarly, in Cj1∆tssM(syn)::kanR_cas all gene tested with 
exception of tssM were transcribed under the growth conditions tested.  This finding 
indicated that expression of genes along the T6SS genes cluster in Cj1∆tssM(syn)::kanR_cas 
was not affected by the mutation.  
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Figure 5.24: Expression of unidentified gene FIG00469624 in opposite transcriptional orientation to tssM by RT-
PCR.  RNA tested were extracted from 24 hr and 48 hr C. jejuni strain Cj1 wild-type and 
Cj1∆tssM(syn)::kanR_cas cultures.  Lane M: GeneRulerTM 100 bp plus DNA ladder (Fermentas); Lane 
1: Cj1 wild-type cDNA from 24 hr culture; Lane 2: Cj1 wild-type cDNA from 48 hr culture; Lane 3: 
Cj1∆tssM(syn)::kanR_cas cDNA from 24 hr culture; Lane 4: Cj1∆tssM(syn)::kanR_cas cDNA from 48 
hr culture; Lane 5: Cj1 wild-type non-RT control from 24 hr culture; Lane 6: Cj1 wild-type non-RT 
control from 48 hr culture; Lane 7: Cj1∆tssM(syn)::kanR_cas non-RT control from 24 hr culture; 
Lane 8: Cj1∆tssM(syn)::kanR_cas non-RT control from 48 hr culture; Lane 9: Cj1 wild-type genomic 
DNA; and Lane 10: No template control.  Transcription of FIG00469624 yielded a product of 386 bps.      
 
 
 
 
 
 
Figure 5.25: Expression of fha in same transcriptional orientation as tssM by RT-PCR.  RNA tested were extracted 
from 24 hr and 48 hr C. jejuni strain Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas cultures.  Lane M: 
GeneRulerTM 100 bp plus DNA ladder (Fermentas); Lane 1: Cj1 wild-type cDNA from 24 hr culture; 
Lane 2: Cj1 wild-type cDNA from 48 hr culture; Lane 3: Cj1∆tssM(syn)::kanR_cas cDNA from 24 hr 
culture; Lane 4: Cj1∆tssM(syn)::kanR_cas cDNA from 48 hr culture; Lane 5: Cj1 wild-type non-RT 
control from 24 hr culture; Lane 6: Cj1 wild-type non-RT control from 48 hr culture; Lane 7: 
Cj1∆tssM(syn)::kanR_cas non-RT control from 24 hr culture; Lane 8: Cj1∆tssM(syn)::kanR_cas non-
RT control from 48 hr culture; Lane 9: Cj1 wild-type genomic DNA; and Lane 10: No template 
control.  Transcription of fha yielded a product of 236 bps. 
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Figure 5.26: Expression of tssM by RT-PCR.  RNA tested were extracted from 24 hr and 48 hr C. jejuni strain Cj1 
wild-type and Cj1∆tssM(syn)::kanR_cas cultures.  Lane M: GeneRulerTM 100 bp plus DNA ladder 
(Fermentas); Lane 1: Cj1 wild-type cDNA from 24 hr culture; Lane 2: Cj1∆tssM(syn)::kanR_cas 
cDNA from 48 hr culture; Lane 3: Cj1∆tssM(syn)::kanR_cas cDNA from 24 hr culture; Lane 4: Cj1 
wild-type cDNA from 48 hr culture; Lane 5: Cj1 wild-type non-RT control from 24 hr culture; Lane 6: 
Cj1 wild-type non-RT control from 48 hr culture; Lane 7: Cj1∆tssM(syn)::kanR_cas non-RT control 
from 24 hr culture; Lane 8: Cj1∆tssM(syn)::kanR_cas non-RT control from 48 hr culture; Lane 9: Cj1 
wild-type genomic DNA; and Lane 10: No template control.  Transcription of tssM yielded a product 
of 421 bps. 
 
 
 
 
 
 
 
 
 
 
Figure 5.27: Expression of tssD in opposite transcriptional orientation to tssM by RT-PCR.  RNA tested were 
extracted from 24 hr and 48 hr C. jejuni strain Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas cultures.  
Lane M: GeneRulerTM 100 bp plus DNA ladder (Fermentas); Lane 1: Cj1 wild-type cDNA from 24 hr 
culture; Lane 2: Cj1 wild-type cDNA from 48 hr culture; Lane 3: Cj1∆tssM(syn)::kanR_cas cDNA 
from 24 hr culture; Lane 4: Cj1∆tssM(syn)::kanR_cas cDNA from 48 hr culture; Lane 5: Cj1 wild-type 
non-RT control from 24 hr culture; Lane 6: Cj1 wild-type non-RT control from 48 hr culture; Lane 7: 
Cj1∆tssM(syn)::kanR_cas non-RT control from 24 hr culture; Lane 8: Cj1∆tssM(syn)::kanR_cas non-
RT control from 48 hr culture; Lane 9: Cj1 wild-type genomic DNA; and Lane 10: No template 
control.  Transcription of tssD yielded a product of 273 bps. 
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Figure 5.28: Expression of tssL in same transcriptional orientation as tssM by RT-PCR.  RNA tested were extracted 
from 24 hr and 48 hr C. jejuni strain Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas cultures.  Lane M: 
GeneRulerTM 100 bp plus DNA ladder (Fermentas); Lane 1: Cj1 wild-type cDNA from 24 hr culture; 
Lane 2: Cj1 wild-type cDNA from 48 hr culture; Lane 3: Cj1∆tssM(syn)::kanR_cas cDNA from 24 hr 
culture; Lane 4: Cj1∆tssM(syn)::kanR_cas cDNA from 48 hr culture; Lane 5: Cj1 wild-type non-RT 
control from 24 hr culture; Lane 6: Cj1 wild-type non-RT control from 48 hr culture; Lane 7: 
Cj1∆tssM(syn)::kanR_cas non-RT control from 24 hr culture; Lane 8: Cj1∆tssM(syn)::kanR_cas non-
RT control from 48 hr culture; Lane 9: Cj1 wild-type genomic DNA; and Lane 10: No template 
control.  Transcription of tssL yielded a product of 276 bps. 
 
 
 
 
 
 
 
 
 
Figure 5.29: Expression of tssI in opposite transcriptional orientation to tssM by RT-PCR.  RNA tested were 
extracted from 24 hr and 48 hr C. jejuni strain Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas cultures.  
Lane M: GeneRulerTM 100 bp plus DNA ladder (Fermentas); Lane 1: Cj1 wild-type cDNA from 24 hr 
culture; Lane 2: Cj1 wild-type cDNA from 48 hr culture; Lane 3: Cj1∆tssM(syn)::kanR_cas cDNA 
from 24 hr culture; Lane 4: Cj1∆tssM(syn)::kanR_cas cDNA from 48 hr culture; Lane 5: Cj1 wild-type 
non-RT control from 24 hr culture; Lane 6: Cj1 wild-type non-RT control from 48 hr culture; Lane 7: 
Cj1∆tssM(syn)::kanR_cas non-RT control from 24 hr culture; Lane 8: Cj1∆tssM(syn)::kanR_cas non-
RT control from 48 hr culture; Lane 9: Cj1 wild-type genomic DNA; and Lane 10: No template 
control.  Transcription of tssI yielded a product of 701 bps. 
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5.3  Discussion 
 
The T6SS is the most recently identified secretion system (Coulthurst, 2013).  An analysis of 
506 available genome sequences identified 176 T6SS genes clusters distributed across 92 
different bacteria (Boyer et al., 2009).  It is commonly found in Proteobacteria except for the 
epsilon sub-group (Coulthurst, 2013).  Among the different bacteria harbouring the T6SS, 
about a third of them had been found to have more than one T6SS gene cluster, ranging from 
two to six clusters (Boyer et al., 2009).  It has been reported that the T6SS is involved in the 
interactions of its parent organism with either eukaryotic cells, other prokaryotic cells or both 
(Coulthurst, 2013).  The interaction with eukaryotic cells could help the bacteria to establish 
an infection in the host organism, for example, in the case of V. cholerae (Ma and Mekalanos, 
2010).  On the other hand, interactions with other prokaryotic cells could help the bacteria to 
establish its population within a mixed species environment, such as biofilm (Filloux, 2013). 
The T6SS system had also been found in two strains of C. jejuni, ATCC 43431 and an 
intestinal isolate 108 (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012).  Both strains 
have been reported to have only one cluster of the T6SS genes (Bleumink-Pluym et al., 2013; 
Lertpiriyapong et al., 2012).  Hence, it was of interest to find out if the patients isolates 
obtained in Thailand carry any T6SS gene clusters.   
 
Among the 5 isolates screened by genome sequencing, only one of them, strain Cj1, contains 
a cluster of genes for T6SS components.  The putative T6SS genes cluster in Cj1 had only 12 
out of 13 T6SS core COGs.  COG0542 corresponding to tssH (also known as clpV) is absent.  
This is consistent with the T6SS genes clusters reported in ATCC 43431 and 108, as both 
strains also lacks tssH (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012).  The 
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arrangement of the genes within the cluster of Cj1 is similar to that of ATCC 43431 
(Lertpiriyapong et al., 2012).     
 
The missing component in all three C. jejuni T6SS, TssH, belongs to a sub-type of the 
ATPase AAA+ family - suggested as an energy provider for the secretion system (Schlieker 
et al., 2005).  TssH had also been shown to interact with the contractile sheath-like tubular 
structure formed by two other core components of the T6SS, TssB and TssC (also known as 
VipA and VipB, respectively).  TssH provides the energy required for the disassembly of the 
TssB/TssC tubules (Kapitein and Mogk, 2013).  The disassembled TssB and TssC return to 
the cytosol pool and new tubules can be formed (Basler et al., 2012; Bönemann et al., 2009).  
It has been reported that TssH is not required for assembly of the T6SS (Zheng et al., 2011).  
Hence, the TssB/TssC tubule could still be assembled in the absence of TssH.  However, after 
the first contraction, the tubule needs to be disassembled and reassembled before the next 
contraction can occur.  Without the aid of TssH in its disassembly, the TssB/TssC tubules 
could only deliver its "goods" once and that could potentially lessen the efficacy of T6SS 
(Zheng et al., 2011).  
 
A point to note was that MG-RAST annotation picked up another protein belonging to the 
ATPase AAA+ family (ClpB) in a different Cj1 contig (scf_30956_6_contig_1).  It is 
possible that ClpB complements the absence of TssH in the T6SS.  In Rhizobium 
leguminosarum tssH was absent from the T6SS (previously known as imp) cluster.  In this 
case, it was suggested that the T6SS utilised a protein from clpV gene found in other part of 
the genome (Filloux et al., 2008).     
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Although TssH is absent in both reported strains it has been demonstrated that the T6SS in 
them were functional (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012).  
Functionalities of the systems were marked by the secretion of TssD into the culture 
supernatants (Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012; Pukatzki et al., 2007).   
 
A hallmark indicator for a functional T6SS in bacteria is the presence of TssD in culture 
media (Pukatzki et al., 2007).  TssD was detected in the culture supernatant of Cj1 cells 
grown in MHB for approximately 24 hr at 37°C under microaerophilic conditions.  
Successful detection of TssD in the culture supernatant suggested that T6SS in Cj1 is 
functional.  This finding coincided with the two other C. jejuni strains ATCC 43431 and 108 
(Bleumink-Pluym et al., 2013; Lertpiriyapong et al., 2012).   
 
It had been reported that secretion of TssD in C. jejuni strain 108 was evident under most 
growth conditions (Bleumink-Pluym et al., 2013).  This differs from other bacterial species 
where secretion of TssD was dependent on environmental cues (Bernard et al., 2010).  In this 
study TssD was detected in culture supernatant when Cj1 was grown for 24 hr at 37°C in 
broth media.  Previous work by a visiting researcher had shown that tssD and tssI were 
expressed when Cj1 was grown in broth at 37°C but not when the cells were grown at 42°C.  
This information suggested that expression of T6SS in Cj1 might be temperature dependent.  
All subsequent assays conducted on Cj1 were performed using broth cultures grown at 37°C.   
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Currently, there are two main strategies for making mutants in Campylobacter: insertion or 
insertion-deletion approach.  The insertion approach disrupts the reading frame of the target 
gene by inserting an antibiotic resistance cassette (Coward et al., 2006; Labigne-Roussel et al., 
1988).  As for insertion-deletion approach, either all or most of the target gene is deleted and 
replaced by an antibiotic cassette (Coward et al., 2006; Hansen et al., 2007; Weerakoon and 
Olson, 2008).  To date, two antibiotic resistance cassettes are commonly used in 
Campylobacter cloning work.  They are the kanamycin resistance cassette and the 
chloramphenicol resistance cassette.  The kanamycin resistance cassette was derived from C. 
coli plasmid pIP1433 (Labigne-Roussel et al., 1987), while the chloramphenicol cassette was 
from C. coli plasmid pNR9589 (Wang and Taylor, 1990).  The availability of two different 
cassettes provides the flexibility of mutating two different genes within the same strain (Yao 
et al., 1993).    
 
In this study, two components of T6SS, tssD and tssM were selected for disruption.  The tssD 
gene was suggested to be involved in the formation of the needle-like structure of the 
secretion system (Zhou et al., 2012).  It had also been suggested to play a role modulating 
host cell cytokine production or cytoskeleton rearrangement (Zhou et al., 2012).  tssM 
consisting of trans-membrane domains (Filloux et al., 2008) was thought to play a role in 
anchoring the T6SS assembly to the cell membrane (Coulthurst, 2013; Lertpiriyapong et al., 
2012).  The deletion of the two selected genes might result in disruption of T6SS 
functionality in Cj1 and thus the mutants could be used to better understand the role played 
by T6SS in this strain. 
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The strategy used for constructing the tssD and tssM mutants is the insertion-deletion 
approach.  In these mutants 50 bps of the target gene at 5' end and 3' end was retained, while 
the intervening region was deleted and replaced by a kanR_cas.  The retention of the 50 bps of 
the target gene at each end should ensure that expression of neighbouring genes is not 
affected by the mutation.   
 
Transcriptional orientation of kanR_cas was also checked.  It was reported that when the 
inserted antibiotic cassette was in a different orientation from the target gene it might result in 
a polar effect (van Vliet et al., 1998).  Both the Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas mutants used in subsequent work have the cassette inserted in the 
same orientation as its target gene.   
 
In most published reports, functionality of T6SS was tested by Western blotting to determine 
the presence of TssD in culture supernatant.  However, due to the lack of antibodies against 
Cj1 TssD functionality of T6SS in Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas 
mutants were determined using mass spectrometry.  Both culture supernatant and cell pellet 
lysate (partial, 15-35 kDa) from the two mutants were tested.  TssD was only detected in the 
cell lysate of Cj1∆tssM(syn)::kanR_cas.  The results showed that the disruption of tssD in 
Cj1∆tssD(syn)::kanR_cas had resulted in no production of TssD.  The production of TssD in 
Cj1∆tssM(syn)::kanR_cas was not affected by the disruption of tssM.  However, the protein 
could not be secreted into the culture supernatant.  This indicates that the disruption of tssM 
had affected the secretion ability of the T6SS.  This finding supports the suggestion that 
TssM anchors the apparatus of T6SS onto the membrane in order to facilitate secretion 
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(Coulthurst, 2013; Lertpiriyapong et al., 2012).  It has also been reported that mutation of 
tssM prevented secretion of TssD in other bacterial species (Pukatzki et al., 2006; Wu et al., 
2008; Zheng and Leung, 2007).     
  
Transcriptomics analysis of the tssM mutant, Cj1∆tssM(syn)::kanR_cas shown that genes 
upstream and downstream of tssM, in both transcriptional orientations, were not affected by 
the insertion-deletion mutation.  Hence, any phenotypic differences observed between Cj1 
wild-type and Cj1∆tssM(syn)::kanR_cas are unlikely to be due to polar effects.  The Cj1 wild-
type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas mutants were tested in various 
infection assays and results obtained are presented in Chapter 6. 
 
Two T6SS mutants were made in this study, however, no complemented strains were made.  
It is important to construct complemented strains for each mutant made.  The mutant could be 
complemented by insertion of a copy of the wild-type gene into the mutant.  When the 
complemented strain exhibits phenotypes similar to wild-type strain it confirms that the 
different phenotypes observed in mutant strains were a direct effect of the disrupted gene and 
not due to other factors, such as polar effects.    
 
Several shuttle vectors had been made to incorporate either one of the antibiotic resistance 
cassettes into Campylobacter (Labigne-Roussel et al., 1987; Yao et al., 1993).  These shuttle 
plasmids could also be used for gene delivery, such as reporter genes (e.g. antibiotic 
resistance or fluorescence reporter genes) or wild-type genes in complementation analysis 
(Malik-Kale et al., 2007; Miller et al., 2000; Mixter et al., 2003; Yao et al., 1993).  For 
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complementation, the wild type gene together with its native promoter was amplified by PCR 
and inserted into a shuttle vector; downstream of an antibiotic resistance cassette (Fields and 
Thompson, 2008; Malik-Kale et al., 2007).   
 
It has been reported that several shuttle vectors could not be introduced into various C. jejuni 
strains which includes the typed strain Cj11168 (Karlyshev and Wren, 2005).  Besides using 
shuttle vectors, genes delivery into Campylobacter could also be done via an insertional 
system (Karlyshev and Wren, 2005; Kim et al., 2008).  When it is used to complement a 
mutant, the wild-type gene, together with its native promoter, is cloned into a suicide vector.  
The suicide vector consists of a chromosomal sequence that will be directed towards either 
rRNA genes (Karlyshev and Wren, 2005) or a pseudogene, cj0046 (Kim et al., 2008).  The 
complement suicide vectors carry an antibiotic resistance cassette that is different from the 
one used in the making of the mutant (Yao et al., 1993).  The wild-type target gene would 
then be incorporated into the bacterial chromosome at the directed sites: rRNA genes or 
cj0046.  An insertional system has also been used to deliver the fluorescence reporter gene, 
gfp, into C. jejuni rRNA genes (Karlyshev and Wren, 2005).    
 
The tssD and tssM mutants made in this study used a kanamycin resistance cassette as the 
marker.  In order to complement the two mutants, either the shuttle vector or the insertional 
system approach could be applied.  For both approaches chloramphenicol resistance cassette 
would be the alternative marker used.  However, for the shuttle vector approach, it is 
dependent on shuttle vectors being introduced into Cj1.  In terms of the insertional system, 
the genome analysis of Cj1 showed that it has the pseudogene cj0046, hence 
complementation into this pseudogene, would be possible. 
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Chapter 6:  Role of T6SS in C. jejuni strain Cj1  
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6.1 Introduction 
 
6.1.1 Role of T6SS 
 
There have been numerous reports on the different roles played by T6SS in various bacteria, 
which mainly classify it into two main categories.  One was a mechanism targeting a 
eukaryotic host, while the other involved a mechanism against other prokaryotic cells.  An 
anti-eukaryotic role has been reported in various bacteria, for example, V. cholerae and 
Pseudomonas aeruginosa (Pukatzki et al., 2006; Purcell and Shuman, 1998; Sana et al., 2012; 
Schwarz et al., 2010).  An anti-prokaryotic role has been demonstrated in Burkholderia 
thailandensis, P. aeruginosa and V. cholerae (MacIntyre et al., 2010; Sana et al., 2012; 
Schwarz et al., 2010).  The role of the T6SS in both scenarios is to ensure bacterial survival 
in the host or in the environment.  The T6SS in V. anguillarum has also been demonstrated to 
be involved in modulating general stress response regulators (Weber et al., 2009).  
 
The T6SS in C. jejuni was previously reported to be involved in bacterial survival in 
deoxycholic acid and the adhesion and invasion of epithelial and macrophage cells 
(Lertpiriyapong et al., 2012).  It has also been shown to have cytotoxic effects towards red 
blood cells, in a contact dependent manner and in the absence of capsule (Bleumink-Pluym et 
al., 2013). 
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6.1.2 Aim of study 
 
The aim of this study was to determine involvement of T6SS in in vitro cell growth and 
eukaryotic host infection.  
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6.2 Results 
 
6.2.1 Growth rate of C. jejuni strain Cj1 wild-type and its T6SS mutants 
 
Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas were cultured in broth 
at 37 °C under microaerophilic conditions.  The starter cultures were prepared to OD590 of 
approximately 0.1.  The OD590 of the cultures were monitored over 120 hours.  Figure 6.1 
shows mean OD590 readings of wild-type and T6SS mutants strains from four independent 
experiments and the standard error of the mean (SEM).   
 
Growth of both T6SS mutants was slower as compared to wild-type.  The cell density 
obtained by Cj1∆tssD(syn)::kanR_cas by stationary phase was significantly lower than wild-
type.  However, mean cell optical density of Cj1∆tssM(syn)::kanR_cas after 48 hr, although 
lower than wild-type, was not significantly different.    
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Figure 6.1: Growth curve of C. jejuni strain Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas.  Cell were inoculated into 50 ml of broth to OD590 of 
approximately 0.1.  The cultures were incubated at 37 °C under microaerophilic conditions for up to 120 hr.  OD590 of the three strains were plotted against time.  
Each strain was plotted based on mean values.  Error bars represent SEM.  Mean values and SEM were calculated from four individual experiments.  Growth curve of 
Cj1 wild-type is shown by pink line with diamond markers.  Growth curve of Cj1∆tssD(syn)::kanR_cas is shown by green line with triangle markers.  Growth curve of 
Cj1∆tssM(syn)::kanR_cas is shown by lavender line with square markers.   
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6.2.2 The adhesion and invasion of macrophages by C. jejuni strain Cj1 wild-type and 
T6SS mutants  
 
Mouse macrophage-like cells RAW264.7 were infected with Cj1 wild-type 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas at MOI of approximately 10.  The 
data was analysed in GraphPad Prism version 6.  A two-way ANOVA using Fisher's LSD 
test was performed at a 90% confidence interval for comparison of Cj1 wild-type with 
Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas respectively.  Figure 6.2 shows the 
percentage of bacterial cells that adhered to macrophage cells or that invaded macrophage 
cells.  The data presented were mean values from 3 individual experiments and SEM.   
 
The percentage of bacterial cells adhering to and/or invading macrophage cells was very low 
- less than 1 % for wild-type and T6SS mutants.  The percentage of wild-type cells adhering 
to macrophage cells was 0.70%, and 0.38% had invaded them.  In comparison, 
Cj1∆tssD(syn)::kanR_cas achieved 0.93% adherence and 0.48% invasion of macrophage cells, 
while Cj1∆tssM(syn)::kanR_cas obtained 0.94% adherence and 0.54% invasion.  The mean 
percentage of Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas that adhered to 
macrophage cells was significantly higher than that of Cj1 wild-type (P-value = 0.0088 and 
0.0071, respectively).  Mean percentage of Cj1∆tssM(syn)::kanR_cas that had invaded 
macrophage cells was also significantly higher compared to Cj1 wild-type with P-value = 
0.0684.      
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Figure 6.2: Percentage of C. jejuni strain Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas adhered to or invaded mouse macrophage cells RAW264.7.  Cj1 
wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas used were cultured in MHB at 37 °C for 24 hr.  The MOI for the assay was approximately 10.  
Percentage of bacterial cells adhered to macrophages were enumerated at 4 hpi.  Percentage of bacterial cells that had invaded macrophages were enumerated after 
additional 2 hr of gentamicin treatment, at 6 hpi.  The graph was plotted with mean and SEM values from three independent experiments, each with 3 replicates.  
Error bars represent SEM.  Mean percentage of Cj1 wild-type: i) adhered to macrophage cells was 0.70 % (SEM = 0.047) and ii) invaded macrophage cells was 0.38 % 
(SEM = 0.027).  Mean percentage of Cj1∆tssD(syn)::kanR_cas: i) adhered to macrophage cells was 0.93 % (SEM = 0.090) and ii) invaded macrophage cells was 0.48 % 
(SEM = 0.028).  Mean percentage of Cj1∆tssM(syn)::kanR_cas: i) adhered to macrophage cells was 0.94 % (SEM = 0.090) and ii) invaded macrophage cells was 0.54 
% (SEM = 0.051).   
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6.2.3  Infection of 28 hpf ZFE with Cj1 wild-type and T6SS mutants 
 
ZFE were challenged with Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas at embryo stages between 28 to 32 hpf.  The challenge doses were 
between 1500 to 7000 cfu per embryo.  In each experiment the number of ZFE challenged by 
each strain was 20.  The data was analysed in GraphPad Prism version 6.  One-way ANOVA 
using Fisher's LSD test was performed with a 90% confidence interval for comparison of Cj1 
wild-type with Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas respectively.  Figure 
6.3 shows the survival chart of infected embryos at 24 hpi.  The data presented were mean 
values from 6 individual experiments and SEM.   
 
Results obtained showed that 39% of ZFE infected with Cj1 wild-type survived at 24 hpi, 
with SEM value of 3.005.  The survival percentage of Cj1∆tssD(syn)::kanR_cas was very 
similar to Cj1 wild-type at 38 % with SEM value of 6.280.  ZFE infected with 
Cj1∆tssM(syn)::kanR_cas had the highest survival percentage of 54 % with SEM value of 
6.760.  The analysis showed that there was no significant differences between Cj1 wild-type 
and Cj1∆tssD(syn)::kanR_cas.  However, there was a significant difference between the 
survival percentage of Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas (P-value = 0.0952). 
248 
 
 
 
 
 
 
 
 
 
 
 
         
Figure 6.3: Survival chart of ZFE infected with C. jejuni strain Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas at 24 hpi.  ZFE at stages between 28-32 hpf 
were used.  Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas used were cultured in MHB at 37 °C for 24 hr.  The bacterial cells were delivered 
into embryo's yolk-sac through micro-injection.  The infection dose ranged between 1500 - 7000 cfu per embryo.  The graph was plotted with mean values from six 
independent experiments.  Error represents SEM.  Mean survival rate Cj1 wild-type set was 39 % (SEM = 3.005).  Mean survival rate Cj1∆tssD(syn)::kanR_cas set was 
38 % (SEM = 6.280).  Mean survival rate Cj1∆tssM(syn)::kanR_cas set was 54 % (SEM = 6.760).   
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6.2.4 Infection of newborn piglets with Cj1 wild-type and T6SS mutants 
 
This study was performed at the Institute of Infection, Immunity and Inflammation at 
University of Glasgow using C. jejuni Cj1 wild-type, Cj1∆tssD(syn)::kanR_cas and 
Cj1∆tssM(syn)::kanR_cas.  Competitive index challenge was performed on two groups of 
animals - each consisting of 9 piglets.  In each group, the piglets were inoculated with equal 
amount of wild-type and a mutant.  Faecal samples were collected daily up to Day 5 post-
infection.  Faecal samples were quantified for wild-type and respective T6SS mutant by 
culturing.  No bacterial cells were recovered by culture from faecal samples collected from 
Day 1 to 4.  Bacterial counts recovered from Day 5 faecal samples are presented in Figure 6.4. 
 
On Day 5 in Group A, Cj1∆tssM(syn)::kanR_cas faecal count was at Log10(5.46), which was 
lower than the inoculated dose of Log10(8.4).  It was also lower compared to the Cj1 wild-
type count of Log10(10.13).  In fact, Cj1 wild-type count had increased slightly on Day 5 
from Log10(8.8) to Log10(10.13).  In Group B, bacterial counts recovered from both Cj1 wild-
type and Cj1∆tssD(syn)::kanR_cas were comparable at Log10(10.371) and Log10(10.246) 
respectively.  The counts for both were higher than the inoculated dose as 
Cj1∆tssD(syn)::kanR_cas was inoculated at Log10(8.5).       
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Figure 6.4: Competitive index challenge performed on 2 groups of newborn piglets, 9 animals in each group.  Group A was challenged with approximately equal amount of C. 
jejuni strain Cj1 wild-type and Cj1∆tssM(syn)::kanR_cas.  Group B was challenged with approximately equal amount of Cj1 wild-type and Cj1∆tssD(syn)::kanR_cas.  
Inoculation dose for Cj1 wild-type was Log10(8.8), Cj1∆tssM(syn)::kanR_cas was Log10(8.4) and Cj1∆tssD(syn)::kanR_cas was Log10(8.5).  In Group A, count on Day 5 
post-infection for Cj1 wild-type was Log10(10.13) and for Cj1∆tssM(syn)::kanR_cas was Log10(5.46).   In Group B, count on Day 5 post-infection for Cj1 wild-type was 
Log10(10.371) and for Cj1∆tssD(syn)::kanR_cas was Log10(10.246).  Error bars represent standard deviation. 
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6.2.5 Detection of capsule in Cj1 wild-type under two growth conditions  
 
It has been reported that the presence of capsule could hinder T6SS machinery in C. jejuni 
(Bleumink-Pluym et al., 2013).  It was unclear if capsule was produced in Cj1 strains under 
the growth conditions used.  Cj1 wild-type was cultured under two different growth 
conditions; i) 37 °C in MHB for 24 hr; ii) 37 °C on CBA+ for 48 hr.  Cells were then 
harvested for capsule detection.  Culturing in MHB was the growth condition used in most 
studies, such as growth curve, ZFE infection and macrophage cells adhesion and invasion.  
Cells grown on CBA+ was used for piglets challenge.   
 
Capsule was detected in Cj1 wild-type cultured under both growth conditions.  Thickness of 
capsule varied from cell to cell but cells cultured in broth seemed to have a thicker layer of 
capsule as compared to agar grown cells. 
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Figure 6.5: Electron micrograph of C. jejuni cell stained with Alcian Blue for capsule detection.  Positive control for Alcain Blue staining: C. jejuni strain NCTC11168H wild-type.  
Negative control for Alcain Blue staining: C. jejuni strain NCTC11168H∆cj1413 (acapsular mutant).  Capsule stained by Alcain Blue were the black deposits around the 
cell (white arrow), which was not present in acapsular mutant (NCTC11168H∆cj1413).  Capsule was detected in both NCTC11168 and Cj1 wild-type cultured in broth 
and on agar.  Cells grown in broth had thicker capsule as compared to those grown on agar.    
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6.3 Discussion 
 
It has been previously reported that T6SS promotes host cell adhesion and invasion in V. 
parahaemolyticus and avian pathogenic E. coli (APEC) (de Pace et al., 2011; de Pace et al., 
2010; Yu et al., 2012).  Similar observations have been made in a recent study conducted 
with the C. jejuni strain ATCC 43431 (Lertpiriyapong et al., 2012).  
 
In this study Cj1 wild-type cells were used to infect macrophages.  The percentages of Cj1 
wild-type adhering to or invading mouse macrophage-like cells RAW264.7 were lower than 
reported in C. jejuni strain ATCC 43431 wild-type (Lertpiriyapong et al., 2012).  This result 
could be due to inherent differences in adhesion and invasion ability between the two strains.  
It has been suggested that the presence of capsule would affect the functionality of the T6SS 
(Bleumink-Pluym et al., 2013).  Hence, the presence of capsule on Cj1 wild-type was 
investigated.  Capsule was detected in Cj1 wild-type (Figure 6.5) when it was cultured in 
broth.  The growth conditions tested for capsule presence here are the same as conditions 
used to culture the Cj1 wild-type cells prior to using it for the macrophage assays.  Thus, a 
lower amount of adhered Cj1 wild-type could be due to the presence of capsule.  The 
presence of capsule and its effect on C. jejuni strain ATCC 43431 was not investigated. 
Therefore, no direct comparison could be made.     
 
With the current cloning techniques and tools available it is possible to first make an 
acapsular mutant in Cj1 and then to construct a double mutant targeting the T6SS in the Cj1 
acapsular mutant.  For example, a kanamycin resistance marker could be used for 
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construction of the first mutant and a chloramphenicol resistance marker could be used in the 
construction of the second mutation within the same strain (Yao et al., 1993).  The 
availability of T6SS mutants in an acapsular background would facilitate the study of T6SS 
functionality without its interference from the bacterial capsule. 
 
It has been previously reported that in both V. parahaemolyticus and APEC the disruption of 
tssD and tssM led to a reduction in adhesion and invasion of epithelial cells, HeLa and CaCo2 
cells (de Pace et al., 2011; de Pace et al., 2010; Yu et al., 2012).  For APEC, disruption of 
tssD did not affect its intra-macrophage survival, but when tssM was disrupted intra-
macrophage survival had decreased (de Pace et al., 2011; de Pace et al., 2010).   
 
The number of bacterial cells adhering to and/or invading macrophage cells was significantly 
higher for both Cj1∆tssD(syn)::kanR_cas and Cj1∆tssM(syn)::kanR_cas when compared to 
Cj1 wild-type.  These findings contradicted results previously reported for C. jejuni strain 
ATCC 43431.  It has been reported that disruption of tssD or tssM in C. jejuni strain ATCC 
43431 resulted in a reduction of host cell adhesion and invasion (Lertpiriyapong et al., 2012).   
 
In another report, an insertional mutation of icmF (equivalent to tssM) of V. cholerae had 
resulted in enhanced adhesion to intestinal epithelial cells (Das et al., 2002).  Disruption of 
tssM could prevent assembly of T6SS machinery on the cell membrane and cause changes in 
the bacterial surface structures (Das et al., 2002).  A similar change might rendered 
Cj1∆tssM(syn)::kanR_cas to adhere and possibly invade macrophages more efficiently.                         
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Differences observed between T6SS mutants constructed from the two strains could be due to 
inherent strain differences or presence of capsule.  It could also be that the role played by 
T6SS in both strains differs.   
 
C. jejuni strain Cj1 wild-type and its T6SS mutants were put through two different animal 
models: zebrafish embryo model, and piglet model.  In both models Cj1∆tssM(syn)::kanR_cas 
was shown to be attenuated, but not Cj1∆tssD(syn)::kanR_cas.  Attenuation observed in 
Cj1∆tssM(syn)::kanR_cas indicates that T6SS in Cj1 might have a role to play in establishing 
infection in both animal models.  The T6SS mutants were also put through the G. mellonella 
model, however the results obtained were not presented here.  This is because when 2 batches 
of larvae were infected with a lethal dose of the reference strain, C. jejuni NCTC11168H, 80-
100% of the larvae survived after 24 hours post-infection.  This is in contrast to previously 
reported rate of no survival by 24 hours post-infection (Champion et al., 2010).  Since the G. 
mellonella model was not performing as it should when infected with the reference strain, the 
results obtained for larvae infected with Cj1 wild-type and its T6SS mutants were 
inconclusive., thus were not included for comparison with the ZFE and piglet models.         
 
It has also been suggested that reduced virulence of a T6SS mutant observed in a higher 
eukaryotic host might not be directly linked to anti-eukaryotic activity (Coulthurst, 2013).  It 
could be because the mutant was less able to compete with endogenous micro-flora or its 
wild-type strain in competitive studies (Coulthurst, 2013).  The attenuation of 
Cj1∆tssM(syn)::kanR_cas observed in the piglet model could not be due to its inability to 
compete against endogenous micro-flora as the newborn piglets do not have gut flora.  The 
attenuation observed was also unlikely to be a result of competition against wild-type cells.  
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This was because, Cj1∆tssD(syn)::kanR_cas, being the slowest in terms of growth rate among 
the three strains, was recovered in the same amount as Cj1 wild-type cells in the piglet 
competitive index study.  On the same note, the cell densities achieved by 
Cj1∆tssM(syn)::kanR_cas by stationary phase were not significantly different from that of Cj1 
wild-type.   
 
In the ZFE model, Cj1∆tssM(syn)::kanR_cas was not challenged together with Cj1 wild-type 
cells, hence, the attenuation observed was unlikely to be due to its inability to compete 
against Cj1 wild-type strain.  With regards to competition against endogenous flora the 
existence of micro-flora in ZFE at 28-32 hpf would be minimal, hence once again, the 
attenuation observed was unlikely to be due to out-competition of Cj1∆tssM(syn)::kanR_cas 
by the micro-flora communities.   
 
TssD has previously been shown to form hexameric rings and assemble into nano-tubes 
(Ballister et al., 2008; Mougous et al., 2006).  This tube-like structure was suggested to be a 
conduit of the T6SS assembly on the bacterial cell surface (Filloux et al., 2008).  It might be 
involved in transportation of other T6SS effectors out into the environment or host cell 
(Filloux et al., 2008).  The loss of TssD in Cj1∆tssD(syn)::kanR_cas did not alter its virulence 
in both animal models.  This suggests that either T6SS remain functional in 
Cj1∆tssD(syn)::kanR_cas, or TssD does not play a role in virulence.  The only difference 
observed between Cj1∆tssD(syn)::kanR_cas and wild-type is in the enhanced ability of the 
former to adhere to macrophage cells.   
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It has been reported that TssB and TssC formed a complex of contractile sheath-like structure 
and was involved in secretions of effectors from the bacterial cell (Coulthurst, 2013).  It has 
been suggested that the TssB/TssC complex was involved in guiding T6SS effector proteins 
to secretion channels (Bröms et al., 2013).  The complex was also reported to be essential for 
secretion of TssD (Lin et al., 2013). This process was achieved when the complex wrapped 
around tube-like structure formed by TssD and contracted to push the latter across the 
bacterial membrane (Lin et al., 2013).  Thus, in the absence of TssD, it was uncertain if the 
TssB/TssC complex continued to push proteins across the bacterial membrane to maintain 
T6SS functionality.  The identity of other T6SS components involved in retaining the 
bacterial virulence in Cj1∆tssD(syn)::kanR_cas, also remained uncertain.   
 
The observed attenuation of Cj1∆tssM(syn)::kanR_cas was supported by similar observations 
made in IL-10-deficient mice infected with tssM mutant of C. jejuni strain ATCC 43431 
(Lertpiriyapong et al., 2012).  At 30 days post-infection, C. jejuni strain ATCC 43431 tssM 
mutants were detected in a lesser number of mice (Lertpiriyapong et al., 2012).  The amount 
of bacterial cells detected in both cecum and faeces samples were also lower as compared to 
wild-type (Lertpiriyapong et al., 2012).   
 
TssM has been reported to be located in the inner membrane and consists of both cytosolic 
and periplasmic domains (Bönemann et al., 2009).  A Walker A motif conferring ATPase 
function was identified in the cytosolic domain of TssM (Bönemann et al., 2009).  It has been 
reported that TssM was the energising components for TssD secretion (Ma et al., 2012).  Cj1 
T6SS lacked the commonly known energising component TssH - knocking out tssM in Cj1 
might partially or entirely disable the secretion system.  Beside its potential role as energy 
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provider, TssM might also be a key component in assembling and anchoring the T6SS 
apparatus to the cell membrane (Coulthurst, 2013; Lertpiriyapong et al., 2012).  In its absence, 
the secretion system might not be able to assemble or anchor to the cell membrane which 
may render the system partially or entirely non-functional.  Again, with the potential for 
disrupting the assembly of the system, surface structures of the bacterial might be altered as 
well (Das et al., 2002).  This could have affected the interaction of bacteria with host immune 
cells, as shown in the macrophage adhesion and invasion assays performed.   
 
It is important to note that the studies conducted here were with T6SS mutant strains.  There 
were no complemented strains constructed and tested.  In order to confirm the observations 
made, especially in the attenuation of Cj1∆tssM(syn)::kanR_cas,  it is important to 
complement the mutants.  This serves to check if the observed phenotype could be restored to 
wild-type with complementation.  The various approaches for complementation were 
discussed in Chapter 5.      
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Concluding remarks 
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In this project, the interactions between C. jejuni and host cells were studied.   
 
Initially, I explored the use of Raman spectroscopy to determine the molecular make-up of 
bacteria cells with a view towards using this information to interrogate host-pathogen 
interactions.  The exploratory work was carried out using an established model of mouse 
macrophage-like cells infected with S. Typhimurium.  SRS images of S. Typhimurium within 
macrophage cells were obtained using selected wavenumbers.  There are several reports on 
bacteria detection, imaging and sorting in complex matrixes, for example in biofilms (Beier 
et al., 2012; Li et al., 2012), and the imaging of eukaryotic cells (Downes and Elfick, 2010), 
using the Raman spectroscopy technique.  In a study conducted by Neugebauer et al., they 
stated good signal-to-noise Raman images were recorded from formaldehyde fixed 
endothelial cell infected with S. aureus and statistical analysis of the Raman maps acquired 
were able to resolved host's nucleus and individual bacteria cells (Neugebauer et al., 2012).  
However, no Raman images on the infected endothelial cells were presented in the 
publication.  The SRS images from live bacteria within macrophages presented here are the 
first of its kind.  Unfortunately, in subsequent imaging attempts, the quality of the images at 
the lower frequencies were poor and no features could be identified.  This was mainly due to 
the instability of the laser system used.  The study with Raman based imaging was not 
extended to C. jejuni after the exploratory work on S. Typhimurium.  Nonetheless, this 
exploratory work had shown a potential for this technique to be used for future work on 
interrogation of host-pathogen interactions.  Besides using the Raman spectroscopy technique 
for label-free real-time imaging, potentially, Raman spectra could be obtained from a single 
bacteria cell residing within a eukaryotic host cell over time.  Data processed from the spectra 
collected will then provide information on molecular changes taking place inside the bacteria.  
The labelling of bacteria cells with deuterium oxide in this study was used for imaging, 
261 
 
however, this labelling technique could also be applied for monitoring cell metabolism.  
Neugebauer et al. also reported the use of digital holographic microscopy to perform live cell 
imaging of S. aureus within endothelial cells.  It is a phase contrast technique and was able to 
capture images of the infected endothelial cell at high spatial resolution in a label-free, non-
destructive and non-contact manner (Neugebauer et al., 2012).  This could be another 
technique to explore for real-time imaging of Campylobacter. 
 
In order to better understand the interaction of C. jejuni with its host, a new animal model of 
infection which would allowed real-time imaging was developed.  C. jejuni was able to 
establish an infection in ZFE and the death of challenged embryo was shown to be dose-
dependent.  The ZFE model was used to screen several mutants and strains.  The different C. 
jejuni mutants used to challenge ZFE had showed differences in their virulence in this model 
and together with its low cost of maintenance and ease of handling, the ZFE is a suitable 
infection model for C. jejuni strains and mutants screening.  Optical transparency is the other 
key property of ZFE that allows the tracking of bacterial cells throughout the whole organism 
and monitoring of bacterial interactions with host immune cells.  A GFP labelled C. jejuni 
was constructed in this study to exploit the advantage provided by ZFE in real-time imaging.  
However, due to the low fluorescence level of GFP tagged in the constructed C. jejuni the 
migration of the bacteria within the host organism could not be tracked and the images 
obtained were not able to reveal interactions between the bacteria and ZFE immune cells - in 
this case mCherry tagged macrophages.  The ability to track the bacteria cells and its 
interaction with host immune cells especially with macrophages would help to address the 
debating issue on the fate of the bacteria after being taken up by macrophages - does it 
survive or not within macrophages (Hickey et al., 2005; Kiehlbauch et al., 1985; Watson and 
Galan, 2008)?  When a strongly fluorescing C. jejuni is available, and with the use of an 
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inverted fluorescent microscope that allows higher magnification and without damaging the 
ZFE - such as a Confocal or Two-photon microscopy - real-time imaging could be performed 
to track the migration of the bacteria from the site of infection as well as to capture bacterial 
interactions with immune cells.  This would then provide an insight into how C. jejuni 
interacts with a whole host organism; a new dimension to the study of Campylobacteriosis 
that is not possible in other animal models.  The weak fluorescence in the GPF constructed in 
this study could potentially be due to the promoter used resulting in weak transcriptions.  The 
transcription level could be checked by relative-quantification real-time PCR, for example, 
against a house-keeping gene.  If the cause of weak fluorescence was due to the promoter, 
then a stronger promoter could be used instead.  It would also be worth looking into 
integration of the gene encoding GFP - together with a strong promoter, into genome rRNA 
genes or a pseudogene, for example, cj0046.         
 
The T6SS was recently reported in several Proteobacteria including C. jejuni.  A clinical 
strain (Cj1) isolated from Thailand was sequenced in this project and a gene cluster 
consisting of 12 out of 13 T6SS core COGs was identified.  When a bacteria - harbouring the 
T6SS genes - was cultured under suitable conditions for the expression of the T6SS, it has 
been suggested that the detection of TssD in culture supernatant indicates a functional T6SS 
(Pukatzki et al., 2007).  In the culture supernatant of Cj1, TssD was detected thus suggested 
that the secretion mechanism of T6SS in Cj1 is functional.  Two T6SS mutants in Cj1 
targeting deletion of tssD or tssM respectively were constructed: Cj1∆tssD(syn)::kanR_cas 
and Cj1∆tssM(syn)::kanR_cas.  TssD was suggested to form the 'needle' structure of the 
secretion system and was wrapped around by TssB/TssC complex (Filloux et al., 2008; Lin et 
al., 2013).  It is not known if the secretion mechanism of the T6SS remains functional in its 
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absence.  The TssM component of the T6SS was suggested to be a key component in 
anchoring the apparatus into the cell membrane (Das et al., 2002).  In its absence other 
components could not be assembled or anchored, resulting in disruption of the secretion 
mechanism.  In this study TssD was detected in cell lysate, but not in culture supernatants of 
tssM deleted mutant of Cj1.  This finding demonstrated that the deletion of tssM had 
disrupted the secretion mechanism of T6SS in Cj1.   
 
Both the tssD and tssM deletion mutants showed significant increase in adherence to the 
macrophages, but only Cj1∆tssM(syn)::kanR_cas showed significant increase in invasion - 
indicating that the T6SS played a negative role in host cells adhesion and invasion.  When the 
T6SS mutants were used for challenge in ZFE and piglet models, only 
Cj1∆tssM(syn)::kanR_cas was attenuated.   
 
In the adhesion an invasion assays, the tssD deletion mutant showed an increased in adhesion 
but not invasion of the macrophages.  On the contrary, tssM deletion mutant showed 
increased adhesion and invasion.  When TssD was absent (in tssD deletion mutant) or not 
secreted (in tssM deletion mutant), adhesion to macrophages were increased.  This showed 
that TssD may play a part in preventing adherence the bacteria to macrophages.  In the tssM 
deletion mutant, where the T6SS was disrupted, an increase in invasion was observed.  In the 
tssD deletion mutant, where the T6SS could possibly remain functional, invasion was not 
significantly different from wild type.  This suggests that TssD is unlikely to participate in 
resisting invasion of macrophages and other components of the secretion system could be the 
one playing a part in resisting invasion.   
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The tssM deletion mutant showed enhanced engulfment by host macrophages and reduced 
virulence observed in both animal models, while for tssD deletion mutant, the bacteria was 
likely to resist uptake by macrophages and thus remained as virulent as wild-type as 
demonstrated in the two animal models.  Overall, the findings suggested that the role of T6SS 
in Cj1 could be in resisting uptake by macrophages for the bacteria survival in host organisms.  
The full mechanisms utilised by the bacteria in establishing an infection and whether it 
involves T6SS remains to be answered.    
 
The growth of rates both the tssD and tssM deletion mutants were slower when compared to 
wild type - tssD deletion mutant being the slowest in growth and had the lowest cell density 
at stationary stage.  The difference in growth rate is unlikely to be the contributing factor for 
the attenuated phenotype observed in tssM deletion mutant.  This is because although tssD 
deletion mutant is the slowest in growth, when challenged in piglets together with wild type 
cells the amount of tssD deletion mutant recovered from challenged piglet at Day 5 were 
higher than input dose and was also approximately the same amount as wild-type cells.     
 
A point of note is that the host cells or animal models challenge were not performed with 
complemented strains.  So, in order to be conclusive with regards to the phenotype observed 
in the two mutants, the assays need to be repeated using complemented strains.  The infection 
assays performed with the piglets were competitive index challenge.  The main advantage of 
such challenge is that two strains tested were subjected to the same host organism, however a 
major drawback is that there might be a competition in growth between the two strains used 
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and one might be stronger in growth and out competes the other.  If this happens, the 
outcomes recorded might not be a true indication of one strain being more virulent than the 
other.   
 
In this project, T6SS in Cj1 has been demonstrated to play a role against eukaryotic cells.  As 
it seems that there is only one T6SS in Campylobacter, it would be interesting to find out if 
the T6SS has an anti-prokaryotic role as well.  Currently, the T6SS has shown to be 
expressing under the growth condition tested.  It would also be interesting to look into 
environmental factors regulating its expression, for example, temperature, pH and nutrient 
level.       
 
Overall, this project has revealed the potential of using Raman based techniques to perform 
live-imaging of bacteria cells within infected macrophage cells.  A new animal model, ZFE, 
was developed for Campylobacteriosis study that can used for screening of strains and 
mutants.  The potential of using ZFE in fluorescence based live-imaging was also 
demonstrated.  The investigations into the role of the recently identified T6SS in C. jejuni 
shows its involvement in adhesion and invasion of macrophage cells and its virulence in both 
ZFE and piglet models.   
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